bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

Cold-adapted live attenuated SARS-CoV-2 vaccine completely protects

2

human ACE2 transgenic mice from SARS-CoV-2 infection

3

Sang Heui Seo 1,2, * & Yunyueng Jang 1,2
1

4

Laboratory of Influenza Research, College of Veterinary Medicine,
2

5

Institute of Influenza Virus,

6

Chungnam National University, Daejeon 34134,

7

Republic of Korea.

8
9

Short title: Cold-adapted live attenuated SARS-CoV-2 vaccine

10

*

11

Professor Sang Heui Seo, DVM, PhD

12

Laboratory of Influenza Research

13

College of Veterinary Medicine

14

Institute of Influenza Virus

15

Chungnam National University, 99 Dae-Hak Ro, Yuseong Gu, Daejeon 34134, Korea.

16

Tel: +82 42 821 7819; Fax: +82 42 821 6762; E-mail: seos@cnu.ac.kr

Corresponding Author:

17
18
19
20
21
22
23
24
1

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has infected more than

2

16,000,000 people and has caused the death of more than 650,000 individuals since

3

December 2019. A safe and effective vaccine that can provide herd immunity against

4

SARS-CoV-2 is urgently needed to stop the spread of this virus among humans. Many

5

human viral vaccines are live attenuated forms of viruses that elicit humoral and

6

cellular immunity. Here, we describe the development of a cold-adapted live attenuated

7

vaccine (SARS-CoV-2/human/Korea/CNUHV03-CA22°C/2020) by gradually adapting

8

the growth of SARS-CoV-2 from 37°C to 22°C in Vero cells. This vaccine can be

9

potentially administered to humans through nasal spray. Its single dose was observed to

10

strongly induce the neutralising antibody (>640), cellular immunity, and mucosal IgA

11

antibody in intranasally immunised K18-hACE2 mice, which are very susceptible to

12

SARS-CoV-2 and SARS-CoV infection. The one-dose vaccinated mice were completely

13

protected from SARS-CoV-2 infection and did not show loss of body weight, death, and

14

the presence of virus in tissues, such as the nasal turbinates, brain, lungs, and kidneys.

15

Taken together, the cold-adapted live attenuated SARS-CoV-2 vaccine developed by us

16

may contribute to saving of human lives from the threat of SARS-CoV-2.

17
18
19
20
21
22
23
24
25
2

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

In December 2019, human cases of mysterious severe pneumonia were reported from

2

the city of Wuhan in eastern China (1,2). The initial symptoms were found to be similar to

3

those of patients infected with Severe Acute Respiratory Syndrome (SARS) virus.

4

Sequencing of the causative agent showed that its genome was similar to that of SARS,

5

leading to its designation as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-

6

CoV-2) (1,2). The World Health Organization (WHO) declared coronavirus disease 2019

7

(COVID-19), the disease caused by SARS-CoV-2, as a pandemic on the 11 March 2020.

8

SARS-CoV-2 belongs to the family of coronaviruses, which are enveloped, positive-

9

sense single-stranded RNA viruses (3). The genome size of SARS-CoV-2 is about 30 kb.

10

SARS-CoV-2 consists of four structural proteins, namely nucleocapsid (N), membrane (M),

11

envelope (E), and spike (S) proteins, which form the structural backbone of the virus; sixteen

12

non-structural proteins (nsp1–nsp16); and several accessory proteins (4). The S protein is

13

located on the surface of SARS-CoV-2 and binds to human angiotensin converting enzyme 2

14

(hACE2) receptor to initiate the infection (5,6).

15

Patients infected with SARS-CoV-2 commonly show fever, cough, myalgia, and

16

fatigue, and some patients might also develop acute respiratory distress syndrome (ARDS)

17

(7). Among the 99 patients infected with SARS-CoV-2 in Wuhan, China, 74 showed bilateral

18

pneumonia, 14 showed multiple mottling and ground-grass opacity in the lungs, and one

19

patient had pneumothorax; 17 patients had ARSD, and 11 of these patients died of multiple

20

organ failure (8). In Washington, USA, ARDS was observed in 15 of 21 patients, and

21

mechanical ventilation was required for these patients (9). In addition to pneumonia and

22

ARDS, SARS-CoV-2 is responsible for clinical signs related to the affliction of the central

23

nervous system (CNS); these include loss of taste and smell, headaches, twitching, seizures,

24

vision impairment, nerve pain, dizziness, impaired consciousness, nausea, vomiting,
3

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

hemiplegia, ataxia, stroke, and cerebral haemorrhage (10,11).

2

As of date, there is no effective licenced vaccine for SARS-CoV-2. Therefore, there

3

is an urgent need to develop a safe and effective SARS-CoV-2 vaccine to protect humans

4

from the COVID-19 pandemic. Various types of SARS-CoV-2 vaccines are under

5

development; these include DNA- and mRNA-based vaccines, encoding the S protein of

6

SARS-CoV-2 (12-14), adenovirus-, measles virus-, and vesicular stomatitis virus-based

7

vectors expressing the S gene (15-18), and purified inactivated vaccine (19). Most of the

8

licenced human viral vaccines, such as those against measles, mumps, rubella, rotavirus,

9

smallpox, chickenpox, yellow fever, and influenza virus (nasal inoculation), are live

10

attenuated forms of the respective virus (20-27). Cold-adapted live influenza vaccines for

11

seasonal influenza viruses are produced in primary chick kidney cells or embryonated eggs at

12

25oC and are administered intranasally to humans (26,27). Live attenuated vaccines are

13

similar to natural infectious agents; they elicit strong and long-lasting immune response, and

14

thereby, have good protective effects in humans.

15

In this study, we developed a cold-adapted live attenuated SARS-CoV-2 vaccine

16

strain by gradually adapting the growth of SARS-CoV-2 virus from 37oC to 22oC in Vero

17

cells. The attenuation of the SARS-CoV-2 vaccine strain (designated as SARS-CoV-

18

2/human/Korea/CNUHV03-CA22°C/2020) and its efficacy as a vaccine was confirmed in

19

hACE-2 transgenic mice (K18-hACE2 mice), which were found to be lethal to SARS-CoV

20

and SARS-CoV-2 (28-32).

21

To develop a live attenuated vaccine for SARS-CoV-2, amenable to intranasal

22

delivery, we gradually adapted SARS-CoV-2 isolated from a human patient (SARS-CoV-

23

2/human/Korea/CNUHV03/2020; referred to as CoV-2-CNUHV03 in this study) (GenBank

24

accession number: MT678839) (33) to a temperature from 37oC to 22oC in Vero cells
4

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

cultured in an atmosphere of 5% CO2 in a humidified incubator. When cells infected with

2

SARS-CoV-2 showed complete cytopathic effects (CPE) at the set temperature, they were

3

incubated at the next lower temperature. SARS-CoV-2 viruses that were successfully

4

passaged more than five times (>p = 5) at 22°C were used for the vaccine efficacy study.

5

SARS-CoV-2 adapted at 22oC was designated as SARS-CoV-2/human/Korea/CNUHV03-

6

CA22°C/2020 (herein referred to as CoV-2-CNUHV03-CA22°C).

7

Vero cells grown in 6-well plates were infected with wild-type SARS-CoV-2 (CoV-

8

2-CNUHV03) or cold-adapted vaccine SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) in a

9

humidified 5% CO2 incubator at 37°C and 41°C to determine the temperature sensitivity of

10

the vaccine strain (fig. S1). At 37oC and 0.00001 multiplicity of infections (m.o.i) (fig. S1A),

11

the viral titers of CoV-2-CNUHV03-CA22oC and CoV-2-CNUHV03 were 2.6 X 105 plaque

12

forming units (pfu)/ml and 7.9 X 105 pfu/ml, respectively. At 37oC and 0.000001 m.o.i (fig

13

S1A), those of CoV-2-CNUHV03-CA22oC and CoV-2-CNUHV03 were 0 pfu/ml and 7.9 X

14

104 pfu/ml, respectively. At 41oC and 0.00001 m.o.i (fig. S1B), the viral titers of CoV-2-

15

CNUHV03-CA22oC and CoV-2-CNUHV03 were 0 pfu/ml and 10 X 103 pfu/ml, respectively.

16

At 41oC and 0.000001 m.o.i. (fig. S1B), those of CoV-2-CNUHV03-CA22oC and CoV-2-

17

CNUHV03 were 0 pfu/ml and 8 X 103 pfu/ml, respectively.

18

To confirm the attenuation of CoV-2-CNUHV03-CA22°C in an animal, we

19

intranasally (i.n.) infected hACE-2 transgenic mice (K18-hACE2), which are very susceptible

20

to SARS-CoV-2, with CoV-2-CNUHV03-CA22°C (2 × 104 pfu) (Fig. 1). The infected mice

21

were monitored for mortality (Fig. 1A) and change in body weight (Fig. 1B) for 14 days. All

22

these mice survived and did not show any loss of body weight, whereas all the K18-hACE2

23

mice infected with CoV-2-CNUHV03 showed loss of body weight (5.8%) until 8 days post-

24

infection (p.i.) and eventually died.
5

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

We measured the virus titres in different tissues (nasal turbinates, brain, lungs,

2

kidneys, spleen) of infected mice by determining the log10 tissue culture infectious dose 50

3

(log10TCID50) values in Vero cells as well as by performing real-time quantitative polymerase

4

chain reaction (RT-qPCR) with SARS-CoV-2 N primers and probe on day 6 p.i. The virus

5

titres were lower in the tissues of K18-hACE2 mice infected with CoV-2-CNUHV03-

6

CA22°C than in the tissues of K18-hACE2 mice infected with CoV-2-CNUHV03 (Fig. 1C,

7

& fig. S2). When we measured the virus titres in terms of the log10TCID50 value, viruses were

8

detected only in the lungs of K18-hACE2 mice infected with CoV-2-CNUHV03-CA22°C

9

with a titre of 1.83 TCID50/0.1g; however, the virus was detected in the nasal turbinates (3.0

10

TCID50/0. g), brain (7.5 TCID50/0.1 g), lungs (3.5 TCID50/0.1 g), and kidneys (3.5

11

TCID50/0.1 g) of K18-hACE2 mice infected with CoV-2-CNUHV03 (Fig. 1C). Using RT-

12

qPCR, the virus was detected in the nasal turbinates (5.9 × 103 pfu/0.1 g) and lungs (11 × 103

13

pfu/0.1 g) of K18-hACE2 mice infected with CoV-2-CNUHV03-CA22°C, whereas it was

14

detected in the nasal turbinates (10 × 103 pfu/0.1g), brain (2.5 × 106 pfu/0.1g), lungs (14 × 103

15

pfu/0.1 g), and kidneys (1.3 × 103 pfu/0.1 g) of K18-hACE2 mice infected with CoV-2-

16

CNUHV03 (fig. S2A & S2B). On day 14 p.i., no virus was detected in the tissues of K18-

17

hACE2 mice infected with CoV-2-CNUHV03-CA22°C (Fig. 1C & fig. S2A & S2B).

18

We stained the lung tissue sections of K18-hACE2 mice with haematoxylin and

19

eosin (H&E) and brain, lungs, and kidneys with the SARS-CoV-2 NP antibody (Fig. 2, fig.

20

S3, & fig. S4). The lung tissue of K18-hACE2 mice infected with CoV-2-CNUHV03-

21

CA22°C (Fig. 2B) showed much milder pneumonia than that of K18-hACE2 mice infected

22

with CoV-2-CNUHV03 (Fig. 2C) on day 6 p.i. The antigen staining in the lung of K18-

23

hACE2 mice infected with CoV-2-CNUHV03-CA22°C (Fig. 2E) was much sparse than that

24

in mice infected with CoV-2-CNUHV03 (Fig. 2F) on day 6 p.i. No antigen staining was
6

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

observed in the brain (fig. S3B) and kidneys (fig. S3E) of K18-hACE2 mice infected with

2

CoV-2-CNUHV03-CA22°C on day 6 p.i., whereas profuse antigen staining was observed in

3

the brain (fig. S3C) and kidneys (fig. S3F) of K18-hACE2 mice infected with CoV-2-

4

CNUHV03 on day 6 p.i. No antigen staining was observed in the lungs (fig. S4A), brain (fig.

5

S4B), and kidney (fig. S4C) of K18-hACE2 mice infected with CoV-2-CNUHV03-CA22°C

6

on day 14 p.i.

7

K18-hACE2 mice were immunised by i.n. administration of 2 × 104 or 2 × 103 pfu of

8

CoV-2-CNUHV03-CA22°C, and sera were collected 19 days post vaccination (p.v.). The

9

titre of the neutralising antibody (NA) was measured using CoV-2-CNUHV03 and CoV-2-

10

KCDC03 in Vero cells. Strong NA titres, in the range of 640–4960, were induced in K18-

11

hACE2 mice immunised with 2 × 104 (Fig. 3A) or 2 × 103 (Fig. 3B) pfu of CoV-2-

12

CNUHV03-CA22°C. No NA was detected in the sera of K18-hACE2 mice, collected before

13

vaccination (fig. S5). We measured the levels of IgA antibody, which is responsible for

14

mucosal immunity, in the different tissues (nasal turbinates, lungs, and kidneys) using

15

purified inactivated SARS-CoV-2 antigen (CoV-2-CNUHV03) and goat horseradish

16

peroxidase (HRP)-labelled anti-mouse IgA antibody (fig. S6A) and T cells expressing IFN-γ

17

(fig. S6B). The detection of IgA indicates the induction of cellular immunity in splenocytes in

18

K18-hACE2 mice immunised with of CoV-2-CNUHV03-CA22°C (2 × 104 pfu). IgA was

19

detected in all the tissues that were assessed, with the highest amount detected in nasal

20

turbinates (OD: 0.298) (fig. S6A). The number of IFN-γ expressing T cells in the immunised

21

and PBS (mock)-immunised K18-hACE2 mice was 1682/250,000 and 249/250,000

22

splenocytes, respectively (fig. S6B).

23

K18-hACE2 mice were i.n. immunised with 2 × 104 or 2 × 103 pfu of CoV-2-

24

CNUHV03-CA22°C and i.n. challenged with 2 × 104 pfu of CoV-2-KCDC03 on 21 days p.v.
7

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

The challenged K18-hACE2 mice were monitored for mortality (Fig. 3C), and change in

2

body weight (Fig. 3D) for 12 days p.i.; the virus titres in different tissues (nasal turbinates,

3

lungs, brain, kidneys, and spleen) were measured 6 days post-challenge (p.c.) by determining

4

the log10TCID50 values (Fig. 3E) and by performing RT-qPCR (fig. S7A & S7B). All the

5

immunised and challenged K18-hACE2 mice survived (Fig. 3C) and did not show loss of

6

body weight (Fig. 3D), whereas all the PBS (mock)-immunised and challenged K18-hACE2

7

mice died (Fig. 3C) within 8 days p.c., and showed loss of body weight (4.6%) (Fig. 3D). No

8

virus titre was detected in the nasal turbinates, brain, lungs, kidneys, and spleen of immunised

9

K18-hACE2 mice determined in terms of the log10TCID50 value (Fig. 3E) as well as by RT-

10

qPCR (fig. S7A & S7B). Considerable virus titres were detected in the nasal turbinates

11

(2.8TCID50/0.1g, 12.0 × 103 pfu/0.1 g), brain (7.8TCID50/0.1 g, 2.7 × 106 pfu/0.1 g), lungs

12

(3.7TCID50/0.1 g, 15.0 × 103 pfu/0.1 g), and kidneys (3.5TCID50/0.1 g, 1.4 × 103 pfu/0.1g) in

13

PBS (mock)-immunised and challenged K18-hACE2 mice (Fig. 3E & fig. S7A & S7B). As

14

in the case of PBS (mock)-immunised and unchallenged K18-hACE2 mice (Fig. 4A), H&E

15

staining of lung tissue samples from challenged K18-hACE2 mice immunised with 2 × 103

16

pfu (Fig. 4B) and 2 × 104 pfu (Fig. 4C) of CoV-2-CNUHV03-CA22°C showed mild

17

pneumonia and no pneumonia, respectively. The lung tissue of PBS (mock)-immunised and

18

challenged K18-hACE2 mice exhibited severe interstitial pneumonia with infiltration of

19

inflammatory cells (Fig. 4D). As in the case of PBS (mock)-immunised and unchallenged

20

K18-hACE2 mice (Fig. 4E), no positive staining was detected with SARS-CoV-2 NP

21

antibody in the lung tissues of challenged K18-hACE2 mice immunised with 2 × 103 pfu (Fig.

22

4F) or 2 × 104 (Fig. 4G) pfu of CoV-2-CNUHV03-CA22°C. Numerous positively stained

23

regions were observed in the lung tissue of PBS (mock)-immunised and challenged K18-

24

hACE2 mice (Fig. 4H). No antigen staining was observed in the brain (fig. S8B) and kidneys
8

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

(fig. S8F) of challenged K18-hACE2 mice (immunised with 2 × 103 pfu) as well as in the

2

brain (fig. S8C) and kidneys (fig. S8G) of challenged K18-hACE2 mice (immunised with 2 ×

3

104 pfu) as was observed for the brain (fig. S8A) and kidneys (Extended Data Fig. 8e) of PBS

4

(mock)-immunised and unchallenged K18-hACE2 mice. Strong positive antigen staining was

5

found in the brain (fig. S8D) and kidneys (fig. S8H) of PBS (mock)-immunised and

6

challenged K18-hACE2 mice.

7

We fully sequenced the genes of CoV-2-CNUHV03-CA22°C and compared the

8

sequences with those of wild-type SARS-CoV-2 (CoV-2-CNUHV03) (Table 1, Table S1,

9

Table S2, fig. S9, fig. s10). Among the 29,874 nucleotides, 59 including 37 nonsynonymous

10

substitutions and 22 synonymous substitutions occurred in CoV-2-CNUHV03-CA22°C

11

compared to those of CoV-2-CNUHV03 (Table S1 & fig. S9). Among the 9,755 amino acid

12

residues, 31 were mutated in CoV-2-CNUHV03-CA22°C compared to that in CoV-2-

13

CNUHV03 (Table S2, fig. S10). To identify the possible unique mutations in CoV-2-

14

CNUHV03-CA22°C, we compared the changed amino acids in CoV-2-CNUHV03-CA22°C

15

with

16

(https://www.ncbi.nlm.nih.gov/nuccore) and GISAID (https://www.gisaid.org/), and found 12

17

such amino acids out of 9755 amino acids in CoV-2-CNUHV03-CA22°C (Table 1). In nsp2

18

(non-structural protein 2), with no known function (34), amino acid residues from 82 to 84

19

[glycine (G), histidine (H), and valine (V)] were deleted, and there was one mutation (M

20

(methionine) 85V). In nsp6, which functions as a potential transmembrane scaffold protein

21

(35), two mutations [N (asparagine) 3609K (lysine), D (aspartic acid) 3671T (threonine)]

22

were present, and in nsp7, which functions as a processivity clamp for RNA polymerase (36),

23

one mutation [D3926A (alanine)] was present. In helicase (nsp13) acting as RNA 5′-

24

triphosphatase (37), one mutation [L (leucine)5604F (phenylalanine)] was present, and in S

those

in

the

genes

of

SARS-CoV-2

9

present

in

the

GenBank

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

protein, which binds to the receptors (38), three mutations [T95I (isoleucine), N185K, S

2

(Serine)968A] were present. When we sequenced the genome of cold-adapted live attenuated

3

SARS-CoV-2 vaccine strain (CoV-2-CNUHV03-CA22°C) in lung tissues of infected K18-

4

ACE2 mice on day 6 p.i., no reverted changes of genes were found (data not shown). Viral

5

growth titer of cold-adapted live attenuated SARS-CoV-2 vaccine strain in Vero cells in

6

tissue culture flask (75cm2) at 22oC is about 2.7 X 106 pfu/ml, which is very comparable to

7

that (3.0 X 106 pfu/ml) of wild type SARS-CoV-2 (CoV-2-CNUHV03) at 37oC (data not

8

shown).

9

SARS-CoV-2 has been continuously spreading in humans since December 2019.

10

Several efforts have been made by scientists around the world to develop safe and effective

11

vaccines to prevent SARS-CoV-2 infection in humans (39). Since March 2020, we have been

12

in the process of developing a cold-adapted live attenuated SARS-CoV-2 vaccine that can

13

elicit mucosal and cellular immunity and can be administered through the nasal route in

14

humans. Our strategy had been to gradually adapt SARS-CoV-2 virus to temperatures from

15

37°C to 22°C in Vero cells. We confirmed the efficacy of the developed cold-adapted live

16

attenuated SARS-CoV-2 vaccine (CoV-2-CNUHV03-CA22°C) in K18-hACE2 mice, which

17

can be readily infected with SARS-CoV-2 and succumb to death upon infection.

18

We developed a cold-adapted live attenuated vaccine for SARS-CoV-2 by adapting it

19

to grow in Vero cells at 22°C. This vaccine strain was found to be sensitive to temperatures

20

of 37°C and 41 °C. The currently used live attenuated vaccine (nasal spray vaccine) for

21

seasonal influenza viruses (influenza A and B viruses) was developed by adapting the virus to

22

multiply in primary chicken kidney cells and embryonated eggs at temperature up to 25°C10.

23

Nasal spray influenza vaccines for the 2019–2020 season contained four influenza viruses

24

(influenza A (H1N1) virus, influenza A (H3N2) virus, and two influenza B viruses). Nasal
10

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

spray influenza vaccines are approved for use in non-pregnant individuals who are 2 years to

2

49 years of age (40).

3

A strong neutralising antibody (640 to 4960) was induced in all the 16 immunised

4

K18-hACE2 mice, which were i.n. inoculated with one dose (2 × 104 or 2 × 103 pfu) of CoV-

5

2-CNUHV03-CA22°C. SARS-CoV-2-specific IgA antibody was also induced in the nasal

6

turbinates, lungs, and kidneys. In addition, T lymphocytes expressing IFN-γ, which are

7

specific for SARS-CoV-2, were strongly induced in the spleen of vaccinated mice at 19 days

8

p.i. In a study on a measles virus (MeV)-based vaccine expressing the spike protein of SARS-

9

CoV-2 (MeVvac2-SARS-S (H) (16), it was observed that after the second immunisation, the

10

neutralising antibody titre for measles virus in all the immunised mice was from 257 to 800,

11

but the titre against SARS-CoV-2 was from 15 to 80 in three out of six immunised mice.

12

We show that all the K18-hACE2 mice i.n. immunised with one dose (2 × 104 or 2 ×

13

103 pfu) of CoV-2-CNUHV03-CA22°C were completely protected from the infection of

14

wild-type SARS-CoV-2 (CoV-2-KCDC03) and did not show any loss of body weight,

15

detection of virus in different tissues (nasal turbinates, brain, lungs, kidneys) in terms of the

16

log10TCID50 values or as determined by RT-qPCR. The study on the adenovirus-based

17

ChAdOX1 nCoV-19 vaccine, expressing the spike protein of SARS-CoV-2, showed

18

significantly reduced virus titres in bronchoalveolar lavage fluid and respiratory tract tissues

19

of vaccinated rhesus macaques that were challenged with SARS-CoV-2 (41).

20

In conclusion, cold-adapted live attenuated SARS-CoV-2 vaccine (CoV-2-

21

CNUHV03-CA22°C) is safe in K18-hACE2 mice, and one-dose vaccination can completely

22

protect K18-hACE2 mice from the challenge of SARS-CoV-2.

23
24
11

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48

REFERENCES AND NOTES
1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu et al; China
Novel Coronavirus Investigating and Research Team, A Novel Coronavirus from Patients with
Pneumonia in China, 2019. N Engl J Med. 382, 727-733 (2020). doi: 10.1056/NEJMoa2001017
Pubmed
Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, K. S. M. Leung, E. H. Y. Lau, J. Y. Wong
et al., Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N
Engl J Med. 382, 1199-1207(2020) doi: 10.1056/NEJMoa2001316. Pubmed
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, The species
Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARSCoV-2, Version 2. Nat Microbiol. 5, 536-544(2020). doi: 10.1038/s41564-020-0695-z Pubmed
A. Wu, Y. Peng, B. Huang, X. Ding, X. Wang, P. Niu, J. Meng, Z. Zhu, Z. Zhang, J. Wang et al.,
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.
Cell Host Microbe 27, 325–328(2020). doi: 10.1016/j.chom.2020.02.001 Pubmed
Z. Liu, X. Xiao, X. Wei, J. Li, J. Yang, H. Tan, J. Zhu, Q. Zhang, J. Wu, L. Liu, Composition and
divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts
of SARS-CoV-2. J Med Virol. 92, 595-601 (2020). doi: 10.1002/jmv.25726 Pubmed
X. Zhai, J. Sun, Z. Yan, J. Zhang, J. Zhao, Z. Zhao, Q. Gao, W. T. He, M. Veit, S. Su, Comparison of
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from
Human, Pets, Farm Animals, and Putative Intermediate Hosts. J Virol. 94, e00831-20 (2020). doi:
10.1128/JVI.00831-20 Pubmed
D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, H. Xiang, Z. Cheng, Y. Xiong et al.,
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected
Pneumonia in Wuhan, China. JAMA 323, 1061-1069 (2020). doi: 10.1001/jama.2020.1585 Pubmed
N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, Y. Qiu, J. Wang, Y. Liu, Y. Wei et al.,
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet 395, 507-513 (2020). doi: 10.1016/S0140-6736(20)30211-7
Pubmed
M. Arentz, E. Yim, L. Klaff, S. Lokhandwala, F. X. Riedo, M. Chong, M. Lee, Characteristics and
Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 323, 16121614(2020). doi: 10.1001/jama.2020.4326 Pubmed
S. Słyk, I. Domitrz, Neurological manifestations of SARS-CoV-2 - a systemic review. Neurol
Neurochir Pol. (2020) doi: 10.5603/PJNNS.a2020.0050 Pubmed
I. Gupta, M. K. Reddy, M. M. Hussain, P. M. Murthy, C. A. Robert, Atypical Neurological
Manifestations of COVID-19. Cureus 12, e8518 (2020). doi: 10.7759/cureus.8518 Pubmed
T. R. F. Smith, A. Patel, S. Ramos, D. Elwood, X. Zhu, J. Yan, E. N. Gary, S. N. Walker, K.
Schultheis, M. Purwar et al., Immunogenicity of a DNA vaccine candidate for COVID-19. Nat
Commun. 11, 2601 (2020). doi: 10.1038/s41467-020-16505-0 Pubmed
M. J. Mulligan, K. E. Lyke, N. Kitchin, J. Absalon, A. Gurtman, S. P. Lockhart, K. Neuzil, V. Raabe,
R. Bailey, K. A. Swanson et al., Phase 1/2 Study to Describe the Safety and Immunogenicity of a
COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
medRxiv (2020); https://doi.org/10.1101/2020.06.30.20142570
L. A. Jackson, E. J. Anderson, N. G. Rouphael, P. C. Roberts, M. Makhene, R. N. Coler, M. P.
McCullough, J. D. Chappell, M. R. Denison, L. J. Stevens; mRNA-1273 Study Group, An mRNA
Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. NEJMoa2022483 (2020). doi:
10.1056/NEJMoa2022483 Pubmed
P. M. Folegatti, K. J. Ewer, P. K. Aley, B. Angus, S. Becker, S. B-Rammerstorfer, D. Bellamy, S. Bibi,
M. Bittaye, E. A. Clutterbuck et al; on behalf of the Oxford COVID Vaccine Trial Group, Safety and
12

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

43
44
45
46
47
48
49

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.
26.

27.

28.

29.

immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a
phase 1/2, single-blind, randomised controlled trial Lancet (2020); https://doi.org/10.1016/S01406736(20)31604-4
C. Hörner, C. Schürmann, A. Auste, A. Ebenig, S. Muraleedharan, M. Herrmann, B. Schnierle, M. D.
Mühlebach, A Highly Immunogenic Measles Virus-based Th1-biased COVID-19 Vaccine bioRxiv
(2020); doi: https://doi.org/10.1101/2020.07.11.198291
J. Brett Case, P. W. Rothlauf, R. E. Chen, N. M. Kafai, J. M. Fox, S. Shrihari, B. T. McCune, I. B.
Harvey, B. Smith, S. P. Keeler, Replication-competent vesicular stomatitis virus vaccine vector
protects
against
SARS-CoV-2-mediated
pathogenesis.
bioRxiv
(2020);
https://doi.org/10.1101/2020.07.09.196386
Y. Y-Ronen, H. Tamir, S. Melamed, B. Politi, O. Shifman, H. Achdout, E. B. Vitner, O. Israeli, E.
Milrot, D. Stein et al., A single dose of recombinant VSV-ΔG-spike vaccine provides protection
against SARS-CoV-2 challenge. bioRxiv (2020); https://doi.org/10.1101/2020.06.18.160655
Q. Gao, L. Bao, H. Mao, L. Wang, K. Xu, M. Yang, Y. Li, L. Zhu, N. Wang, Z. Lv, Development of
an inactivated vaccine candidate for SARS-CoV-2. Science 369, 77-81(2020). doi:
10.1126/science.abc1932 Pubmed
V. Demicheli, A. Rivetti, M.G. Debalini, C. Di Pietrantonj, Vaccines for measles, mumps and rubella
in
children.
Cochrane
Database
Syst.
Rev.
2012(2):CD004407
(2012).
doi:
10.1002/14651858.CD004407.pub3. Pubmed
M. R. Hilleman, E. B. Buynak, R. E. Weibel, Stokes, Live, attenuated mumps-virus vaccine. The New
England Journal of Medicine 278, 227–32 (1968). doi:10.1056/NEJM196802012780501.
P. D. Parkman, H. M. Meyer, R. L. Kirschstein, H. E. Hopps, Development and characterization of a
live attenuated rubella virus. The Journal of Pediatrics 69, 893 (2018). doi:10.1016/S00223476(66)80490-0.
M. O'Ryan, Rotarix (RIX4414): an oral human rotavirus vaccine. Expert Rev Vaccines 6, 11–9 (2007).
doi:10.1586/14760584.6.1.11. Pubmed
J. F. Seward, B. M. Watson, C. L. Peterson, L. Mascola, J. W. Pelosi, J. X. Zhang et al., Varicella
disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287, 606–
611(2002). doi:10.1001/jama.287.5.606. Pubmed
A. D. T. Barrett, Yellow Fever Vaccines, Biologicals 25, 17–25 (1997).
H. F. Maassab, Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature 213,
612-614 (1967). doi: 10.1038/213612a0 Pubmed
S. L. Block, R. Yogev, F. G. Hayden, C. S. Ambrose, W. Zeng, R. E. Walker, Shedding and
immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age. Vaccine. 26,
4940–4946 (2008). doi: 10.1016/j.vaccine.2008.07.013 Pubmed
F. S. Oladunni, J. Park, P. P. Tamayo, O. Gonzalez, A. Akhter, A. A-Guardia, A. Olmo-Fontánez, S.
Gautam, A. Garcia-Vilanova, C. Ye et al., Lethality of SARS-CoV-2 infection in K18 human
angiotensin
converting
enzyme
2
transgenic
mice.
bioRxiv
(2020);
https://doi.org/10.1101/2020.07.18.210179
G. B. Moreau, S. L. Burgess, J. M. Sturek, A. N. Donlan, W. A. Petri Jr., B. J. Mann, Evaluation of
K18-hACE2 mice as a model of SARS-CoV-2 infection. Am J Trop Med Hyg. 00, 1–5 (2020).
doi:10.4269/ajtmh.20-0762 Pubmed

30. R. Rathnasinghe, S. Strohmeier, F. Amanat, V. L. Gillespie, F. Krammer, A. García-Sastre, L.
Coughlan, M. Schotsaert, M. Uccellini. Comparison of Transgenic and Adenovirus hACE2 Mouse
Models for SARS-CoV-2 Infection. bioRxiv (2020); https://doi.org/10.1101/2020.07.06.190066
31. E. S. Winkler, A. L. Bailey, N. M. Kafai, S. Nair, B. T. McCune, J. Yu, J. M. Fox, R. E. Chen, J. T.
Earnest, S. P. Keeler, SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes
severe inflammation, immune cell infiltration, and compromised respiratory function. bioRxiv (2020);
https://doi.org/10.1101/2020.07.09.196188
13

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

32. P. B. McCray Jr., L. Pewe, C. Wohlford-Lenane, M. Hickey, L. Manzel, L. Shi, J. Netland, H. P. Jia, C.
Halabi, C. D. Sigmund, Lethal infection of K18-hACE2 mice infected with severe acute respiratory
syndrome coronavirus. J Virol. 81, 813-821 (2007). doi: 10.1128/JVI.02012-06 Pubmed
33. Y. Jang, S. H. Seo, Gene expression pattern differences in primary human pulmonary epithelial cells
infected with MERS-CoV or SARS-CoV-2. Arch Virol. (2020). doi: 10.1007/s00705-020-04730-3
Pubmed
34. R. L. Graham, A. C. Sims, S. M. Brockway, R. S. Baric, M. R. Denison, The nsp2 replicase proteins of
murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral
replication. J Virol. 79, 13399-19411(2005). doi: 10.1128/JVI.79.21.13399-13411.2005 Pubmed
35. M. Oostra, M. C. Hagemeijer, M. v. Gent, C. P. J. Bekker, E. G. te Lintelo, P. J. M. Rottier, C. A. M.
de Haan, Topology and membrane anchoring of the coronavirus replication complex: not all
hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol. 82, 12392-12405 (2008). doi:
10.1128/JVI.01219-08 Pubmed
36. Y. Zhai, F. Sun, X. Li, H. Pang, X. Xu, M. Bartlam, Z. Rao, Insights into SARS-CoV transcription and
replication from the structure of the nsp7-nsp8 hexadecamer. Nat Struct Mol Biol.12, 980-6 (2005). doi:
10.1038/nsmb999 Pubmed
37. K. A. Ivanov, J. Ziebuhr, Human coronavirus 229E nonstructural protein 13: characterization of
duplex-unwinding, nucleoside triphosphatase, and RNA 5'-triphosphatase activities. J Virol. 78, 78337838 (2004). doi: 10.1128/JVI.78.14.7833-7838.2004 Pubmed
38. Y. Wan, J. Shang, R. Graham, R. S. Baric, F. Li, Receptor Recognition by the Novel Coronavirus from
Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 94,
e00127-20 (2020). doi: 10.1128/JVI.00127-20 Pubmed
39. Word Health Organization, Draft landscape of COVID-19 candidate vaccines (WHO, 2020);
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
40. Centers for Disease Control and Prevention, Live Attenuated Influenza Vaccine [LAIV] (The Nasal
Spray Flu Vaccine) (CDC, 2019); https://www.cdc.gov/flu/prevent/nasalspray.htm
41. N. v. Doremalen, T. Lambe, A. Spencer, S. Belij-Rammerstorfer, J. N. Purushotham, J. R. Port, V.
Avanzato, T. Bushmaker, A. Flaxman, M. Ulaszewska et al., ChAdOx1 nCoV-19 vaccination prevents
SARS-CoV-2 pneumonia in rhesus macaque. nature (2020); https://doi.org/10.1038/ s41586-0202608-y

31
32
33
34
35
36
37
38
39

14

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1
2

ACKNOWLEDMENTS

3

Author information: SHS designed the study, developed cold-adapted live attenuated

4

SARS-CoV-2 vaccine strain, performed the cold sensitivity of vaccine strain, all animal study

5

and antigen staining of tissues, analyzed the data, and wrote the manuscript. YJ sequenced

6

the genome of cold-adapted live attenuated SARS-CoV-2 vaccine and performed the staining

7

of tissues with H&E. All authors approved the submitted version of manuscript.

8

Competing interests: All authors declare that they have no competing interests.

9

Data and materials availability: All data supporting the results of this study are within the

10

manuscript, and its Extended Data tables and figures, and are available from the

11

corresponding author when they are requested. The sequence of cold-adapted live attenuated

12

SARS-CoV-2 vaccine strain (CoV-2-CNUHV03-CA22°C) is available in GenBank:

13

MT810119.

14
15
16
17

15

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Table1. Unique sequences of amino acids in cold-adapted live attenuated SARS-CoV-2
vaccine strain (SARS-CoV-2/human/Korea/CNUHV03-CA22oC/2020)
Protein name

nsp2
ORF1a

ORF1ab
polyprotein
polyprotein

Difference of amino acid
sequences
Deletion : GHV(82~84),
M85V
N3609K, D3671T
D3926A
L5604F
T95I, N185K, S968A

The number of changed
sequence

4/641

2/290
1/83
2/601
ORF1b
3/1274
S protein
12/9755 (including
Total amino acids
nonchanged ORFs)
We compared the amino acid sequences of SARS-CoV-2/human/Korea/CNUHV03CA22oC/2020 with those in GenBank (https://www.ncbi.nlm.nih.gov/nuccore) and GISAID
(https://www.gisaid.org/). We found out the unique amino acids in our cold-adapted live
attenuated SARS-CoV-2 vaccine strain (SARS-CoV-2/human/Korea/CNUHV03CA22oC/2020).
Single letter abbreviation name of amino acid: Glycine(G), Alanine(A), Valine(V),
Leucine(L), Isoleucine(I), Methionine(M), Phenylalanine(F), Serine(S), Threonine(T),
Asparagine(N), Lysine(K), Histidine(H), Aspartic Acid(D)
nsp6
nsp7
helicase

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

B

Mouse surviving rate (%)

100
90

Cold-adapted
SARS-CoV-2
infected mice

80
70
50

Wild-type SARSCoV-2 infected
mice

40

PBS-mock mice

60

30
20
10

Mouse body weight change (%)

A

140
120
100
80
60

2

4

6

7

8

0

14

0

Viral titers in tissues (log10TCID50/0.1g)

**

9

2
4
6
8
14
Days post infections

Cold-adapted SARS-CoV-2 infected mice on 6 days

8

Cold-adapted SARS-CoV-2 infected mice on 14 days

7

Wild-type SARS-CoV-2 infected mice on 6 days

6
5

PBS-mock mice

20

Days post infections

C

Wild-type SARS-CoV2 infected mice

40

0
0

Cold-adapted SARSCoV-2 infected mice

**

*

**

Lung

Kideny

4
3
2
1
0
Nasal
turbinate

Brain

Spleen

Tissues
Fig. 1. Attenuation of cold-adapted SARS-CoV-2 vaccine strain in hACE2 transgenic mice. K18-ACE2 mice were i.n.
infected with cold adapted SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) (2X104 pfu) (n=14) or were i.n. infected with wildtype SARS-CoV-2 (CoV-2-CNUHV03) (2X104 pfu) (n=6). Mice were monitored for mortality and the change of body
weights for 14 days. On day 6 p.i., mice (n=3 per group) were euthanized for viral titers in tissues. One day 14 p.i., mice (n=3)
infected with CoV-2-CNUHV03-CA22oC were also euthanized. PBS-mock infected K18-ACE-2 mice (n=4) were used as a
control group and among them, one mice were euthanized on day 6. A , mice mortality rate (%); B, the change of mouse body
weights (%) compared to those before infections, C, Viral titers in mouse tissues (n=3 per group) of nasal turbinate, brain,
lung, kidney, and spleen by log10 TCID50/0.1g. Viral titers are the mean of 3 tissues ± standard deviations. Detection limit of
virus is 1 TCID50/0.1g.
*p<0.05, **p<0.001

B

C

D

E

F

Fig. 2. Lung histopathology and antigen staining of cold-adapted SARS-CoV-2 vaccine strain in hACE2 transgenic
mice. Lung tissues (Fig. 1C) of K18-ACE2 mice on 6 days p.i. were stained with hematoxylin & eosin (A,B,C) (X100), and
SARS-CoV-2 NP antibody (D,E,F) (X400). A&D, lung tissues of PBS-mock mice, B&E, lung tissues of mice i.n. infected
with cold adapted SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) (2X104 pfu), C&F, lung tissues of mice infected with wildtype SARS-CoV-2 (CoV-2-CNUHV03) (2X104 pfu). Arrow: positive antigen staining.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

B
5500
5000
4500
4000
3500
3000
2500
2000
1500
1000
500
0

Against CoV-2CNUHV03
Against CoV-2KCDC03

0 1 2 3 4 5 6 7 8
Serum number

C

Neutralizing antibody titers
(2X103 pfu vaccination)

A

Neutralizing antibody titers
(2X104 pfu vaccination)

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Against CoV-2CNUHV03
Against CoV-2KCDC03

0

1

2 3 4 5 6
Serum number

7

8

D

Cold-adapted SARS-CoV-2 vaccinated (20,000 pfu) & challenged mice
Cold-adapted SARS-CoV-2 vaccinated (2000 pfu) & challenged mice
PBS-mock & challenged mice
PBS-mock & unchallenged mice

Cold-adapted SARS-CoV-2 vaccinated (20,000 pfu) & challenged mice
Cold-adapted SARS-CoV-2 vaccinated (2000 pfu) & challenged mice
PBS-mock & challenged mice
PBS-mock & unchallenged mice

120

100
90
80
70
60
50
40
30
20
10
0

Mouse body
weight change (%)

Mouse surviving rate (%)

5500
5000
4500
4000
3500
3000
2500
2000
1500
1000
500
0

100
80
60
40
20
0

0

Viral titers in tissues
(log10TCID50/0.1g)

E

2

4
6
7
Days post challenge

9
8
7
6
5
4
3
2
1
0

8

0

12

2
4
6
Days post challenge

8

12

**
Cold-adapted SARS-CoV-2 vaccinated (20,000 pfu)
& challenged mice

**

**

**

Cold-adapted SARS-CoV-2 vaccinated (2000 pfu) &
challenged mice

PBS-mock & challenged mice

Nasal Brain
turbinate

Lung

Kideny Spleen

Tissues

Fig. 3 Neutralizing antibodies and challenge of immunized hACE2 transgenic mice with cold-adapted SARS-CoV-2
vaccine strain. Sera collected from K18-ACE2 mice (n=8 per group) immunized with 2X104 pfu or 2X103 pfu of cold adapted
SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) 19 days ago, and their neutralizing antibody titers were determined against wildtype SARS-CoV-2 viruses, CoV-2-CNUHV03 and CoV-2-KCDC03 in Vero cells. A, Sera from immunized mice with
2X104 pfu of CoV-2-CNUHV03-CA22oC; B, Sera from immunized mice with 2X103 pfu of CoV-2-CNUHV03-CA22oC. Sera
(n=16) collected before immunization were used as a control. Detection limit of neutralizing antibody is 10. *p<0.05, **p<0.001.
K18-ACE2 mice (n=8 per group) immunized with 2X104 pfu or 2X103 pfu of cold adapted SARS-CoV-2 (CoV-2-CNUHV03CA22oC) 21 days ago were i.n. challenged with 2X104 pfu of wild-type SARS-CoV-2 (CoV-2-KCDC03). PBS-mock vaccinated
mice (n=6) were also i.n. challenged with 2X104 pfu of CoV-2-KCDC03 and PBS-mock and unchallenged mice (n=3) were
used as a control. The challenged mice were monitored for mortality and the change of body weights for 12 days. On 6 days
post challenge, the challenged mice (n=3) were euthanized for viral titers in tissues. One mouse of PBS-mock and unchallenged
mice was euthanized on day 6. C, mice mortality rate (%); D, the change of mouse body weights (%) compared to those before
challenge, E, Viral titers in mouse tissues (n=3 per group) of nasal turbinate, brain, lung, kidney, and spleen by
log10TCID50/0.1g. Viral titers are the mean of 3 tissues ± standard deviations. Detection limit of virus is 1 TCID50/0.1g.*p<0.05,
**p<0.001

B

C

D

E

F

G

H

Fig. 4. Lung histopathology and antigen-staining of the immunized and challenged hACE2 transgenic mice. Lung tissues (Fig. 3E) of
the immunized and challenged K18-ACE2 were stained with hematoxylin & eosin (A,B,C,D) (X100) and SARS-CoV-2 NP antibody
(E,F,G,H) (X400). A&E, Lung tissue of PBS-mock mouse; B&F Lung tissue of the immunized mouse (2X103 pfu) and challenged with
CoV-2-KCDC03 (2X104 pfu); C&G, Lung tissue of the immunized mouse (2X104 pfu) and challenged with CoV-2-KCDC03 (2X104 pfu);
D&H, Lung tissue of PBS-mock and challenged mouse with CoV-2-KCDC03 (2X104 pfu). Arrow: positive antigen staining.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

SUPPLEMENTARY MATERIALS for
Cold-adapted live attenuated SARS-CoV-2 vaccine completely protects
human ACE2 transgenic mice from SARS-CoV-2 infection
Sang Heui Seo 1,2, * & Yunyueng Jang 1,2
1

Laboratory of Influenza Research, College of Veterinary Medicine,
2

Institute of Influenza Virus,

Chungnam National University, Daejeon 34134,
Republic of Korea.

This PDF file includes
Materials and Methods
Table S1-S4
Figs. S1-S10

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

Materials and Methods

2

Viruses and cells

3

The SARS-CoV-2 strain (SARS-CoV-2/human/Korea/CNUHV03/2020) (referred to as CoV-

4

2-CNUHV03 in this paper) (GenBank accession number: MT678839), isolated in our

5

laboratory from a human clinical sample collected at the Chungnam National University

6

Hospital (Daejeon, South Korea), and BetaCoV/South Korea/KCDC03/2020 (referred to as

7

CoV-2-KCDC03 in this paper), which was provided by the Korean Centers for Disease Control

8

and Prevention (KCDC), were propagated in Vero-E6 cells obtained from American Type

9

Culture Collection (Manassas, Virginia, USA). Minimal essential medium (MEM),

10

supplemented with 10% foetal bovine serum (FBS) and 1× antibiotic–antimycotic solution

11

(Sigma, St. Louis, USA), was used for the culture of cells. All experimental procedures

12

involving potential contact with SARS-CoV-2 were conducted in a biosafety level 3 laboratory

13

certified by the Korean government.

14

Animals

15

Female (5–6-week-old) human angiotensin converting enzyme 2 (ACE-2) transgenic mice

16

(B6.Cg-Tg(K18-ACE2)2Prlmn/J) (referred to as K18-hACE2 in this paper) were kindly

17

provided by The Jackson Laboratory (Bar Harbor, Maine, USA). The mice were fed a standard

18

chow diet and water.

19

Development of the cold-adapted live attenuated SARS-CoV-2 vaccine strain

20

The SARS-CoV-2 strain (SARS-CoV-2/human/Korea/CNUHV03/2020) was gradually

21

adapted from 37°C to 22 °C in Vero cells in MEM with 200 mM L-glutamine (Hyclone, South

22

Logan, Utah, USA), supplemented with 1.5% bovine serum albumin (BSA; Rocky Mountain
1

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

Biologicals, Missoula, MT, USA) and 1× antibiotic–antimycotic solution (Sigma). Vero cells

2

were cultured in MEM with 10% FBS in a humidified 5% CO2 incubator (37°C) and washed

3

twice with warm PBS (pH 7.4). The washed Vero cells were inoculated with SARS-CoV-2

4

virus (SARS-CoV-2/human/Korea/CNUHV03/2020) and incubated in a humidified 5% CO2

5

incubator (from 37°C to 22°C). When the infected Vero cells showed cytopathic effects (CPE),

6

the next lower temperature was used to adapt the virus. When SARS-CoV-2 virus was

7

successfully passaged at 22°C more than five times (>passage = 5), it was used for the vaccine

8

study, and for sequencing of the whole genome. The cold-adapted live attenuated vaccine strain

9

was designated as SARS-CoV-2/human/Korea/CNUHV03-CA22°C/2020 (referred to as CoV-

10

2-CNUHV03-CA22°C in this paper). At passage 5, at 22 °C, the SARS-CoV-2 cold-adapted

11

vaccine virus was cloned by limited-dilution infection in Vero cells in 96-well plates three

12

times. Virus titres for the cold passaged SARS-CoV-2 were determined by RT-qPCR using

13

SARS-CoV-2 N primers and Taqman probe and by plaque assay at 22 °C in terms of pfu.

14

Confirmation of temperature sensitivity of the cold-adapted live attenuated SARS-CoV-

15

2 vaccine strain

16

Vero cells grown to confluence in 6-well plates were infected with 0.00001 or 0.000001

17

multiplicity of infections (m.o.i) of CoV-2-CNUHV03-CA22°C and wild-type SARS-CoV-2

18

(CoV-2-CNUHV03). The infected cells were incubated in a humidified 5% CO2 incubator at

19

37°C or 41°C, and virus titres in the supernatants were quantified 3 days later by RT-qPCR

20

using the SARS-CoV-2 N primers and probe.

21

Measurement of plaque forming units by plaque assay

22

Stocks of SARS-CoV-2 (CoV-2-CNUHV03 or CoV-2-CNUHV03-CA22°C) were serially 10-

23

fold diluted in MEM with 1.5% BSA. Confluent Vero cells growing in 24-well plates were
2

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

infected with the diluted virus suspensions for 4h in a humidified 5% CO2 incubator (37 °C for

2

CoV-2-CNUHV03 and 22 °C for CoV-2-CNUHV03-CA22°C). After removing the inoculum,

3

Vero cells were overlaid with 1% electrophoretic agar (LPS Solution, Korea) in MEM and

4

incubated for 4 or 7 days in a humidified 5% CO2 incubator (37 °C for CoV-2-CNUHV03 and

5

22 °C for CoV-2-CNUHV03-CA22°C). The cells were then stained with 0.1% crystal violet

6

(Sigma-Aldrich, St. Louis, MO, USA) prepared in 37% formaldehyde solution, or with SARS-

7

CoV-2 NP antibody and fluorescent-labelled secondary antibody. After removal of agar, the

8

cells were fixed and permeabilised with 80% cold acetone (Samchun Pure Chemical Co.,

9

Gyeonggi-do, Korea). The cells were treated with SARS-CoV-2 nucleocapsid rabbit polyclonal

10

antibody (Thermo Fisher Scientific, Waltham, MA, USA) and subsequently with fluorescent-

11

labelled goat anti-rabbit antibody (Thermo Fisher Scientific). The number of plaques was

12

counted under a fluorescence microscope (Olympus, Tokyo, Japan).

13

Measurement of virus titres using real-time quantitative PCR

14

RNA from virus samples was isolated using the RNeasy Mini Kit (QIAGEN, Hilden, Germany).

15

Briefly, 100 μL of supernatant containing the virus was disrupted in 350 μL Buffer RLT, and

16

then 550 μL of 70% ethanol was added. The sample (700 μL) was transferred to the RNeasy

17

Mini spin column and subjected to centrifugation for 15s at 13,500 rpm. After discarding the

18

flow-through, 700 μL of RW1 buffer was added to the spin column and it was centrifuged for

19

15s at 13,500 rpm. The flow-through was discarded and 500 μL of RPE buffer was added to

20

the spin column before it was centrifuged for 15s at 13,500 rpm. The spin column was then

21

placed in a new 1.5 mL collection tube and viral RNA was eluted using 40 μL of RNAse-free

22

water.

23

To detect the virus, we used TaqMan real-time fluorescent PCR with TOPrealTM One3

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

step RT qPCR Kit (Enzynomics, Daejeon, Korea) and SARS-CoV-2 N primers and probe. In a

2

total volume of 20 μL, the following components were mixed: 5 μL of TOPrealTM One-step RT

3

qPCR Kit (TaqMan probe), 1 μL of 10 pmol primers containing N_Sarbeco_F (5′-

4

CACATTGGCACCCGCAAT-3′), N_Sarbeco-R (5′-GAGGAACGAGAAGAGGCTTG-3′),

5

and N_Sarbeco_P (5′FAM-ACTTCCTCAAGGAACAACATTGCCA-3′BHQ1) (1), 10 μL of

6

viral RNA, and 2 µL of nuclease-free water. Real-time amplification was performed on a Rotor-

7

Gene 6000 system (QIAGEN, Hilden, Germany) using the following temperature profile:

8

initial incubation at 50°C for 30 min and at 95°C for 10 min, followed by 45 cycles of 95°C

9

for 5s and 60°C for 30s. Standard curves were generated using data for stock viruses with

10

known pfu titres determined by plaque assay.

11

Confirmation of attenuation of the cold-adapted live attenuated SARS-CoV-2 vaccine

12

strain in hACE-2 transgenic mice

13

K18-hACE2 mice were i.n. immunised with 50 µL (2 × 104 pfu) of the cold-adapted vaccine

14

strain (n = 14) or wild-type virus (n = 6) after they were lightly anaesthetized with isoflurane

15

USP (Gujarat, India). PBS (mock)-infected mice (n = 4) were used as controls. The infected

16

mice were monitored for body weight change, and mortality. Six days p.i., three mice per virus

17

(vaccine strain or wild-type virus)-infected group and one PBS (mock)-infected mouse were

18

euthanized for determining virus titres in different tissues (nasal turbinates, brain, lungs, and

19

kidneys) and for histopathology. Tissues (0.1 g per sample) were homogenised using a

20

BeadBlaster homogeniser (Benchmark Scientific, Edison, New Jersey, USA) in 1 mL of PBS

21

(pH 7.4) to measure virus titres by RT-qPCR and by determining the log10TCID50/0.1 g values.

22

The remaining portions of tissues were used for histopathology and antibody staining.

23
4

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

Staining of tissues by haematoxylin and eosin

2

Mouse tissues were fixed in 10% neutral buffered formalin (10%) and then embedded in

3

paraffin. The lung tissue was cut into 5 μm sections, which were stained with haematoxylin (H)

4

solution for 4 min. The stained tissue sections were washed with tap water for 10 min and then

5

stained with eosin (E) solution. The stained sections were visualised under an Olympus DP70

6

microscope and photographed (Olympus Corporation, Tokyo, Japan).

7

Staining of tissues with the SARS-CoV-2 NP antibody

8

Tissue sections were stained with SARS-CoV-2 nucleocapsid rabbit polyclonal antibody

9

(Thermo Fisher Scientific). The sections were treated with antigen retrieval solution in a

10

microwave oven and blocked with normal rabbit serum in PBS (pH 7.4). They were then

11

incubated with the rabbit antibody against SARS-CoV-2 NP (1:100 dilution), and subsequently

12

treated with biotin-labelled goat anti-rabbit immunoglobulin (Vector Laboratories, Burlingame,

13

CA, USA), and Vectastain ABC-AP (Vector Laboratories) and Vector Red alkaline

14

phosphatase substrate (Vector Laboratories). The labelled lung sections were counterstained

15

with haematoxylin QS (Vector Laboratories) and observed under an Olympus DP70

16

microscope (Olympus Corporation).

17

Measurement of virus titres in terms of log10TCID50/mL

18

Vero cells grown in tissue culture flasks were detached by treatment with trypsin-EDTA and

19

were seeded in 96-well tissue culture plates with MEM containing 10% FBS and 1× antibiotic-

20

antimycotic solution. When confluent, the cells were washed with warm PBS (pH 7.4) and

21

infected with virus samples, which were 10-fold diluted in MEM with 1.5% BSA. The cells in

22

four wells were infected with the diluted virus samples for 4 days in a humidified incubator at

23

37°C (wild-type SARS-CoV-2 strain) or 22°C (cold-adapted SARS-CoV-2 vaccine strain). The
5

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

cells were then fixed and permeabilised with 80% cold acetone (Samchun Pure Chemical Co.).

2

They were subsequently incubated with SARS-CoV-2 nucleocapsid rabbit polyclonal antibody

3

(Thermo Fisher Scientific) and fluorescent-labelled goat anti-rabbit antibody (Thermo Fisher

4

Scientific). The titre was calculated using the method described by Muench and Reed (2).

5

Assessment of the efficacy of vaccine in hACE-2 transgenic mice

6

On 21 days p.v., the hACE-2 mice (n = 8 per group) immunised with 2 × 104 or 2 × 103 pfu of

7

CoV-2-CNUHV03-CA22°C were i.n. challenged with 50µL (2 × 104 pfu) of CoV-2-KCDC03.

8

PBS (mock)-immunised hACE-2 mice (n = 6) were also i.n. challenged with 50 µL (2 × 104

9

pfu) of CoV-2-KCDC03. PBS (mock)-vaccinated and uninfected hACE-2 mice (n = 3) were

10

used as controls. The infected mice were monitored body weight change, and mortality. Six

11

days post-challenge, three mice per virus (vaccine strain or wild-type virus)-infected group and

12

one PBS (mock)-infected mouse were euthanized for determining virus titres in different

13

tissues (nasal turbinate, brain, lung, and kidney) and for histopathology. Virus titres were

14

quantified by RT-qPCR and by determining the log10TCID50/0.1 g values.

15

Measurement of neutralising antibody titres.

16

Sera (n = 8 per group) collected from hACE-2 mice that were i.n. immunised with 50 µL (2 ×

17

104 or 2 × 103 pfu) of CoV-2-CNUHV03-CA22°C on 19 day after vaccination were 10-fold

18

diluted in MEM with 1.5% BSA and then serially two-fold diluted before they were incubated

19

with 100TCID50/mL (100 µL:100 µL) of wild-type SARS-CoV-2 virus, CoV-2-CNUHV03 or

20

CoV-2-KCDC03, for 1 h in a humidified 5% CO2 incubator (37°C). Vero cells grown in a 96-

21

well cell culture plate were washed with warm PBS (pH 7.4) and were inoculated with a

22

mixture of serum and virus. Cells were incubated for 4 days and checked for CPE. The titre of
6

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

the neutralising antibody was determined as the reciprocal of the highest dilution of serum at

2

which the infectivity was neutralised in 100% of the cell in wells. The assay was performed in

3

four replicates. Sixteen sera samples collected from hACE-2 mice before vaccination were

4

used as controls.

5

Enzyme-linked immunosorbent spot assay (ELISpot) assay for mouse IFN−γ

6

The immunised hACE-2 transgenic mice (n = 3) i.n. inoculated with 50 µL (2 × 104 pfu) of

7

CoV-2-CNUHV03-CA22°C were euthanized to collect the spleen on 19 day p.v. The spleen

8

samples were homogenised in PBS (pH 7.4) and the cells were collected. The nasal turbinates,

9

lungs, and kidneys were homogenised in 10% PBS (pH 7.4) and the homogenates were used

10

for detection of IgA specific for SARS-CoV-2 by enzyme-linked immunosorbent spot

11

(ELISpot) assay. The collected cells were overlaid on HISTOPAQUE-1077 (Sigma) and

12

centrifuged for 30 min at 1500 rpm at 4°C. The lymphocyte layer was collected for the IFN-γ

13

ELISpot assay performed using the Mouse IFN-γ ELISpotPlus kit (MABTECH, Nacka Strand,

14

Sweden). The plate was removed from the sealed package and washed four times with sterile

15

PBS (200 µL/well). The plate was conditioned with RPMI 1640 medium (200 µL/well)

16

containing 10% FBS for 30 min at room temperature. The purified lymphocytes (250,000/well)

17

mixed with 0.01 m.o.i of CoV-2-CNUHV03-CA22°C were added to the wells and the plate

18

was incubated in a humidified 5% CO2 incubator at 37°C for 24 h. Thereafter, the solution was

19

decanted from the plate and the cells were washed five times with PBS (pH 7.4) (200 µL

20

PBS/well for each wash). The detection antibody (R4-6A2-biotin) diluted to 1 g/mL in PBS

21

(pH 7.4) containing 0.5% FBS (200 µL/well) was added and the plate was incubated for 2 h at

22

room temperature. The plate was washed five times with PBS (pH 7.4) (200 µL PBS/well for

23

each wash) and streptavidin-ALP (1:1000) in PBS-0.5% FBS (100 µL/well) was added to the
7

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

wells. The cells were incubated for 1 h at room temperature. The plate was washed five times

2

with PBS as described above and the substrate solution (BCIP/NBT-plus) was added (100

3

µL/well). The plate was developed until distinct spots emerged. The colour development was

4

stopped by extensive washing under tap water. Spots were inspected and counted under a

5

microscope (Olympus). Three PBS (mock)-immunised hACE-2 mice were used as controls.

6

Detection of IgA antibody specific for SARS-CoV-2 in tissues of immunised mice by

7

enzyme-linked immunosorbent assay (ELISA)

8

The

9

2/human/Korea/CNUHV03/2020) was diluted to a final concentration of 100 μg/mL in a

10

coating buffer (carbonate–bicarbonate buffer, pH 9.6). The diluted antigen (100 μL) was coated

11

onto the wells of a Nunc-Immuno™ MicroWell™ 96 well solid plate (Sigma-Aldrich) by

12

incubated overnight at 4 °C. After removing the coating buffer, the plate was washed twice by

13

filling the wells with 400 μL of washing buffer (0.05% Tween 20 PBS (pH 7.4) containing 4%

14

horse serum). To block the remaining protein-binding sites, 400 μL of blocking buffer (PBS

15

containing 4% skimmed milk) was added to the plate and the plate was kept overnight at 4 °C.

16

The buffer was removed, and the supernatant (100 μL) of the homogenised tissue (nasal

17

turbinates, lungs, and kidneys) from vaccinated and non-vaccinated mice 19 days after

18

vaccination, diluted 10-fold in blocking buffer, was added to the plate and incubated for 1 h at

19

room temperature. The plate was washed four times with the washing buffer. Goat anti-mouse

20

IgA cross-adsorbed secondary antibody HRP (Invitrogen, MA, USA) (100 μL), diluted 1:5000

21

in blocking buffer, was added to each well and incubated for 1 h at room temperature. After

22

washing the plate four times with the washing buffer, 100 μL TMB ELISA substrate

23

(MABTECH) was dispensed in each well and the plate was incubated for 30 min at 4 °C.

purified

and

inactivated

SARS-CoV-2

8

antigen

(SARS-CoV-

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

ABTS® Peroxidase Stop Solution (KPL, MD, USA) (100 μL) was subsequently added to each

2

well. The absorbance of the solution in each well was measured at 450 nm using an iMARK™

3

Microplate Absorbance Reader (Bio-Rad, CA, USA).

4

Sequencing of the full genome of cold-adapted live attenuated SARS-CoV-2 vaccine strain

5

The genome of CoV-2-CNUHV03-CA22°C was fully sequenced using overlapping primers

6

(Table S3). Viral RNA was extracted using the RNeasy Mini Kit (QIAGEN, Venlo,

7

Netherlands). Tissue culture supernatant (200 μL) containing the virus was disrupted in 350 μL

8

Buffer RLT, and then 500 μL of 70% ethanol was added to the mixture. The disrupted samples

9

(700 μL) were transferred to the RNeasy Mini spin column, and the column was centrifuged

10

for 15 s at 13,500 rpm. After discarding the flow-through, 700 μL of RW1 buffer was added to

11

the spin column and it was centrifuged for 15 s at 13,500 rpm. The flow-through was again

12

discarded and 500 μL of RPE buffer was added to the spin column, which was then centrifuged

13

for 2 min at 13,500 rpm. The spin column was placed in a new 1.5 mL collection tube and viral

14

RNA was eluted with 50 μL of RNAse-free water. The extracted RNA was reverse transcribed

15

to cDNAs using GoScript™ Reverse Transcription System (Promega, Madison, USA) and 12

16

reverse primers (covid2500R, covid5000R, covid7500R, covid10000R, covid12500R,

17

covid15000R, covid17500R, covid20000R, covid22500R, covid25000R, covid27500R,

18

covid29843R) (Table S4). Twelve viral genes were amplified by PCR with GoTaq Hot Start

19

Green Master Mix (Promega) and a segment-specific primer set. Amplicons were separated by

20

gel electrophoresis and purified using the QIAquick Gel Extraction Kit (QIAGEN). The

21

purified genes were cloned into the pGEM-T Easy vector (Promega) and the vector construct

22

was used for transformation of chemically competent Escherichia coli DH5α cells

23

(Enzynomics, Daejeon, Korea). The plasmids were extracted using the HiGene Plasmid Mini

24

Prep Kit (BIOFACT, Daejeon, Korea) and the sequences were determined by Macrogen (Seoul,
9

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

Korea). Three clones per segment were sequenced. The sequenced genes were arranged using

2

DNASTAR Lasergene (Madison, Wisconsin, USA). The sequence of CoV-2-CNUHV03-

3

CA22°C was deposited in GenBank under the accession number MT810119.

4

Ethical approval

5

The protocol (202003-CNU-023) for the study of SARS-CoV-2 vaccine efficacy in

6

mice was approved by the Internal Animal Use Committee at Chungnam National Univer

7

sity (CNU). All the studies were approved and were conducted in accordance with the

8

relevant legal guidelines and regulations prescribed by CNU, Republic of Korea.

9

Statistical analysis

10

Differences between mice infected with cold-adapted live attenuated SARS-CoV-2 vaccine

11

strain and wild-type SARS-CoV-2 virus or between vaccinated and PBS (mock)-infected

12

mice were analysed by Student’s t-test with IBM SPSS Statistics version 20. A value of

13

P < 0.05 was considered statistically significant. The statistically significant differences are

14

indicated with * (P < 0.05) or ** (P < 0.001).

15

REFERENCES AND NOTES

16
17
18
19
20

1.

2.

V. M. Corman, O. Landt, M. Kaiser, R. Molenkamp, A. Meijer, D. K. Chu, T. Bleicker, S. Brünink, J.
Schneider, M. L. Schmidt et al., Detection of 2019 novel coronavirus (2019-nCoV) by real-time RTPCR. Euro Surveill. 25, 2000045 (2020). doi: 10.2807/1560-7917.ES.2020.25.3.2000045 Pubmed
L. J. Reed, H. Muench, A simple method of estimating fifty percent endpoints. The American Journal of
Hygiene. 27, 493–497(1938); https://doi.org/10.1093/oxfordjournals.aje.a118408

21

10

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Table S1. The changed nucleotide sequences in cold-adapted live attenuated SARS-CoV2 vaccine strain (SARS-CoV-2/human/Korea/CNUHV03-CA22oC/2020)
Gene name

Changed nucleotide sequences

Deletion : GGTCATGTT(244~252) (NS),
A253G (NS), G698A (NS), T2271C (S)
G3288A(S), A3550G (NS), C3855T (S),
G4754A (NS), G5765A (NS), G6126A
(S), G6240A (S), C6933T (S), C7115T
(NS). C7311T (S), A7419G (S), C8031T
(S), C8174T (NS), C8258T (NS)
A8611G (NS), C8914T (NS), G8953A
(NS)
T10818G (NS), T10827A (NS), T10851G
(S)
A11777C (NS)

nsp2

nsp3
ORF1a

nsp4

nsp6

nsp7

nsp10
RNAdependent
RNA
polymerase

ORF1ab

helicase
ORF1b

3’-to-5’
exonuclease
endoRNAse
2’-0-ribose
methyl
transferase

14 [6 (NS) + 8
(S)]/5835

3 (NS)/1500

3 [2(NS)+ 1
(S)/870
1 (NS)/249

C12882T (S), G13050A (S)

2 (S)/417

C13822T (NS), G14417A (NS), C15464T
(NS)

3 (NS)/2796

C16810T (NS), C17508T (S), G17545A
(NS)

3[2(NS)+ 1
(S)]/1803

C18349T (S)

1(S)/1581

T19506G (S)

1(S)/1038

G21113C (NS), C21168T (S), C21175T
(NS)

3 [2(NS)+1
(S)]/894

M

G113A (NS), C257T (NS), G287A (NS),
G451A (NS), C2511T (S), T2902G (NS),
C3003T (S)
C537T (S)

ORF7a

C141T (S), A201G (NS)

ORF8

C63T (S)

N

N243T (S), T1082A (NS)

S

The number of
changed sequence
12 [11 (NS) + 1
(S)/1923

Total nucleotides

7 [5 (NS)+ 2
(S)]/3822

1 (S)/669
2 [1(NS)+
1(S)/366
1 (S)/366
2[1(NS)+1
(S)/1260
59 [37 (NS)+22
(S)/29874
including noncoding
nucleotides

We compared the nucleotide sequences of cold-adapted live attenuated SARS-CoV-2 vaccine
strain (SARS-CoV-2/human/Korea/CNUHV03-CA22℃/2020) with those in wild-type
SARS-CoV-2: (SARS-CoV-2/human/Korea/CNUHV03/2020), which was used for
developing cold-adapted live attenuated vaccine strain in Vero cells.
(S): (synonymous substitution). (NS): (nonsynonymous substitution)

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Table S2. Changed amino acid sequences in cold-adapted live attenuated SARS-CoV-2
vaccine strain (SARS-CoV-2/human/Korea/CNUHV03-CA22oC/2020)
The number of
changed sequence

nsp4

Changed amino acid
sequences
Deletion : GHV(82~84),
M85V, G233E
N1184D, G1585D,
S1922N, A2372V, P2725L,
A2753V
S2871G, P2972S, G2985R

nsp6

F3606L, N3609K

2/290

Protein name

nsp2

ORF1a
polyprotein
ORF1ab
polyprotein

nsp3

nsp7
D3926A
RNA-dependent
R4608W, S4806N, A5155V
RNA polymerase
helicase
L5604F, V5849I
ORF1b
2’-0-ribose methyl
C7038S, P7059S
transferase
C38Y, S86F, G96E,
S protein
G151S, S968A
ORF7a
Y67C

N protein

I361K

Total amino acids

5/641

6/1945

3/500

1/83

3/932

2/601

2/298

5/1274

1/122

1/420
31/9755
(including nonchanged ORFs)

We compared the amino acid sequences of cold-adapted live attenuated SARS-CoV-2
vaccine strain (SARS-CoV-2/human/Korea/CNUHV03-CA22oC/2020) with those in wildtype SARS-CoV-2 (SARS-CoV-2/human/Korea/CNUHV03/2020), which was used for
developing cold-adapted live attenuated vaccine strain in Vero cells.
Single letter abbreviation name of amino acid: Glycine(G), Alanine(A), Valine(V), Cysteine(C),
Proline(P), Leucine(L), Isoleucine(I), Methionine(M), Tryptophan(W), Phenylalanine(F),
Serine(S), Tyrosine(Y), Asparagine(N), Lysine(K), Arginine(R), Histidine(H), Aspartic Acid(D),
Glutamic Acid(E)

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Table S3. Primers used for PCR amplification of the gene segments in cold-adapted live
attenuated SARS-CoV-2 vaccine strain (SARS-CoV-2/human/Korea/CNUHV03CA22oC/2020)
segment

F Primer

1

1F

2

F sequence

R primer

R sequence

ATTAAAGGTTTATACCTTCCCAGGTAAC

1300R

CACCTTCTTTAGTCAAATTCTCAGTG

1200F

GCAACCAAATGTGCCTTTCAAC

2500R

TTCTCCCTCTAAGAAGATAATTTCTTTT

3

2400F

ACTCAAAGGGATTGTACAGAAAGTGTGT

3750R

GTGCGAACAGTATCTACACAAACTCTTA

4

3650F

GACATTCAACTTCTTAAGAGTGCTTAT

5000R

GGTTAATGTTGTCTACTGTTGTAAACAC

5

4901F

CTAGATGGTGAAGTTATCACCTTTGACA

6250R

GCTTTATTAGTTGCATTGTTAACATGCC

6

6150F

GACTTAAATGGTGATGTGGTGGC

7500R

CACATCATACAAGTTGATGAATTACAAC

7

7400F

GCTATGGTTAGAATGTACATCTTCTTTG

8750R

GTTAGCAAAACAAGTATCTGTAGATGC

8

8650F

CCTGTTCATGTCATGTCTAAACATACTGACT

10,000R

ACCTGAGTTACTGAAGTCATTGAGAGCC

9

9900F

ATAAGTACAAGTATTTTAGTGGAGCAAT

11250R

ACCATATCCAACCATGTCATAATAC

10

11150F

GTCAAACATAAGCATGCATTTCTCTGT

12,500R

TGTTATAGTCTGGTAAGACAACCATTAG

11

12,400F

CAACAACATTATCAACAATGCAAGAGAT

13750R

TACCATGTCACCGTCTATTCTAAAC

12

13650F

TGTAGTTAAGAGACACACTTTCTCTAA

15,000R

ACTCATTGAATCATAATAAAGTCTAGCC

13

14,900F

GTATTAATGCTAACCAAGTCATCGTCAA

16250R

CTGTGAATTGCAAAGAACACAAGCC

14

16150F

ACACATGTTAGACATGTATTCTGTTATGC

17,500R

AATATTCTGGTTCTAGTGTGCCCTTAGT

15

17,400F

TGCCAGATTACGTGCTAAGCACTATGTG

18750R

CCCCATTGTTGAACATCAATCATAAACGG

16

18650F

CCTGAGCGCACCTGTTGTCTATG

20,000R

ACTCTACCATCAAAAAAGACAGTGAGTG

17

19,900F

GCACATATATCTACTATTGGTGTTTGTT

21250R

GCTTCAGATGATGACGCATTCAC

18

21150F

GGAGGTTCCGTGGCTATAAAGAT

22,500R

TAGATTCCTTTTTCTACAGTGAAGGATT

19

22,401F

ATGAAAATGGAACCATTACAGATGCTGT

23750R

CTGATGTCTTGGTCATAGACACTG

20

23650F

CTACACTATGTCACTTGGTGCAGA

25,000R

GTCTAATTCAGGTTGCAAAGGATCATAA

21

24,900F

AAATCATTACTACAGACAACACATTTGT

26250R

CTCTTCCGAAACGAATGAGTAC

22

26150F

CGACGGTTCATCCGGAGTTGTT

27,500R

GAGCAAGGTTCTTTTAAAAGTACTGTTG

23

27,400F

ATTATTCTTTTCTTGGCACTGATAACAC

28700R

CGGGTGCCAATGTGATCTTTTG

24

28600F

TTCTACTACCTAGGAACTGGGC

29,843R

GTCATTCTCCTAAGAAGCTATTAAAATC

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Table S4. Primers for the synthesis of cDNA for cold-adapted live attenuated SARSCoV-2 vaccine strain (SARS-CoV-2/human/Korea/CNUHV03-CA22oC/2020)

Primer
2500R
5000R
7500R
10,000R
12,500R
15,000R
17,500R
20,000R
22,500R
25,000R
27,500R
29,843R

Sequence
TTCTCCCTCTAAGAAGATAATTTCTTTT
GGTTAATGTTGTCTACTGTTGTAAACAC
CACATCATACAAGTTGATGAATTACAAC
ACCTGAGTTACTGAAGTCATTGAGAGCC
TGTTATAGTCTGGTAAGACAACCATTAG
ACTCATTGAATCATAATAAAGTCTAGCC
AATATTCTGGTTCTAGTGTGCCCTTAGT
ACTCTACCATCAAAAAAGACAGTGAGTG
TAGATTCCTTTTTCTACAGTGAAGGATT
GTCTAATTCAGGTTGCAAAGGATCATAA
GAGCAAGGTTCTTTTAAAAGTACTGTTG
GTCATTCTCCTAAGAAGCTATTAAAATC

B

**
**

10
8

Vaccine strain (CoV-2CNUHV03-CA22oC)

6
4

Wild-type strain (CoV-2CNUHV03)

2
0
0.00001

0.000001

Viral titers at 41oC, (RT-qPCR,
plaque forming units/ml, X103)

Viral titersat at 37oc (RT-qPCR,
plaque forming units/ml, X105)

12

**

12

**

10
8

Vaccine strain (CoV-2CNUHV03-CA22oC)

6
Wild-type strain (CoV2-CNUHV03)

4
2
0
0.00001

Mulitplicity of infections

0.000001

Mulitplicity of infections

Fig. S1. Temperature sensitivity of cold-adapted SARS-CoV-2 vaccine strain. Vero cells were infected with 0.00001 or 0.000001 m.o.i of
cold-adapted SARS-CoV-2 vaccine strain (CoV-2-CNUHV03-CA22oC) or wild-type SARS-CoV-2 (CoV-2-CNUHV03) and were incubated
at 37oC or 41oC for 3 days. Viral titers in cell supernatants were determined by RT-qPCR using SARS-CoV-2 N primers and probe. Viral
detection limit is 10 pfu. A, viral titers at 37oC; B, viral titers at 41oC. *p<0.05, **p<0.001

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

16

*

Cold-adapted SARS-CoV-2
infected mice on 6 days

14
12

*

Cold-adapted SARS-CoV-2
infected mice on 14 days

10
Wild-type SARS-CoV-2 infected
mice on 6 days

8
6

**

4
2
0
Nasal
turbinate

Lung

Kideny

Spleen

Viral titers (RT-qPCR, plaque
forming units/0.1g, X106)

Viral titers (RT-qPCR, plaque forming
units/0.1g, x103)

B
3

**

Cold-adapted SARS-CoV-2
infected mice on 6 days

2.5
Cold-adapted SARS-CoV-2
infected mice on 14 days

2

Wild-type SARS-CoV-2 infected
mice on 6 days

1.5
1
0.5
0

Tissues

Brain

Tissue

Fig. S2. Viral titers in tissues of hACE2 transgenic mice infected with cold adapted SARS-CoV-2. Viral titers in tissues of Fig.1c
were quantified RT-qPCR. Viral titers are the mean of 3 tissues ± standard deviations. Viral detection limit is 10 pfu. A, viral titers in
nasal turbinate, lung, kidney, and spleen, B, viral titers in brain. *p<0.05, **p<0.001

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

B

C

D

E

F

Fig. S3. Antigen staining in brain and kidney of hACE2 transgenic mice infected with cold adapted SARS-CoV-2. Brain and
kidney tissues of Fig. 1C (on day 6 p.i.) were stained with SARS-CoV-2 NP antibody (X400). A, brain tissue of PBS-mock mouse; B,
brain tissue of mouse i.n. infected with cold adapted SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) (2X104 pfu); C, brain tissue of mouse
i.n. infected with wild-type SARS-CoV-2 (CoV-2-CNUHV03) (2X104 pfu); D, kidney tissue of PBS-mock mouse; E, kidney tissue of
mouse i.n. infected with cold adapted SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) (2X104 pfu); F, kidney tissue of mouse i.n. infected
with wild-type SARS-CoV-2 (CoV-2-CNUHV03) (2X104 pfu). Arrow: positive antigen staining.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

B

C

Fig. S4. Antigen staining in lung, brain and kidney of hACE2 transgenic mice infected with cold adapted SARS-CoV-2 on day 14
p.i. Lung, brain and kidney tissues of Fig. 1 (on day 14 p.i.) were stained with SARS-CoV-2 NP antibody (X400). A, lung tissue of
mouse i.n. infected with cold adapted SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) (2X104 pfu); B, brain tissue of mouse i.n. infected
with cold adapted SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) (2X104 pfu); C, kidney tissue of mouse i.n. infected with cold adapted
SARS-CoV-2 (CoV-2-CNUHV03-CA22oC) (2X104 pfu).

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

collected from K18-ACE2 mice (n=16) before immunization, and their neutralizing antibody titers were determined against
wild-type SARS-CoV-2 viruses, CoV-2-CNUHV03 and CoV-2-KCDC03 in Vero cells. Detection limit of neutralizing
antibody is 10.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Fig. S5. Neutralizing antibody titers in sera collected from hACE2 transgenic mice before immunization. Sera were

IgA titers (optical density at 450nm)

PBS-mock mice

0.35

*

0.3
0.25
0.2
0.15
0.1
0.05
0
Nasal turbinate

b

Lung

Tissues

Kidney

B
Number of IFN-gamma expressing T cells
/250,000 splenocytes

Cold-adapted SARS-CoV-2 vaccinated mice

2000

**

1800
1600
1400
1200
1000
800
600
400
200
0
Cold-adapted SARSCoV-2 vaccinated mice

PBS-mock mice

Fig S6. IgA antibody titers and the number of T lymphocytes expressing IFN-γ in the immunized hACE2 transgenic mice. The
immunized K18-ACE2 mice (n=3) with 2X104 pfu of CoV-2-CNUHV03-CA22oC were euthanized to collect tissues (nasal turbinate, lungs,
kidneys, spleens) on 19 days after immunization. Nasal turbinate, lungs, and kidneys were homogenized in PBS and were used for detection
of IgA antibody by ELISA using the purified and inactivated SARS-CoV-2 antigen (SARS-CoV-2/human/Korea/CNUHV03/2020).
Lymphocytes were collected from spleens and used to determine the number of T lymphocytes expressing IFN-γ by ELISPOT assay. Data
are the mean of 3 tissues ± standard deviations. A, IgA antibody titers; B, number of T lymphocytes expressing IFN-γ. *p<0.05, **p<0.001

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

14

Cold-adapted SARS-CoV-2
vaccinated (20,000 pfu) &
challenged mice

**

Cold-adapted SARS-CoV-2
vaccinated (2000 pfu) &
challenged mice

12
10

PBS-mock & challenged mice

8
6

**

4
2

Viral titers (RT-qPCR,
plaque forming units/0.1g, X106)

16
Viral titers (RT-qPCR,
plaque forming unit/0.1g, X103)

B

**

0
Nasal
turbinate

Lung

Kideny

Spleen

Tissues

3.5

**

3

Cold-adapted SARS-CoV-2
vaccinated (20,000 pfu) &
challenged mice

Cold-adapted SARS-CoV-2
vaccinated (2000 pfu) &
challenged mice

2.5

PBS-mock & challenged mice

2
1.5
1
0.5
0
Brain

Tissue

Fig. S7. Viral titers in tissues of the immunized and challenged hACE2 transgenic mice. Viral titers in tissues of Fig.3E were
quantified RT-qPCR. Viral titers are the mean of 3 tissues ± standard deviations. Viral detection limit is 10 pfu. A, viral titers in nasal
turbinate, lung, kidney, and spleen; B, Viral titer in brain. *p<0.05, **p<0.001

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

B

C

D

E

F

G

H

Fig. S8. Antigen staining in brain and kidney of the immunized and challenged hACE2 transgenic mice. Brain and kidney tissues of
challenged K18-ACE2 mice (Fig. 3E) were stained with SARS-CoV-2 NP antibody (X400). A, brain tissue of PBS-mock mouse; B, brain
tissue of vaccinated mouse with CoV-2-CNUHV03-CA22oC (2X103 pfu) and challenged with CoV-2-KCDC03 (2X104 pfu) ; C, brain
tissue of vaccinated mouse with CoV-2-CNUHV03-CA22oC (2X104 pfu) and challenged with CoV-2-KCDC03 (2X104 pfu); D, brain
tissue of PBS-mock vaccinated mouse challenged with CoV-2-KCDC03 (2X104 pfu); E, kidney tissue of PBS-mock mouse; F, kidney
tissue of vaccinated mouse with CoV-2-CNUHV03-CA22oC (2X103 pfu) and challenged with CoV-2-KCDC03 (2X104 pfu); G, kidney
tissue of vaccinated mouse with CoV-2-CNUHV03-CA22oC (2X104 pfu) and challenged with CoV-2-KCDC03(2X104 pfu); H, kidney
tissue of PBS-mock vaccinated mouse challenged with CoV-2-KCDC03 (2X104 pfu). Arrow: positive antigen staining.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

GGTCTTATCAGAGGCACGTCAACATCTTAAAGATGGCACTTGTGGCTTAGTAGAAGTTGAAAAAGGCGTTTTGCCTCAACTTGAACAGCCCTATGTGTTCATCAAACGTT
120
130
140
150
160
170
180
190
200
210
220
Wild ORF1ab GGTCTTATCAGAGGCACGTCAACATCTTAAAGATGGCACTTGTGGCTTAGTAGAAGTTGAAAAAGGCGTTTTGCCTCAACTTGAACAGCCCTATGTGTTCATCAAACGTT
Vac ORF1ab GGTCTTATCAGAGGCACGTCAACATCTTAAAGATGGCACTTGTGGCTTAGTAGAAGTTGAAAAAGGCGTTTTGCCTCAACTTGAACAGCCCTATGTGTTCATCAAACGTT

CGGATGCTCGAACTGCACCTCATGGTCATGTTGTGGTTGAGCTGGTAGCAGAACTCGAAGGCATTCAGTACGGTCGTAGTGGTGAGACACTTGGTGTCCTTGTCCCTCAT
230
240
250
260
270
280
290
300
310
320
330
Wild ORF1ab CGGATGCTCGAACTGCACCTCATGGTCATGTTATGGTTGAGCTGGTAGCAGAACTCGAAGGCATTCAGTACGGTCGTAGTGGTGAGACACTTGGTGTCCTTGTCCCTCAT
Vac ORF1ab CGGATGCTCGAACTGCACCTCAT---------GTGGTTGAGCTGGTAGCAGAACTCGAAGGCATTCAGTACGGTCGTAGTGGTGAGACACTTGGTGTCCTTGTCCCTCAT

GTGGGCGAAATACCAGTGGCTTACCGCAAGGTTCTTCTTCGTAAGAACGGTAATAAAGGAGCTGGTGGCCATAGTTACGGCGCCGATCTAAAGTCATTTGACTTAGGCGA
340
350
360
370
380
390
400
410
420
430
440
Wild ORF1ab GTGGGCGAAATACCAGTGGCTTACCGCAAGGTTCTTCTTCGTAAGAACGGTAATAAAGGAGCTGGTGGCCATAGTTACGGCGCCGATCTAAAGTCATTTGACTTAGGCGA
Vac ORF1ab GTGGGCGAAATACCAGTGGCTTACCGCAAGGTTCTTCTTCGTAAGAACGGTAATAAAGGAGCTGGTGGCCATAGTTACGGCGCCGATCTAAAGTCATTTGACTTAGGCGA

CGAGCTTGGCACTGATCCTTATGAAGATTTTCAAGAAAACTGGAACACTAAACATAGCAGTGGTGTTACCCGTGAACTCATGCGTGAGCTTAACGGAGGGGCATACACTC
450
460
470
480
490
500
510
520
530
540
550
Wild ORF1ab CGAGCTTGGCACTGATCCTTATGAAGATTTTCAAGAAAACTGGAACACTAAACATAGCAGTGGTGTTACCCGTGAACTCATGCGTGAGCTTAACGGAGGGGCATACACTC
Vac ORF1ab CGAGCTTGGCACTGATCCTTATGAAGATTTTCAAGAAAACTGGAACACTAAACATAGCAGTGGTGTTACCCGTGAACTCATGCGTGAGCTTAACGGAGGGGCATACACTC

GCTATGTCGATAACAACTTCTGTGGCCCTGATGGCTACCCTCTTGAGTGCATTAAAGACCTTCTAGCACGTGCTGGTAAAGCTTCATGCACTTTGTCCGAACAACTGGAC
560
570
580
590
600
610
620
630
640
650
660
Wild ORF1ab GCTATGTCGATAACAACTTCTGTGGCCCTGATGGCTACCCTCTTGAGTGCATTAAAGACCTTCTAGCACGTGCTGGTAAAGCTTCATGCACTTTGTCCGAACAACTGGAC
Vac ORF1ab GCTATGTCGATAACAACTTCTGTGGCCCTGATGGCTACCCTCTTGAGTGCATTAAAGACCTTCTAGCACGTGCTGGTAAAGCTTCATGCACTTTGTCCGAACAACTGGAC

TTTATTGACACTAAGAGGGGTGTATACTGCTGCCGTGGACATGAGCATGAAATTGCTTGGTACACGGAACGTTCTGAAAAGAGCTATGAATTGCAGACACCTTTTGAAAT
670
680
690
700
710
720
730
740
750
760
770
Wild ORF1ab TTTATTGACACTAAGAGGGGTGTATACTGCTGCCGTGGACATGAGCATGAAATTGCTTGGTACACGGAACGTTCTGAAAAGAGCTATGAATTGCAGACACCTTTTGAAAT
Vac ORF1ab TTTATTGACACTAAGAGGGGTGTATACTGCTGCCGTGAACATGAGCATGAAATTGCTTGGTACACGGAACGTTCTGAAAAGAGCTATGAATTGCAGACACCTTTTGAAAT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGGAGAGCCTTGTCCCTGGTTTCAACGAGAAAACACACGTCCAACTCAGTTTGCCTGTTTTACAGGTTCGCGACGTGCTCGTACGTGGCTTTGGAGACTCCGTGGAGGA
10
20
30
40
50
60
70
80
90
100
110
Wild ORF1ab ATGGAGAGCCTTGTCCCTGGTTTCAACGAGAAAACACACGTCCAACTCAGTTTGCCTGTTTTACAGGTTCGCGACGTGCTCGTACGTGGCTTTGGAGACTCCGTGGAGGA
Vac ORF1ab ATGGAGAGCCTTGTCCCTGGTTTCAACGAGAAAACACACGTCCAACTCAGTTTGCCTGTTTTACAGGTTCGCGACGTGCTCGTACGTGGCTTTGGAGACTCCGTGGAGGA

ATGGCTTTATGGGTAGAATTCGATCTGTCTATCCAGTTGCGTCACCAAATGAATGCAACCAAATGTGCCTTTCAACTCTCATGAAGTGTGATCATTGTGGTGAAACTTCA
890
900
910
920
930
940
950
960
970
980
990
Wild ORF1ab ATGGCTTTATGGGTAGAATTCGATCTGTCTATCCAGTTGCGTCACCAAATGAATGCAACCAAATGTGCCTTTCAACTCTCATGAAGTGTGATCATTGTGGTGAAACTTCA
Vac ORF1ab ATGGCTTTATGGGTAGAATTCGATCTGTCTATCCAGTTGCGTCACCAAATGAATGCAACCAAATGTGCCTTTCAACTCTCATGAAGTGTGATCATTGTGGTGAAACTTCA

TGGCAGACGGGCGATTTTGTTAAAGCCACTTGCGAATTTTGTGGCACTGAGAATTTGACTAAAGAAGGTGCCACTACTTGTGGTTACTTACCCCAAAATGCTGTTGTTAA
1000
1010
1020
1030
1040
1050
1060
1070
1080
1090
1100
Wild ORF1ab TGGCAGACGGGCGATTTTGTTAAAGCCACTTGCGAATTTTGTGGCACTGAGAATTTGACTAAAGAAGGTGCCACTACTTGTGGTTACTTACCCCAAAATGCTGTTGTTAA
Vac ORF1ab TGGCAGACGGGCGATTTTGTTAAAGCCACTTGCGAATTTTGTGGCACTGAGAATTTGACTAAAGAAGGTGCCACTACTTGTGGTTACTTACCCCAAAATGCTGTTGTTAA

AATTTATTGTCCAGCATGTCACAATTCAGAAGTAGGACCTGAGCATAGTCTTGCCGAATACCATAATGAATCTGGCTTGAAAACCATTCTTCGTAAGGGTGGTCGCACTA
1110
1120
1130
1140
1150
1160
1170
1180
1190
1200
1210
Wild ORF1ab AATTTATTGTCCAGCATGTCACAATTCAGAAGTAGGACCTGAGCATAGTCTTGCCGAATACCATAATGAATCTGGCTTGAAAACCATTCTTCGTAAGGGTGGTCGCACTA
Vac ORF1ab AATTTATTGTCCAGCATGTCACAATTCAGAAGTAGGACCTGAGCATAGTCTTGCCGAATACCATAATGAATCTGGCTTGAAAACCATTCTTCGTAAGGGTGGTCGCACTA

TTGCCTTTGGAGGCTGTGTGTTCTCTTATGTTGGTTGCCATAACAAGTGTGCCTATTGGGTTCCACGTGCTAGCGCTAACATAGGTTGTAACCATACAGGTGTTGTTGGA
1220
1230
1240
1250
1260
1270
1280
1290
1300
1310
1320
Wild ORF1ab TTGCCTTTGGAGGCTGTGTGTTCTCTTATGTTGGTTGCCATAACAAGTGTGCCTATTGGGTTCCACGTGCTAGCGCTAACATAGGTTGTAACCATACAGGTGTTGTTGGA
Vac ORF1ab TTGCCTTTGGAGGCTGTGTGTTCTCTTATGTTGGTTGCCATAACAAGTGTGCCTATTGGGTTCCACGTGCTAGCGCTAACATAGGTTGTAACCATACAGGTGTTGTTGGA

GAAGGTTCCGAAGGTCTTAATGACAACCTTCTTGAAATACTCCAAAAAGAGAAAGTCAACATCAATATTGTTGGTGACTTTAAACTTAATGAAGAGATCGCCATTATTTT
1330
1340
1350
1360
1370
1380
1390
1400
1410
1420
1430
Wild ORF1ab GAAGGTTCCGAAGGTCTTAATGACAACCTTCTTGAAATACTCCAAAAAGAGAAAGTCAACATCAATATTGTTGGTGACTTTAAACTTAATGAAGAGATCGCCATTATTTT
Vac ORF1ab GAAGGTTCCGAAGGTCTTAATGACAACCTTCTTGAAATACTCCAAAAAGAGAAAGTCAACATCAATATTGTTGGTGACTTTAAACTTAATGAAGAGATCGCCATTATTTT

GGCATCTTTTTCTGCTTCCACAAGTGCTTTTGTGGAAACTGTGAAAGGTTTGGATTATAAAGCATTCAAACAAATTGTTGAATCCTGTGGTAATTTTAAAGTTACAAAAG
1440
1450
1460
1470
1480
1490
1500
1510
1520
1530
1540
Wild ORF1ab GGCATCTTTTTCTGCTTCCACAAGTGCTTTTGTGGAAACTGTGAAAGGTTTGGATTATAAAGCATTCAAACAAATTGTTGAATCCTGTGGTAATTTTAAAGTTACAAAAG
Vac ORF1ab GGCATCTTTTTCTGCTTCCACAAGTGCTTTTGTGGAAACTGTGAAAGGTTTGGATTATAAAGCATTCAAACAAATTGTTGAATCCTGTGGTAATTTTAAAGTTACAAAAG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TAAATTGGCAAAGAAATTTGACACCTTCAATGGGGAATGTCCAAATTTTGTATTTCCCTTAAATTCCATAATCAAGACTATTCAACCAAGGGTTGAAAAGAAAAAGCTTG
780
790
800
810
820
830
840
850
860
870
880
Wild ORF1ab TAAATTGGCAAAGAAATTTGACACCTTCAATGGGGAATGTCCAAATTTTGTATTTCCCTTAAATTCCATAATCAAGACTATTCAACCAAGGGTTGAAAAGAAAAAGCTTG
Vac ORF1ab TAAATTGGCAAAGAAATTTGACACCTTCAATGGGGAATGTCCAAATTTTGTATTTCCCTTAAATTCCATAATCAAGACTATTCAACCAAGGGTTGAAAAGAAAAAGCTTG

ACTCTTGAAACTGCTCAAAATTCTGTGCGTGTTTTACAGAAGGCCGCTATAACAATACTAGATGGAATTTCACAGTATTCACTGAGACTCATTGATGCTATGATGTTCAC
1660
1670
1680
1690
1700
1710
1720
1730
1740
1750
1760
Wild ORF1ab ACTCTTGAAACTGCTCAAAATTCTGTGCGTGTTTTACAGAAGGCCGCTATAACAATACTAGATGGAATTTCACAGTATTCACTGAGACTCATTGATGCTATGATGTTCAC
Vac ORF1ab ACTCTTGAAACTGCTCAAAATTCTGTGCGTGTTTTACAGAAGGCCGCTATAACAATACTAGATGGAATTTCACAGTATTCACTGAGACTCATTGATGCTATGATGTTCAC

ATCTGATTTGGCTACTAACAATCTAGTTGTAATGGCCTACATTACAGGTGGTGTTGTTCAGTTGACTTCGCAGTGGCTAACTAACATCTTTGGCACTGTTTATGAAAAAC
1770
1780
1790
1800
1810
1820
1830
1840
1850
1860
1870
Wild ORF1ab ATCTGATTTGGCTACTAACAATCTAGTTGTAATGGCCTACATTACAGGTGGTGTTGTTCAGTTGACTTCGCAGTGGCTAACTAACATCTTTGGCACTGTTTATGAAAAAC
Vac ORF1ab ATCTGATTTGGCTACTAACAATCTAGTTGTAATGGCCTACATTACAGGTGGTGTTGTTCAGTTGACTTCGCAGTGGCTAACTAACATCTTTGGCACTGTTTATGAAAAAC

TCAAACCCGTCCTTGATTGGCTTGAAGAGAAGTTTAAGGAAGGTGTAGAGTTTCTTAGAGACGGTTGGGAAATTGTTAAATTTATCTCAACCTGTGCTTGTGAAATTGTC
1880
1890
1900
1910
1920
1930
1940
1950
1960
1970
1980
Wild ORF1ab TCAAACCCGTCCTTGATTGGCTTGAAGAGAAGTTTAAGGAAGGTGTAGAGTTTCTTAGAGACGGTTGGGAAATTGTTAAATTTATCTCAACCTGTGCTTGTGAAATTGTC
Vac ORF1ab TCAAACCCGTCCTTGATTGGCTTGAAGAGAAGTTTAAGGAAGGTGTAGAGTTTCTTAGAGACGGTTGGGAAATTGTTAAATTTATCTCAACCTGTGCTTGTGAAATTGTC

GGTGGACAAATTGTCACCTGTGCAAAGGAAATTAAGGAGAGTGTTCAGACATTCTTTAAGCTTGTAAATAAATTTTTGGCTTTGTGTGCTGACTCTATCATTATTGGTGG
1990
2000
2010
2020
2030
2040
2050
2060
2070
2080
2090
Wild ORF1ab GGTGGACAAATTGTCACCTGTGCAAAGGAAATTAAGGAGAGTGTTCAGACATTCTTTAAGCTTGTAAATAAATTTTTGGCTTTGTGTGCTGACTCTATCATTATTGGTGG
Vac ORF1ab GGTGGACAAATTGTCACCTGTGCAAAGGAAATTAAGGAGAGTGTTCAGACATTCTTTAAGCTTGTAAATAAATTTTTGGCTTTGTGTGCTGACTCTATCATTATTGGTGG

AGCTAAACTTAAAGCCTTGAATTTAGGTGAAACATTTGTCACGCACTCAAAGGGATTGTACAGAAAGTGTGTTAAATCCAGAGAAGAAACTGGCCTACTCATGCCTCTAA
2100
2110
2120
2130
2140
2150
2160
2170
2180
2190
2200
Wild ORF1ab AGCTAAACTTAAAGCCTTGAATTTAGGTGAAACATTTGTCACGCACTCAAAGGGATTGTACAGAAAGTGTGTTAAATCCAGAGAAGAAACTGGCCTACTCATGCCTCTAA
Vac ORF1ab AGCTAAACTTAAAGCCTTGAATTTAGGTGAAACATTTGTCACGCACTCAAAGGGATTGTACAGAAAGTGTGTTAAATCCAGAGAAGAAACTGGCCTACTCATGCCTCTAA

AAGCCCCAAAAGAAATTATCTTCTTAGAGGGAGAAACACTTCCCACAGAAGTGTTAACAGAGGAAGTTGTTTTGAAAACTGGTGATTTACAACCATTAGAACAACCTACT
2210
2220
2230
2240
2250
2260
2270
2280
2290
2300
2310
Wild ORF1ab AAGCCCCAAAAGAAATTATCTTCTTAGAGGGAGAAACACTTCCCACAGAAGTGTTAACAGAGGAAGTTGTTTTGAAAACTGGTGATTTACAACCATTAGAACAACCTACT
Vac ORF1ab AAGCCCCAAAAGAAATTATCTTCTTAGAGGGAGAAACACTTCCCACAGAAGTGTTAACAGAGGAAGTTGTCTTGAAAACTGGTGATTTACAACCATTAGAACAACCTACT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

GAAAAGCTAAAAAAGGTGCCTGGAATATTGGTGAACAGAAATCAATACTGAGTCCTCTTTATGCATTTGCATCAGAGGCTGCTCGTGTTGTACGATCAATTTTCTCCCGC
1550
1560
1570
1580
1590
1600
1610
1620
1630
1640
1650
Wild ORF1ab GAAAAGCTAAAAAAGGTGCCTGGAATATTGGTGAACAGAAATCAATACTGAGTCCTCTTTATGCATTTGCATCAGAGGCTGCTCGTGTTGTACGATCAATTTTCTCCCGC
Vac ORF1ab GAAAAGCTAAAAAAGGTGCCTGGAATATTGGTGAACAGAAATCAATACTGAGTCCTCTTTATGCATTTGCATCAGAGGCTGCTCGTGTTGTACGATCAATTTTCTCCCGC

GGTAACAAACAATACCTTCACACTCAAAGGCGGTGCACCAACAAAGGTTACTTTTGGTGATGACACTGTGATAGAAGTGCAAGGTTACAAGAGTGTGAATATCACTTTTG
2430
2440
2450
2460
2470
2480
2490
2500
2510
2520
2530
Wild ORF1ab GGTAACAAACAATACCTTCACACTCAAAGGCGGTGCACCAACAAAGGTTACTTTTGGTGATGACACTGTGATAGAAGTGCAAGGTTACAAGAGTGTGAATATCACTTTTG
Vac ORF1ab GGTAACAAACAATACCTTCACACTCAAAGGCGGTGCACCAACAAAGGTTACTTTTGGTGATGACACTGTGATAGAAGTGCAAGGTTACAAGAGTGTGAATATCACTTTTG

AACTTGATGAAAGGATTGATAAAGTACTTAATGAGAAGTGCTCTGCCTATACAGTTGAACTCGGTACAGAAGTAAATGAGTTCGCCTGTGTTGTGGCAGATGCTGTCATA
2540
2550
2560
2570
2580
2590
2600
2610
2620
2630
2640
Wild ORF1ab AACTTGATGAAAGGATTGATAAAGTACTTAATGAGAAGTGCTCTGCCTATACAGTTGAACTCGGTACAGAAGTAAATGAGTTCGCCTGTGTTGTGGCAGATGCTGTCATA
Vac ORF1ab AACTTGATGAAAGGATTGATAAAGTACTTAATGAGAAGTGCTCTGCCTATACAGTTGAACTCGGTACAGAAGTAAATGAGTTCGCCTGTGTTGTGGCAGATGCTGTCATA

AAAACTTTGCAACCAGTATCTGAATTACTTACACCACTGGGCATTGATTTAGATGAGTGGAGTATGGCTACATACTACTTATTTGATGAGTCTGGTGAGTTTAAATTGGC
2650
2660
2670
2680
2690
2700
2710
2720
2730
2740
2750
Wild ORF1ab AAAACTTTGCAACCAGTATCTGAATTACTTACACCACTGGGCATTGATTTAGATGAGTGGAGTATGGCTACATACTACTTATTTGATGAGTCTGGTGAGTTTAAATTGGC
Vac ORF1ab AAAACTTTGCAACCAGTATCTGAATTACTTACACCACTGGGCATTGATTTAGATGAGTGGAGTATGGCTACATACTACTTATTTGATGAGTCTGGTGAGTTTAAATTGGC

TTCACATATGTATTGTTCTTTCTACCCTCCAGATGAGGATGAAGAAGAAGGTGATTGTGAAGAAGAAGAGTTTGAGCCATCAACTCAATATGAGTATGGTACTGAAGATG
2760
2770
2780
2790
2800
2810
2820
2830
2840
2850
2860
Wild ORF1ab TTCACATATGTATTGTTCTTTCTACCCTCCAGATGAGGATGAAGAAGAAGGTGATTGTGAAGAAGAAGAGTTTGAGCCATCAACTCAATATGAGTATGGTACTGAAGATG
Vac ORF1ab TTCACATATGTATTGTTCTTTCTACCCTCCAGATGAGGATGAAGAAGAAGGTGATTGTGAAGAAGAAGAGTTTGAGCCATCAACTCAATATGAGTATGGTACTGAAGATG

ATTACCAAGGTAAACCTTTGGAATTTGGTGCCACTTCTGCTGCTCTTCAACCTGAAGAAGAGCAAGAAGAAGATTGGTTAGATGATGATAGTCAACAAACTGTTGGTCAA
2870
2880
2890
2900
2910
2920
2930
2940
2950
2960
2970
Wild ORF1ab ATTACCAAGGTAAACCTTTGGAATTTGGTGCCACTTCTGCTGCTCTTCAACCTGAAGAAGAGCAAGAAGAAGATTGGTTAGATGATGATAGTCAACAAACTGTTGGTCAA
Vac ORF1ab ATTACCAAGGTAAACCTTTGGAATTTGGTGCCACTTCTGCTGCTCTTCAACCTGAAGAAGAGCAAGAAGAAGATTGGTTAGATGATGATAGTCAACAAACTGTTGGTCAA

CAAGACGGCAGTGAGGACAATCAGACAACTACTATTCAAACAATTGTTGAGGTTCAACCTCAATTAGAGATGGAACTTACACCAGTTGTTCAGACTATTGAAGTGAATAG
2980
2990
3000
3010
3020
3030
3040
3050
3060
3070
3080
Wild ORF1ab CAAGACGGCAGTGAGGACAATCAGACAACTACTATTCAAACAATTGTTGAGGTTCAACCTCAATTAGAGATGGAACTTACACCAGTTGTTCAGACTATTGAAGTGAATAG
Vac ORF1ab CAAGACGGCAGTGAGGACAATCAGACAACTACTATTCAAACAATTGTTGAGGTTCAACCTCAATTAGAGATGGAACTTACACCAGTTGTTCAGACTATTGAAGTGAATAG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

AGTGAAGCTGTTGAAGCTCCATTGGTTGGTACACCAGTTTGTATTAACGGGCTTATGTTGCTCGAAATCAAAGACACAGAAAAGTACTGTGCCCTTGCACCTAATATGAT
2320
2330
2340
2350
2360
2370
2380
2390
2400
2410
2420
Wild ORF1ab AGTGAAGCTGTTGAAGCTCCATTGGTTGGTACACCAGTTTGTATTAACGGGCTTATGTTGCTCGAAATCAAAGACACAGAAAAGTACTGTGCCCTTGCACCTAATATGAT
Vac ORF1ab AGTGAAGCTGTTGAAGCTCCATTGGTTGGTACACCAGTTTGTATTAACGGGCTTATGTTGCTCGAAATCAAAGACACAGAAAAGTACTGTGCCCTTGCACCTAATATGAT

ACCTTAAACATGGAGGAGGTGTTGCAGGAGCCTTAAATAAGGCTACTAACAATGCCATGCAAGTTGAATCTGATGATTACATAGCTACTAATGGACCGCTTAAAGTGGGT
3200
3210
3220
3230
3240
3250
3260
3270
3280
3290
3300
Wild ORF1ab ACCTTAAACATGGAGGAGGTGTTGCAGGAGCCTTAAATAAGGCTACTAACAATGCCATGCAAGTTGAATCTGATGATTACATAGCTACTAATGGACCGCTTAAAGTGGGT
Vac ORF1ab ACCTTAAACATGGAGGAGGTGTTGCAGGAGCCTTAAATAAGGCTACTAACAATGCCATGCAAGTTGAATCTGATGATTACATAGCTACTAATGGACCACTTAAAGTGGGT

GGTAGTTGTGTTTTAAGCGGACACAATCTTGCTAAACACTGTCTTCATGTTGTCGGCCCAAATGTTAACAAAGGTGAAGACATTCAACTTCTTAAGAGTGCTTATGAAAA
3310
3320
3330
3340
3350
3360
3370
3380
3390
3400
3410
Wild ORF1ab GGTAGTTGTGTTTTAAGCGGACACAATCTTGCTAAACACTGTCTTCATGTTGTCGGCCCAAATGTTAACAAAGGTGAAGACATTCAACTTCTTAAGAGTGCTTATGAAAA
Vac ORF1ab GGTAGTTGTGTTTTAAGCGGACACAATCTTGCTAAACACTGTCTTCATGTTGTCGGCCCAAATGTTAACAAAGGTGAAGACATTCAACTTCTTAAGAGTGCTTATGAAAA

TTTTAATCAGCACGAAGTTCTACTTGCACCATTATTATCAGCTGGTATTTTTGGTGCTGACCCTATACATTCTTTAAGAGTTTGTGTAGATACTGTTCGCACAAATGTCT
3420
3430
3440
3450
3460
3470
3480
3490
3500
3510
3520
Wild ORF1ab TTTTAATCAGCACGAAGTTCTACTTGCACCATTATTATCAGCTGGTATTTTTGGTGCTGACCCTATACATTCTTTAAGAGTTTGTGTAGATACTGTTCGCACAAATGTCT
Vac ORF1ab TTTTAATCAGCACGAAGTTCTACTTGCACCATTATTATCAGCTGGTATTTTTGGTGCTGACCCTATACATTCTTTAAGAGTTTGTGTAGATACTGTTCGCACAAATGTCT

ACTTAGCTGTCTTTGATAAAAATCTCTATGACAAACTTGTTTCAAGCTTTTTGGAAATGAAGAGTGAAAAGCAAGTTGAACAAAAGATCGCTGAGATTCCTAAAGAGGAA
3530
3540
3550
3560
3570
3580
3590
3600
3610
3620
3630
Wild ORF1ab ACTTAGCTGTCTTTGATAAAAATCTCTATAACAAACTTGTTTCAAGCTTTTTGGAAATGAAGAGTGAAAAGCAAGTTGAACAAAAGATCGCTGAGATTCCTAAAGAGGAA
Vac ORF1ab ACTTAGCTGTCTTTGATAAAAATCTCTATGACAAACTTGTTTCAAGCTTTTTGGAAATGAAGAGTGAAAAGCAAGTTGAACAAAAGATCGCTGAGATTCCTAAAGAGGAA

GTTAAGCCATTTATAACTGAAAGTAAACCTTCAGTTGAACAGAGAAAACAAGATGATAAGAAAATCAAAGCTTGTGTTGAAGAAGTTACAACAACTCTGGAAGAAACTAA
3640
3650
3660
3670
3680
3690
3700
3710
3720
3730
3740
Wild ORF1ab GTTAAGCCATTTATAACTGAAAGTAAACCTTCAGTTGAACAGAGAAAACAAGATGATAAGAAAATCAAAGCTTGTGTTGAAGAAGTTACAACAACTCTGGAAGAAACTAA
Vac ORF1ab GTTAAGCCATTTATAACTGAAAGTAAACCTTCAGTTGAACAGAGAAAACAAGATGATAAGAAAATCAAAGCTTGTGTTGAAGAAGTTACAACAACTCTGGAAGAAACTAA

GTTCCTCACAGAAAACTTGTTACTTTATATTGACATTAATGGCAATCTTCATCCAGATTCTGCCACTCTTGTTAGTGACATTGACATCACTTTCTTAAAGAAAGATGCTC
3750
3760
3770
3780
3790
3800
3810
3820
3830
3840
3850
Wild ORF1ab GTTCCTCACAGAAAACTTGTTACTTTATATTGACATTAATGGCAATCTTCATCCAGATTCTGCCACTCTTGTTAGTGACATTGACATCACTTTCTTAAAGAAAGATGCTC
Vac ORF1ab GTTCCTCACAGAAAACTTGTTACTTTATATTGACATTAATGGCAATCTTCATCCAGATTCTGCCACTCTTGTTAGTGACATTGACATCACTTTCTTAAAGAAAGATGCTC

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TTTTAGTGGTTATTTAAAACTTACTGACAATGTATACATTAAAAATGCAGACATTGTGGAAGAAGCTAAAAAGGTAAAACCAACAGTGGTTGTTAATGCAGCCAATGTTT
3090
3100
3110
3120
3130
3140
3150
3160
3170
3180
3190
Wild ORF1ab TTTTAGTGGTTATTTAAAACTTACTGACAATGTATACATTAAAAATGCAGACATTGTGGAAGAAGCTAAAAAGGTAAAACCAACAGTGGTTGTTAATGCAGCCAATGTTT
Vac ORF1ab TTTTAGTGGTTATTTAAAACTTACTGACAATGTATACATTAAAAATGCAGACATTGTGGAAGAAGCTAAAAAGGTAAAACCAACAGTGGTTGTTAATGCAGCCAATGTTT

CCAACAGACAATTATATAACCACTTACCCGGGTCAGGGTTTAAATGGTTACACTGTAGAGGAGGCAAAGACAGTGCTTAAAAAGTGTAAAAGTGCCTTTTACATTCTACC
3970
3980
3990
4000
4010
4020
4030
4040
4050
4060
4070
Wild ORF1ab CCAACAGACAATTATATAACCACTTACCCGGGTCAGGGTTTAAATGGTTACACTGTAGAGGAGGCAAAGACAGTGCTTAAAAAGTGTAAAAGTGCCTTTTACATTCTACC
Vac ORF1ab CCAACAGACAATTATATAACCACTTACCCGGGTCAGGGTTTAAATGGTTACACTGTAGAGGAGGCAAAGACAGTGCTTAAAAAGTGTAAAAGTGCCTTTTACATTCTACC

ATCTATTATCTCTAATGAGAAGCAAGAAATTCTTGGAACTGTTTCTTGGAATTTGCGAGAAATGCTCGCACATGCAGAAGAAACACGCAAATTAATGCCTGTCTGTGTGG
4080
4090
4100
4110
4120
4130
4140
4150
4160
4170
4180
Wild ORF1ab ATCTATTATCTCTAATGAGAAGCAAGAAATTCTTGGAACTGTTTCTTGGAATTTGCGAGAAATGCTCGCACATGCAGAAGAAACACGCAAATTAATGCCTGTCTGTGTGG
Vac ORF1ab ATCTATTATCTCTAATGAGAAGCAAGAAATTCTTGGAACTGTTTCTTGGAATTTGCGAGAAATGCTCGCACATGCAGAAGAAACACGCAAATTAATGCCTGTCTGTGTGG

AAACTAAAGCCATAGTTTCAACTATACAGCGTAAATATAAGGGTATTAAAATACAAGAGGGTGTGGTTGATTATGGTGCTAGATTTTACTTTTACACCAGTAAAACAACT
4190
4200
4210
4220
4230
4240
4250
4260
4270
4280
4290
Wild ORF1ab AAACTAAAGCCATAGTTTCAACTATACAGCGTAAATATAAGGGTATTAAAATACAAGAGGGTGTGGTTGATTATGGTGCTAGATTTTACTTTTACACCAGTAAAACAACT
Vac ORF1ab AAACTAAAGCCATAGTTTCAACTATACAGCGTAAATATAAGGGTATTAAAATACAAGAGGGTGTGGTTGATTATGGTGCTAGATTTTACTTTTACACCAGTAAAACAACT

GTAGCGTCACTTATCAACACACTTAACGATCTAAATGAAACTCTTGTTACAATGCCACTTGGCTATGTAACACATGGCTTAAATTTGGAAGAAGCTGCTCGGTATATGAG
4300
4310
4320
4330
4340
4350
4360
4370
4380
4390
4400
Wild ORF1ab GTAGCGTCACTTATCAACACACTTAACGATCTAAATGAAACTCTTGTTACAATGCCACTTGGCTATGTAACACATGGCTTAAATTTGGAAGAAGCTGCTCGGTATATGAG
Vac ORF1ab GTAGCGTCACTTATCAACACACTTAACGATCTAAATGAAACTCTTGTTACAATGCCACTTGGCTATGTAACACATGGCTTAAATTTGGAAGAAGCTGCTCGGTATATGAG

ATCTCTCAAAGTGCCAGCTACAGTTTCTGTTTCTTCACCTGATGCTGTTACAGCGTATAATGGTTATCTTACTTCTTCTTCTAAAACACCTGAAGAACATTTTATTGAAA
4410
4420
4430
4440
4450
4460
4470
4480
4490
4500
4510
Wild ORF1ab ATCTCTCAAAGTGCCAGCTACAGTTTCTGTTTCTTCACCTGATGCTGTTACAGCGTATAATGGTTATCTTACTTCTTCTTCTAAAACACCTGAAGAACATTTTATTGAAA
Vac ORF1ab ATCTCTCAAAGTGCCAGCTACAGTTTCTGTTTCTTCACCTGATGCTGTTACAGCGTATAATGGTTATCTTACTTCTTCTTCTAAAACACCTGAAGAACATTTTATTGAAA

CCATCTCACTTGCTGGTTCCTATAAAGATTGGTCCTATTCTGGACAATCTACACAACTAGGTATAGAATTTCTTAAGAGAGGTGATAAAAGTGTATATTACACTAGTAAT
4520
4530
4540
4550
4560
4570
4580
4590
4600
4610
4620
Wild ORF1ab CCATCTCACTTGCTGGTTCCTATAAAGATTGGTCCTATTCTGGACAATCTACACAACTAGGTATAGAATTTCTTAAGAGAGGTGATAAAAGTGTATATTACACTAGTAAT
Vac ORF1ab CCATCTCACTTGCTGGTTCCTATAAAGATTGGTCCTATTCTGGACAATCTACACAACTAGGTATAGAATTTCTTAAGAGAGGTGATAAAAGTGTATATTACACTAGTAAT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

CATATATAGTGGGTGATGTTGTTCAAGAGGGTGTTTTAACTGCTGTGGTTATACCTACTAAAAAGGCTGGTGGCACTACTGAAATGCTAGCGAAAGCTTTGAGAAAAGTG
3860
3870
3880
3890
3900
3910
3920
3930
3940
3950
3960
Wild ORF1ab CATACATAGTGGGTGATGTTGTTCAAGAGGGTGTTTTAACTGCTGTGGTTATACCTACTAAAAAGGCTGGTGGCACTACTGAAATGCTAGCGAAAGCTTTGAGAAAAGTG
Vac ORF1ab CATATATAGTGGGTGATGTTGTTCAAGAGGGTGTTTTAACTGCTGTGGTTATACCTACTAAAAAGGCTGGTGGCACTACTGAAATGCTAGCGAAAGCTTTGAGAAAAGTG

TAACCTCCACACGCAAGTTGTGGGCATGTCAATGACATATGGACAACAGTTTGGTCCAACTTATTTTGATGGAGCTGATGTTACTAAAATAAAACCTCATAATTCACATG
4740
4750
4760
4770
4780
4790
4800
4810
4820
4830
4840
Wild ORF1ab TAACCTCCACACGCAAGTTGTGGGCATGTCAATGACATATGGACAACAGTTTGGTCCAACTTATTTTGATGGAGCTGATGTTACTAAAATAAAACCTCATAATTCACATG
Vac ORF1ab TAACCTCCACACGCAAGTTGTGGACATGTCAATGACATATGGACAACAGTTTGGTCCAACTTATTTTGATGGAGCTGATGTTACTAAAATAAAACCTCATAATTCACATG

AAGGTAAAACATTTTATGTTTTACCTAATGATGACACTCTACGTGTTGAGGCTTTTGAGTACTACCACACAACTGATCCTAGTTTTCTGGGTAGGTACATGTCAGCATTA
4850
4860
4870
4880
4890
4900
4910
4920
4930
4940
4950
Wild ORF1ab AAGGTAAAACATTTTATGTTTTACCTAATGATGACACTCTACGTGTTGAGGCTTTTGAGTACTACCACACAACTGATCCTAGTTTTCTGGGTAGGTACATGTCAGCATTA
Vac ORF1ab AAGGTAAAACATTTTATGTTTTACCTAATGATGACACTCTACGTGTTGAGGCTTTTGAGTACTACCACACAACTGATCCTAGTTTTCTGGGTAGGTACATGTCAGCATTA

AATCACACTAAAAAGTGGAAATACCCACAAGTTAATGGTTTAACTTCTATTAAATGGGCAGATAACAACTGTTATCTTGCCACTGCATTGTTAACACTCCAACAAATAGA
4960
4970
4980
4990
5000
5010
5020
5030
5040
5050
5060
Wild ORF1ab AATCACACTAAAAAGTGGAAATACCCACAAGTTAATGGTTTAACTTCTATTAAATGGGCAGATAACAACTGTTATCTTGCCACTGCATTGTTAACACTCCAACAAATAGA
Vac ORF1ab AATCACACTAAAAAGTGGAAATACCCACAAGTTAATGGTTTAACTTCTATTAAATGGGCAGATAACAACTGTTATCTTGCCACTGCATTGTTAACACTCCAACAAATAGA

GTTGAAGTTTAATCCACCTGCTCTACAAGATGCTTATTACAGAGCAAGGGCTGGTGAAGCTGCTAACTTTTGTGCACTTATCTTAGCCTACTGTAATAAGACAGTAGGTG
5070
5080
5090
5100
5110
5120
5130
5140
5150
5160
5170
Wild ORF1ab GTTGAAGTTTAATCCACCTGCTCTACAAGATGCTTATTACAGAGCAAGGGCTGGTGAAGCTGCTAACTTTTGTGCACTTATCTTAGCCTACTGTAATAAGACAGTAGGTG
Vac ORF1ab GTTGAAGTTTAATCCACCTGCTCTACAAGATGCTTATTACAGAGCAAGGGCTGGTGAAGCTGCTAACTTTTGTGCACTTATCTTAGCCTACTGTAATAAGACAGTAGGTG

AGTTAGGTGATGTTAGAGAAACAATGAGTTACTTGTTTCAACATGCCAATTTAGATTCTTGCAAAAGAGTCTTGAACGTGGTGTGTAAAACTTGTGGACAACAGCAGACA
5180
5190
5200
5210
5220
5230
5240
5250
5260
5270
5280
Wild ORF1ab AGTTAGGTGATGTTAGAGAAACAATGAGTTACTTGTTTCAACATGCCAATTTAGATTCTTGCAAAAGAGTCTTGAACGTGGTGTGTAAAACTTGTGGACAACAGCAGACA
Vac ORF1ab AGTTAGGTGATGTTAGAGAAACAATGAGTTACTTGTTTCAACATGCCAATTTAGATTCTTGCAAAAGAGTCTTGAACGTGGTGTGTAAAACTTGTGGACAACAGCAGACA

ACCCTTAAGGGTGTAGAAGCTGTTATGTACATGGGCACACTTTCTTATGAACAATTTAAGAAAGGTGTTCAGATACCTTGTACGTGTGGTAAACAAGCTACAAAATATCT
5290
5300
5310
5320
5330
5340
5350
5360
5370
5380
5390
Wild ORF1ab ACCCTTAAGGGTGTAGAAGCTGTTATGTACATGGGCACACTTTCTTATGAACAATTTAAGAAAGGTGTTCAGATACCTTGTACGTGTGGTAAACAAGCTACAAAATATCT
Vac ORF1ab ACCCTTAAGGGTGTAGAAGCTGTTATGTACATGGGCACACTTTCTTATGAACAATTTAAGAAAGGTGTTCAGATACCTTGTACGTGTGGTAAACAAGCTACAAAATATCT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

CCTACCACATTCCACCTAGATGGTGAAGTTATCACCTTTGACAATCTTAAGACACTTCTTTCTTTGAGAGAAGTGAGGACTATTAAGGTGTTTACAACAGTAGACAACAT
4630
4640
4650
4660
4670
4680
4690
4700
4710
4720
4730
Wild ORF1ab CCTACCACATTCCACCTAGATGGTGAAGTTATCACCTTTGACAATCTTAAGACACTTCTTTCTTTGAGAGAAGTGAGGACTATTAAGGTGTTTACAACAGTAGACAACAT
Vac ORF1ab CCTACCACATTCCACCTAGATGGTGAAGTTATCACCTTTGACAATCTTAAGACACTTCTTTCTTTGAGAGAAGTGAGGACTATTAAGGTGTTTACAACAGTAGACAACAT

GTCACTATAAACATATAACTTCTAAAGAAACTTTGTATTGCATAGACGGTGCTTTACTTACAAAGTCCTCAGAATACAAAGGTCCTATTACGGATGTTTTCTACAAAGAA
5510
5520
5530
5540
5550
5560
5570
5580
5590
5600
5610
Wild ORF1ab GTCACTATAAACATATAACTTCTAAAGAAACTTTGTATTGCATAGACGGTGCTTTACTTACAAAGTCCTCAGAATACAAAGGTCCTATTACGGATGTTTTCTACAAAGAA
Vac ORF1ab GTCACTATAAACATATAACTTCTAAAGAAACTTTGTATTGCATAGACGGTGCTTTACTTACAAAGTCCTCAGAATACAAAGGTCCTATTACGGATGTTTTCTACAAAGAA

AACAGTTACACAACAACCATAAAACCAGTTACTTATAAATTGGATGGTGTTGTTTGTACAGAAATTGACCCTAAGTTGGACAATTATTATAAGAAAGACAATTCTTATTT
5620
5630
5640
5650
5660
5670
5680
5690
5700
5710
5720
Wild ORF1ab AACAGTTACACAACAACCATAAAACCAGTTACTTATAAATTGGATGGTGTTGTTTGTACAGAAATTGACCCTAAGTTGGACAATTATTATAAGAAAGACAATTCTTATTT
Vac ORF1ab AACAGTTACACAACAACCATAAAACCAGTTACTTATAAATTGGATGGTGTTGTTTGTACAGAAATTGACCCTAAGTTGGACAATTATTATAAGAAAGACAATTCTTATTT

CACAGAGCAACCAATTGATCTTGTACCAAACCAACCATATCCAAGCGCAAGCTTCGATAATTTTAAGTTTGTATGTGATAATATCAAATTTGCTGATGATTTAAACCAGT
5730
5740
5750
5760
5770
5780
5790
5800
5810
5820
5830
Wild ORF1ab CACAGAGCAACCAATTGATCTTGTACCAAACCAACCATATCCAAGCGCAAGCTTCGATAATTTTAAGTTTGTATGTGATAATATCAAATTTGCTGATGATTTAAACCAGT
Vac ORF1ab CACAGAGCAACCAATTGATCTTGTACCAAACCAACCATATCCAAACGCAAGCTTCGATAATTTTAAGTTTGTATGTGATAATATCAAATTTGCTGATGATTTAAACCAGT

TAACTGGTTATAAGAAACCTGCTTCAAGAGAGCTTAAAGTTACATTTTTCCCTGACTTAAATGGTGATGTGGTGGCTATTGATTATAAACACTACACACCCTCTTTTAAG
5840
5850
5860
5870
5880
5890
5900
5910
5920
5930
5940
Wild ORF1ab TAACTGGTTATAAGAAACCTGCTTCAAGAGAGCTTAAAGTTACATTTTTCCCTGACTTAAATGGTGATGTGGTGGCTATTGATTATAAACACTACACACCCTCTTTTAAG
Vac ORF1ab TAACTGGTTATAAGAAACCTGCTTCAAGAGAGCTTAAAGTTACATTTTTCCCTGACTTAAATGGTGATGTGGTGGCTATTGATTATAAACACTACACACCCTCTTTTAAG

AAAGGAGCTAAATTGTTACATAAACCTATTGTTTGGCATGTTAACAATGCAACTAATAAAGCCACGTATAAACCAAATACCTGGTGTATACGTTGTCTTTGGAGCACAAA
5950
5960
5970
5980
5990
6000
6010
6020
6030
6040
6050
Wild ORF1ab AAAGGAGCTAAATTGTTACATAAACCTATTGTTTGGCATGTTAACAATGCAACTAATAAAGCCACGTATAAACCAAATACCTGGTGTATACGTTGTCTTTGGAGCACAAA
Vac ORF1ab AAAGGAGCTAAATTGTTACATAAACCTATTGTTTGGCATGTTAACAATGCAACTAATAAAGCCACGTATAAACCAAATACCTGGTGTATACGTTGTCTTTGGAGCACAAA

ACCAGTTGAAACATCAAATTCGTTTGATGTACTGAAGTCAGAGGACGCGCAGGGAATGGATAATCTTGCCTGCGAGGATCTAAAACCAGTCTCTGAAGAAGTAGTGGAAA
6060
6070
6080
6090
6100
6110
6120
6130
6140
6150
6160
Wild ORF1ab ACCAGTTGAAACATCAAATTCGTTTGATGTACTGAAGTCAGAGGACGCGCAGGGAATGGATAATCTTGCCTGCGAGGATCTAAAACCAGTCTCTGAAGAAGTAGTGGAAA
Vac ORF1ab ACCAGTTGAAACATCAAATTCGTTTGATGTACTGAAGTCAGAGGACGCGCAGGGAATGGATAATCTTGCCTGCGAAGATCTAAAACCAGTCTCTGAAGAAGTAGTGGAAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

AGTACAACAGGAGTCACCTTTTGTTATGATGTCAGCACCACCTGCTCAGTATGAACTTAAGCATGGTACATTTACTTGTGCTAGTGAGTACACTGGTAATTACCAGTGTG
5400
5410
5420
5430
5440
5450
5460
5470
5480
5490
5500
Wild ORF1ab AGTACAACAGGAGTCACCTTTTGTTATGATGTCAGCACCACCTGCTCAGTATGAACTTAAGCATGGTACATTTACTTGTGCTAGTGAGTACACTGGTAATTACCAGTGTG
Vac ORF1ab AGTACAACAGGAGTCACCTTTTGTTATGATGTCAGCACCACCTGCTCAGTATGAACTTAAGCATGGTACATTTACTTGTGCTAGTGAGTACACTGGTAATTACCAGTGTG

GGCCACACAGATCTAATGGCTGCTTATGTAGACAATTCTAGTCTTACTATTAAGAAACCTAATGAATTATCTAGAGTATTAGGTTTGAAAACCCTTGCTACTCATGGTTT
6280
6290
6300
6310
6320
6330
6340
6350
6360
6370
6380
Wild ORF1ab GGCCACACAGATCTAATGGCTGCTTATGTAGACAATTCTAGTCTTACTATTAAGAAACCTAATGAATTATCTAGAGTATTAGGTTTGAAAACCCTTGCTACTCATGGTTT
Vac ORF1ab GGCCACACAGATCTAATGGCTGCTTATGTAGACAATTCTAGTCTTACTATTAAGAAACCTAATGAATTATCTAGAGTATTAGGTTTGAAAACCCTTGCTACTCATGGTTT

AGCTGCTGTTAATAGTGTCCCTTGGGATACTATAGCTAATTATGCTAAGCCTTTTCTTAACAAAGTTGTTAGTACAACTACTAACATAGTTACACGGTGTTTAAACCGTG
6390
6400
6410
6420
6430
6440
6450
6460
6470
6480
6490
Wild ORF1ab AGCTGCTGTTAATAGTGTCCCTTGGGATACTATAGCTAATTATGCTAAGCCTTTTCTTAACAAAGTTGTTAGTACAACTACTAACATAGTTACACGGTGTTTAAACCGTG
Vac ORF1ab AGCTGCTGTTAATAGTGTCCCTTGGGATACTATAGCTAATTATGCTAAGCCTTTTCTTAACAAAGTTGTTAGTACAACTACTAACATAGTTACACGGTGTTTAAACCGTG

TTTGTACTAATTATATGCCTTATTTCTTTACTTTATTGCTACAATTGTGTACTTTTACTAGAAGTACAAATTCTAGAATTAAAGCATCTATGCCGACTACTATAGCAAAG
6500
6510
6520
6530
6540
6550
6560
6570
6580
6590
6600
Wild ORF1ab TTTGTACTAATTATATGCCTTATTTCTTTACTTTATTGCTACAATTGTGTACTTTTACTAGAAGTACAAATTCTAGAATTAAAGCATCTATGCCGACTACTATAGCAAAG
Vac ORF1ab TTTGTACTAATTATATGCCTTATTTCTTTACTTTATTGCTACAATTGTGTACTTTTACTAGAAGTACAAATTCTAGAATTAAAGCATCTATGCCGACTACTATAGCAAAG

AATACTGTTAAGAGTGTCGGTAAATTTTGTCTAGAGGCTTCATTTAATTATTTGAAGTCACCTAATTTTTCTAAACTGATAAATATTATAATTTGGTTTTTACTATTAAG
6610
6620
6630
6640
6650
6660
6670
6680
6690
6700
6710
Wild ORF1ab AATACTGTTAAGAGTGTCGGTAAATTTTGTCTAGAGGCTTCATTTAATTATTTGAAGTCACCTAATTTTTCTAAACTGATAAATATTATAATTTGGTTTTTACTATTAAG
Vac ORF1ab AATACTGTTAAGAGTGTCGGTAAATTTTGTCTAGAGGCTTCATTTAATTATTTGAAGTCACCTAATTTTTCTAAACTGATAAATATTATAATTTGGTTTTTACTATTAAG

TGTTTGCCTAGGTTCTTTAATCTACTCAACCGCTGCTTTAGGTGTTTTAATGTCTAATTTAGGCATGCCTTCTTACTGTACTGGTTACAGAGAAGGCTATTTGAACTCTA
6720
6730
6740
6750
6760
6770
6780
6790
6800
6810
6820
Wild ORF1ab TGTTTGCCTAGGTTCTTTAATCTACTCAACCGCTGCTTTAGGTGTTTTAATGTCTAATTTAGGCATGCCTTCTTACTGTACTGGTTACAGAGAAGGCTATTTGAACTCTA
Vac ORF1ab TGTTTGCCTAGGTTCTTTAATCTACTCAACCGCTGCTTTAGGTGTTTTAATGTCTAATTTAGGCATGCCTTCTTACTGTACTGGTTACAGAGAAGGCTATTTGAACTCTA

CTAATGTCACTATTGCAACCTACTGTACTGGTTCTATACCTTGTAGTGTTTGTCTTAGTGGTTTAGATTCTTTAGACACCTATCCTTCTTTAGAAACTATACAAATTACC
6830
6840
6850
6860
6870
6880
6890
6900
6910
6920
6930
Wild ORF1ab CTAATGTCACTATTGCAACCTACTGTACTGGTTCTATACCTTGTAGTGTTTGTCTTAGTGGTTTAGATTCTTTAGACACCTATCCTTCTTTAGAAACTATACAAATTACC
Vac ORF1ab CTAATGTCACTATTGCAACCTACTGTACTGGTTCTATACCTTGTAGTGTTTGTCTTAGTGGTTTAGATTCTTTAGACACCTATCCTTCTTTAGAAACTATACAAATTACC

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATCCTACCATACAGAAAGACGTTCTTGAGTGTAATGTGAAAACTACCGAAGTTGTAGGAGACATTATACTTAAACCAGCGAATAATAGTTTAAAAATTACAGAAGAGGTT
6170
6180
6190
6200
6210
6220
6230
6240
6250
6260
6270
Wild ORF1ab ATCCTACCATACAGAAAGACGTTCTTGAGTGTAATGTGAAAACTACCGAAGTTGTAGGAGACATTATACTTAAACCAGCGAATAATAGTTTAAAAATTACAGAAGAGGTT
Vac ORF1ab ATCCTACCATACAGAAAGACGTTCTTGAGTGTAATGTGAAAACTACCGAAGTTGTAGGAGACATTATACTTAAACCAGCAAATAATAGTTTAAAAATTACAGAAGAGGTT

GCAATTGTTTTTCAGCTATTTTGCAGTACATTTTATTAGTAATTCTTGGCTTATGTGGTTAATAATTAATCTTGTACAAATGGCCCCGATTTCAGCTATGGTTAGAATGT
7050
7060
7070
7080
7090
7100
7110
7120
7130
7140
7150
Wild ORF1ab GCAATTGTTTTTCAGCTATTTTGCAGTACATTTTATTAGTAATTCTTGGCTTATGTGGTTAATAATTAATCTTGCACAAATGGCCCCGATTTCAGCTATGGTTAGAATGT
Vac ORF1ab GCAATTGTTTTTCAGCTATTTTGCAGTACATTTTATTAGTAATTCTTGGCTTATGTGGTTAATAATTAATCTTGTACAAATGGCCCCGATTTCAGCTATGGTTAGAATGT

ACATCTTCTTTGCATCATTTTATTATGTATGGAAAAGTTATGTGCATGTTGTAGACGGTTGTAATTCATCAACTTGTATGATGTGTTACAAACGTAATAGAGCAACAAGA
7160
7170
7180
7190
7200
7210
7220
7230
7240
7250
7260
Wild ORF1ab ACATCTTCTTTGCATCATTTTATTATGTATGGAAAAGTTATGTGCATGTTGTAGACGGTTGTAATTCATCAACTTGTATGATGTGTTACAAACGTAATAGAGCAACAAGA
Vac ORF1ab ACATCTTCTTTGCATCATTTTATTATGTATGGAAAAGTTATGTGCATGTTGTAGACGGTTGTAATTCATCAACTTGTATGATGTGTTACAAACGTAATAGAGCAACAAGA

GTCGAATGTACAACTATTGTTAATGGTGTTAGAAGGTCCTTTTATGTCTATGCTAATGGAGGTAAAGGCTTTTGCAAACTACACAATTGGAATTGTGTTAATTGTGATAC
7270
7280
7290
7300
7310
7320
7330
7340
7350
7360
7370
Wild ORF1ab GTCGAATGTACAACTATTGTTAATGGTGTTAGAAGGTCCTTTTATGTCTACGCTAATGGAGGTAAAGGCTTTTGCAAACTACACAATTGGAATTGTGTTAATTGTGATAC
Vac ORF1ab GTCGAATGTACAACTATTGTTAATGGTGTTAGAAGGTCCTTTTATGTCTATGCTAATGGAGGTAAAGGCTTTTGCAAACTACACAATTGGAATTGTGTTAATTGTGATAC

ATTCTGTGCTGGTAGTACATTTATTAGTGATGAAGTTGCGAGAGACTTGTCACTACAGTTTAAAAGACCAATAAATCCTACTGACCAGTCTTCTTACATCGTTGATAGTG
7380
7390
7400
7410
7420
7430
7440
7450
7460
7470
7480
Wild ORF1ab ATTCTGTGCTGGTAGTACATTTATTAGTGATGAAGTTGCGAGAGACTTATCACTACAGTTTAAAAGACCAATAAATCCTACTGACCAGTCTTCTTACATCGTTGATAGTG
Vac ORF1ab ATTCTGTGCTGGTAGTACATTTATTAGTGATGAAGTTGCGAGAGACTTGTCACTACAGTTTAAAAGACCAATAAATCCTACTGACCAGTCTTCTTACATCGTTGATAGTG

TTACAGTGAAGAATGGTTCCATCCATCTTTACTTTGATAAAGCTGGTCAAAAGACTTATGAAAGACATTCTCTCTCTCATTTTGTTAACTTAGACAACCTGAGAGCTAAT
7490
7500
7510
7520
7530
7540
7550
7560
7570
7580
7590
Wild ORF1ab TTACAGTGAAGAATGGTTCCATCCATCTTTACTTTGATAAAGCTGGTCAAAAGACTTATGAAAGACATTCTCTCTCTCATTTTGTTAACTTAGACAACCTGAGAGCTAAT
Vac ORF1ab TTACAGTGAAGAATGGTTCCATCCATCTTTACTTTGATAAAGCTGGTCAAAAGACTTATGAAAGACATTCTCTCTCTCATTTTGTTAACTTAGACAACCTGAGAGCTAAT

AACACTAAAGGTTCATTGCCTATTAATGTTATAGTTTTTGATGGTAAATCAAAATGTGAAGAATCATCTGCAAAATCAGCGTCTGTTTACTACAGTCAGCTTATGTGTCA
7600
7610
7620
7630
7640
7650
7660
7670
7680
7690
7700
Wild ORF1ab AACACTAAAGGTTCATTGCCTATTAATGTTATAGTTTTTGATGGTAAATCAAAATGTGAAGAATCATCTGCAAAATCAGCGTCTGTTTACTACAGTCAGCTTATGTGTCA
Vac ORF1ab AACACTAAAGGTTCATTGCCTATTAATGTTATAGTTTTTGATGGTAAATCAAAATGTGAAGAATCATCTGCAAAATCAGCGTCTGTTTACTACAGTCAGCTTATGTGTCA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATTTCATCTTTTAAATGGGATTTAACTGCTTTTGGCTTAGTTGCAGAGTGGTTTTTGGCATATATTCTTTTCACTAGGTTTTTCTATGTACTTGGATTGGCTGCAATCAT
6940
6950
6960
6970
6980
6990
7000
7010
7020
7030
7040
Wild ORF1ab ATCTCATCTTTTAAATGGGATTTAACTGCTTTTGGCTTAGTTGCAGAGTGGTTTTTGGCATATATTCTTTTCACTAGGTTTTTCTATGTACTTGGATTGGCTGCAATCAT
Vac ORF1ab ATTTCATCTTTTAAATGGGATTTAACTGCTTTTGGCTTAGTTGCAGAGTGGTTTTTGGCATATATTCTTTTCACTAGGTTTTTCTATGTACTTGGATTGGCTGCAATCAT

TACCAATGGAAAAACTCAAAACACTAGTTGCAACTGCAGAAGCTGAACTTGCAAAGAATGTGTCCTTAGACAATGTCTTATCTACTTTTATTTCAGCAGCTCGGCAAGGG
7820
7830
7840
7850
7860
7870
7880
7890
7900
7910
7920
Wild ORF1ab TACCAATGGAAAAACTCAAAACACTAGTTGCAACTGCAGAAGCTGAACTTGCAAAGAATGTGTCCTTAGACAATGTCTTATCTACTTTTATTTCAGCAGCTCGGCAAGGG
Vac ORF1ab TACCAATGGAAAAACTCAAAACACTAGTTGCAACTGCAGAAGCTGAACTTGCAAAGAATGTGTCCTTAGACAATGTCTTATCTACTTTTATTTCAGCAGCTCGGCAAGGG

TTTGTTGATTCAGATGTAGAAACTAAAGATGTTGTTGAATGTCTTAAATTGTCACATCAATCTGACATAGAAGTTACTGGCGATAGTTGTAATAACTATATGCTCACCTA
7930
7940
7950
7960
7970
7980
7990
8000
8010
8020
8030
Wild ORF1ab TTTGTTGATTCAGATGTAGAAACTAAAGATGTTGTTGAATGTCTTAAATTGTCACATCAATCTGACATAGAAGTTACTGGCGATAGTTGTAATAACTATATGCTCACCTA
Vac ORF1ab TTTGTTGATTCAGATGTAGAAACTAAAGATGTTGTTGAATGTCTTAAATTGTCACATCAATCTGACATAGAAGTTACTGGCGATAGTTGTAATAACTATATGCTCACCTA

TAACAAAGTTGAAAACATGACACCCCGTGACCTTGGTGCTTGTATTGACTGTAGTGCGCGTCATATTAATGCGCAGGTAGCAAAAAGTCACAACATTGCTTTGATATGGA
8040
8050
8060
8070
8080
8090
8100
8110
8120
8130
8140
Wild ORF1ab CAACAAAGTTGAAAACATGACACCCCGTGACCTTGGTGCTTGTATTGACTGTAGTGCGCGTCATATTAATGCGCAGGTAGCAAAAAGTCACAACATTGCTTTGATATGGA
Vac ORF1ab TAACAAAGTTGAAAACATGACACCCCGTGACCTTGGTGCTTGTATTGACTGTAGTGCGCGTCATATTAATGCGCAGGTAGCAAAAAGTCACAACATTGCTTTGATATGGA

ACGTTAAAGATTTCATGTCATTGTCTGAACAACTACGAAAACAAATACGTAGTGCTGCTAAAAAGAATAACTTACCTTTTAAGTTGACATGTGCAACTACTAGACAAGTT
8150
8160
8170
8180
8190
8200
8210
8220
8230
8240
8250
Wild ORF1ab ACGTTAAAGATTTCATGTCATTGTCTGAACAACCACGAAAACAAATACGTAGTGCTGCTAAAAAGAATAACTTACCTTTTAAGTTGACATGTGCAACTACTAGACAAGTT
Vac ORF1ab ACGTTAAAGATTTCATGTCATTGTCTGAACAACTACGAAAACAAATACGTAGTGCTGCTAAAAAGAATAACTTACCTTTTAAGTTGACATGTGCAACTACTAGACAAGTT

GTTAATGTTGTAACAACAAAGATAGCACTTAAGGGTGGTAAAATTGTTAATAATTGGTTGAAGCAGTTAATTAAAGTTACACTTGTGTTCCTTTTTGTTGCTGCTATTTT
8260
8270
8280
8290
8300
8310
8320
8330
8340
8350
8360
Wild ORF1ab GTTAATGCTGTAACAACAAAGATAGCACTTAAGGGTGGTAAAATTGTTAATAATTGGTTGAAGCAGTTAATTAAAGTTACACTTGTGTTCCTTTTTGTTGCTGCTATTTT
Vac ORF1ab GTTAATGTTGTAACAACAAAGATAGCACTTAAGGGTGGTAAAATTGTTAATAATTGGTTGAAGCAGTTAATTAAAGTTACACTTGTGTTCCTTTTTGTTGCTGCTATTTT

CTATTTAATAACACCTGTTCATGTCATGTCTAAACATACTGACTTTTCAAGTGAAATCATAGGATACAAGGCTATTGATGGTGGTGTCACTCGTGACATAGCATCTACAG
8370
8380
8390
8400
8410
8420
8430
8440
8450
8460
8470
Wild ORF1ab CTATTTAATAACACCTGTTCATGTCATGTCTAAACATACTGACTTTTCAAGTGAAATCATAGGATACAAGGCTATTGATGGTGGTGTCACTCGTGACATAGCATCTACAG
Vac ORF1ab CTATTTAATAACACCTGTTCATGTCATGTCTAAACATACTGACTTTTCAAGTGAAATCATAGGATACAAGGCTATTGATGGTGGTGTCACTCGTGACATAGCATCTACAG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ACCTATACTGTTACTAGATCAGGCATTAGTGTCTGATGTTGGTGATAGTGCGGAAGTTGCAGTTAAAATGTTTGATGCTTACGTTAATACGTTTTCATCAACTTTTAACG
7710
7720
7730
7740
7750
7760
7770
7780
7790
7800
7810
Wild ORF1ab ACCTATACTGTTACTAGATCAGGCATTAGTGTCTGATGTTGGTGATAGTGCGGAAGTTGCAGTTAAAATGTTTGATGCTTACGTTAATACGTTTTCATCAACTTTTAACG
Vac ORF1ab ACCTATACTGTTACTAGATCAGGCATTAGTGTCTGATGTTGGTGATAGTGCGGAAGTTGCAGTTAAAATGTTTGATGCTTACGTTAATACGTTTTCATCAACTTTTAACG

GAAGTGGGTTTTGTCGTGCCTGGTTTGCCTGGCACGATATTACGCACAACTAATGGTGACTTTTTGCATTTCTTACCTAGAGTTTTTAGTGCAGTTGGTAACATCTGTTA
8590
8600
8610
8620
8630
8640
8650
8660
8670
8680
8690
Wild ORF1ab GAAGTGGGTTTTGTCGTGCCTGGTTTGCCTAGCACGATATTACGCACAACTAATGGTGACTTTTTGCATTTCTTACCTAGAGTTTTTAGTGCAGTTGGTAACATCTGTTA
Vac ORF1ab GAAGTGGGTTTTGTCGTGCCTGGTTTGCCTGGCACGATATTACGCACAACTAATGGTGACTTTTTGCATTTCTTACCTAGAGTTTTTAGTGCAGTTGGTAACATCTGTTA

CACACCATCAAAACTTATAGAGTACACTGACTTTGCAACATCAGCTTGTGTTTTGGCTGCTGAATGTACAATTTTTAAAGATGCTTCTGGTAAGCCAGTACCATATTGTT
8700
8710
8720
8730
8740
8750
8760
8770
8780
8790
8800
Wild ORF1ab CACACCATCAAAACTTATAGAGTACACTGACTTTGCAACATCAGCTTGTGTTTTGGCTGCTGAATGTACAATTTTTAAAGATGCTTCTGGTAAGCCAGTACCATATTGTT
Vac ORF1ab CACACCATCAAAACTTATAGAGTACACTGACTTTGCAACATCAGCTTGTGTTTTGGCTGCTGAATGTACAATTTTTAAAGATGCTTCTGGTAAGCCAGTACCATATTGTT

ATGATACCAATGTACTAGAAGGTTCTGTTGCTTATGAAAGTTTACGCCCTGACACACGTTATGTGCTCATGGATGGCTCTATTATTCAATTTCCTAACACCTACCTTGAA
8810
8820
8830
8840
8850
8860
8870
8880
8890
8900
8910
Wild ORF1ab ATGATACCAATGTACTAGAAGGTTCTGTTGCTTATGAAAGTTTACGCCCTGACACACGTTATGTGCTCATGGATGGCTCTATTATTCAATTTCCTAACACCTACCTTGAA
Vac ORF1ab ATGATACCAATGTACTAGAAGGTTCTGTTGCTTATGAAAGTTTACGCCCTGACACACGTTATGTGCTCATGGATGGCTCTATTATTCAATTTCCTAACACCTACCTTGAA

GGTTCTGTTAGAGTGGTAACAACTTTTGATTCTGAGTACTGTGGGCACGGCACTTGTGAAAGATCAGAAGCTGGTGTTTGTGTATCTACTAGTGGTAGATGGGTACTTAA
8920
8930
8940
8950
8960
8970
8980
8990
9000
9010
9020
Wild ORF1ab GGTCCTGTTAGAGTGGTAACAACTTTTGATTCTGAGTACTGTGGGCACGGCACTTGTGAAAGATCAGAAGCTGGTGTTTGTGTATCTACTAGTGGTAGATGGGTACTTAA
Vac ORF1ab GGTTCTGTTAGAGTGGTAACAACTTTTGATTCTGAGTACTGTAGGCACGGCACTTGTGAAAGATCAGAAGCTGGTGTTTGTGTATCTACTAGTGGTAGATGGGTACTTAA

CAATGATTATTACAGATCTTTACCAGGAGTTTTCTGTGGTGTAGATGCTGTAAATTTACTTACTAATATGTTTACACCACTAATTCAACCTATTGGTGCTTTGGACATAT
9030
9040
9050
9060
9070
9080
9090
9100
9110
9120
9130
Wild ORF1ab CAATGATTATTACAGATCTTTACCAGGAGTTTTCTGTGGTGTAGATGCTGTAAATTTACTTACTAATATGTTTACACCACTAATTCAACCTATTGGTGCTTTGGACATAT
Vac ORF1ab CAATGATTATTACAGATCTTTACCAGGAGTTTTCTGTGGTGTAGATGCTGTAAATTTACTTACTAATATGTTTACACCACTAATTCAACCTATTGGTGCTTTGGACATAT

CAGCATCTATAGTAGCTGGTGGTATTGTAGCTATCGTAGTAACATGCCTTGCCTACTATTTTATGAGGTTTAGAAGAGCTTTTGGTGAATACAGTCATGTAGTTGCCTTT
9140
9150
9160
9170
9180
9190
9200
9210
9220
9230
9240
Wild ORF1ab CAGCATCTATAGTAGCTGGTGGTATTGTAGCTATCGTAGTAACATGCCTTGCCTACTATTTTATGAGGTTTAGAAGAGCTTTTGGTGAATACAGTCATGTAGTTGCCTTT
Vac ORF1ab CAGCATCTATAGTAGCTGGTGGTATTGTAGCTATCGTAGTAACATGCCTTGCCTACTATTTTATGAGGTTTAGAAGAGCTTTTGGTGAATACAGTCATGTAGTTGCCTTT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATACTTGTTTTGCTAACAAACATGCTGATTTTGACACATGGTTTAGTCAGCGTGGTGGTAGTTATACTAATGACAAAGCTTGCCCATTGATTGCTGCAGTCATAACAAGA
8480
8490
8500
8510
8520
8530
8540
8550
8560
8570
8580
Wild ORF1ab ATACTTGTTTTGCTAACAAACATGCTGATTTTGACACATGGTTTAGTCAGCGTGGTGGTAGTTATACTAATGACAAAGCTTGCCCATTGATTGCTGCAGTCATAACAAGA
Vac ORF1ab ATACTTGTTTTGCTAACAAACATGCTGATTTTGACACATGGTTTAGTCAGCGTGGTGGTAGTTATACTAATGACAAAGCTTGCCCATTGATTGCTGCAGTCATAACAAGA

TAATGATGTTTCTTTTTTAGCACATATTCAGTGGATGGTTATGTTCACACCTTTAGTACCTTTCTGGATAACAATTGCTTATATCATTTGTATTTCCACAAAGCATTTCT
9360
9370
9380
9390
9400
9410
9420
9430
9440
9450
9460
Wild ORF1ab TAATGATGTTTCTTTTTTAGCACATATTCAGTGGATGGTTATGTTCACACCTTTAGTACCTTTCTGGATAACAATTGCTTATATCATTTGTATTTCCACAAAGCATTTCT
Vac ORF1ab TAATGATGTTTCTTTTTTAGCACATATTCAGTGGATGGTTATGTTCACACCTTTAGTACCTTTCTGGATAACAATTGCTTATATCATTTGTATTTCCACAAAGCATTTCT

ATTGGTTCTTTAGTAATTACCTAAAGAGACGTGTAGTCTTTAATGGTGTTTCCTTTAGTACTTTTGAAGAAGCTGCGCTGTGCACCTTTTTGTTAAATAAAGAAATGTAT
9470
9480
9490
9500
9510
9520
9530
9540
9550
9560
9570
Wild ORF1ab ATTGGTTCTTTAGTAATTACCTAAAGAGACGTGTAGTCTTTAATGGTGTTTCCTTTAGTACTTTTGAAGAAGCTGCGCTGTGCACCTTTTTGTTAAATAAAGAAATGTAT
Vac ORF1ab ATTGGTTCTTTAGTAATTACCTAAAGAGACGTGTAGTCTTTAATGGTGTTTCCTTTAGTACTTTTGAAGAAGCTGCGCTGTGCACCTTTTTGTTAAATAAAGAAATGTAT

CTAAAGTTGCGTAGTGATGTGCTATTACCTCTTACGCAATATAATAGATACTTAGCTCTTTATAATAAGTACAAGTATTTTAGTGGAGCAATGGATACAACTAGCTACAG
9580
9590
9600
9610
9620
9630
9640
9650
9660
9670
9680
Wild ORF1ab CTAAAGTTGCGTAGTGATGTGCTATTACCTCTTACGCAATATAATAGATACTTAGCTCTTTATAATAAGTACAAGTATTTTAGTGGAGCAATGGATACAACTAGCTACAG
Vac ORF1ab CTAAAGTTGCGTAGTGATGTGCTATTACCTCTTACGCAATATAATAGATACTTAGCTCTTTATAATAAGTACAAGTATTTTAGTGGAGCAATGGATACAACTAGCTACAG

AGAAGCTGCTTGTTGTCATCTCGCAAAGGCTCTCAATGACTTCAGTAACTCAGGTTCTGATGTTCTTTACCAACCACCACAAACCTCTATCACCTCAGCTGTTTTGCAGA
9690
9700
9710
9720
9730
9740
9750
9760
9770
9780
9790
Wild ORF1ab AGAAGCTGCTTGTTGTCATCTCGCAAAGGCTCTCAATGACTTCAGTAACTCAGGTTCTGATGTTCTTTACCAACCACCACAAACCTCTATCACCTCAGCTGTTTTGCAGA
Vac ORF1ab AGAAGCTGCTTGTTGTCATCTCGCAAAGGCTCTCAATGACTTCAGTAACTCAGGTTCTGATGTTCTTTACCAACCACCACAAACCTCTATCACCTCAGCTGTTTTGCAGA

GTGGTTTTAGAAAAATGGCATTCCCATCTGGTAAAGTTGAGGGTTGTATGGTACAAGTAACTTGTGGTACAACTACACTTAACGGTCTTTGGCTTGATGACGTAGTTTAC
9800
9810
9820
9830
9840
9850
9860
9870
9880
9890
9900
Wild ORF1ab GTGGTTTTAGAAAAATGGCATTCCCATCTGGTAAAGTTGAGGGTTGTATGGTACAAGTAACTTGTGGTACAACTACACTTAACGGTCTTTGGCTTGATGACGTAGTTTAC
Vac ORF1ab GTGGTTTTAGAAAAATGGCATTCCCATCTGGTAAAGTTGAGGGTTGTATGGTACAAGTAACTTGTGGTACAACTACACTTAACGGTCTTTGGCTTGATGACGTAGTTTAC

TGTCCAAGACATGTGATCTGCACCTCTGAAGACATGCTTAACCCTAATTATGAAGATTTACTCATTCGTAAGTCTAATCATAATTTCTTGGTACAGGCTGGTAATGTTCA
9910
9920
9930
9940
9950
9960
9970
9980
9990
10000
10010
Wild ORF1ab TGTCCAAGACATGTGATCTGCACCTCTGAAGACATGCTTAACCCTAATTATGAAGATTTACTCATTCGTAAGTCTAATCATAATTTCTTGGTACAGGCTGGTAATGTTCA
Vac ORF1ab TGTCCAAGACATGTGATCTGCACCTCTGAAGACATGCTTAACCCTAATTATGAAGATTTACTCATTCGTAAGTCTAATCATAATTTCTTGGTACAGGCTGGTAATGTTCA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

AATACTTTACTATTCCTTATGTCATTCACTGTACTCTGTTTAACACCAGTTTACTCATTCTTACCTGGTGTTTATTCTGTTATTTACTTGTACTTGACATTTTATCTTAC
9250
9260
9270
9280
9290
9300
9310
9320
9330
9340
9350
Wild ORF1ab AATACTTTACTATTCCTTATGTCATTCACTGTACTCTGTTTAACACCAGTTTACTCATTCTTACCTGGTGTTTATTCTGTTATTTACTTGTACTTGACATTTTATCTTAC
Vac ORF1ab AATACTTTACTATTCCTTATGTCATTCACTGTACTCTGTTTAACACCAGTTTACTCATTCTTACCTGGTGTTTATTCTGTTATTTACTTGTACTTGACATTTTATCTTAC

CTTTTTCAGTGTTAGCTTGTTACAATGGTTCACCATCTGGTGTTTACCAATGTGCTATGAGGCCCAATTTCACTATTAAGGGTTCATTCCTTAATGGTTCATGTGGTAGT
10130
10140
10150
10160
10170
10180
10190
10200
10210
10220
10230
Wild ORF1ab CTTTTTCAGTGTTAGCTTGTTACAATGGTTCACCATCTGGTGTTTACCAATGTGCTATGAGGCCCAATTTCACTATTAAGGGTTCATTCCTTAATGGTTCATGTGGTAGT
Vac ORF1ab CTTTTTCAGTGTTAGCTTGTTACAATGGTTCACCATCTGGTGTTTACCAATGTGCTATGAGGCCCAATTTCACTATTAAGGGTTCATTCCTTAATGGTTCATGTGGTAGT

GTTGGTTTTAACATAGATTATGACTGTGTCTCTTTTTGTTACATGCACCATATGGAATTACCAACTGGAGTTCATGCTGGCACAGACTTAGAAGGTAACTTTTATGGACC
10240
10250
10260
10270
10280
10290
10300
10310
10320
10330
10340
Wild ORF1ab GTTGGTTTTAACATAGATTATGACTGTGTCTCTTTTTGTTACATGCACCATATGGAATTACCAACTGGAGTTCATGCTGGCACAGACTTAGAAGGTAACTTTTATGGACC
Vac ORF1ab GTTGGTTTTAACATAGATTATGACTGTGTCTCTTTTTGTTACATGCACCATATGGAATTACCAACTGGAGTTCATGCTGGCACAGACTTAGAAGGTAACTTTTATGGACC

TTTTGTTGACAGGCAAACAGCACAAGCAGCTGGTACGGACACAACTATTACAGTTAATGTTTTAGCTTGGTTGTACGCTGCTGTTATAAATGGAGACAGGTGGTTTCTCA
10350
10360
10370
10380
10390
10400
10410
10420
10430
10440
10450
Wild ORF1ab TTTTGTTGACAGGCAAACAGCACAAGCAGCTGGTACGGACACAACTATTACAGTTAATGTTTTAGCTTGGTTGTACGCTGCTGTTATAAATGGAGACAGGTGGTTTCTCA
Vac ORF1ab TTTTGTTGACAGGCAAACAGCACAAGCAGCTGGTACGGACACAACTATTACAGTTAATGTTTTAGCTTGGTTGTACGCTGCTGTTATAAATGGAGACAGGTGGTTTCTCA

ATCGATTTACCACAACTCTTAATGACTTTAACCTTGTGGCTATGAAGTACAATTATGAACCTCTAACACAAGACCATGTTGACATACTAGGACCTCTTTCTGCTCAAACT
10460
10470
10480
10490
10500
10510
10520
10530
10540
10550
10560
Wild ORF1ab ATCGATTTACCACAACTCTTAATGACTTTAACCTTGTGGCTATGAAGTACAATTATGAACCTCTAACACAAGACCATGTTGACATACTAGGACCTCTTTCTGCTCAAACT
Vac ORF1ab ATCGATTTACCACAACTCTTAATGACTTTAACCTTGTGGCTATGAAGTACAATTATGAACCTCTAACACAAGACCATGTTGACATACTAGGACCTCTTTCTGCTCAAACT

GGAATTGCCGTTTTAGATATGTGTGCTTCATTAAAAGAATTACTGCAAAATGGTATGAATGGACGTACCATATTGGGTAGTGCTTTATTAGAAGATGAATTTACACCTTT
10570
10580
10590
10600
10610
10620
10630
10640
10650
10660
10670
Wild ORF1ab GGAATTGCCGTTTTAGATATGTGTGCTTCATTAAAAGAATTACTGCAAAATGGTATGAATGGACGTACCATATTGGGTAGTGCTTTATTAGAAGATGAATTTACACCTTT
Vac ORF1ab GGAATTGCCGTTTTAGATATGTGTGCTTCATTAAAAGAATTACTGCAAAATGGTATGAATGGACGTACCATATTGGGTAGTGCTTTATTAGAAGATGAATTTACACCTTT

TGATGTTGTTAGACAATGCTCAGGTGTTACTTTCCAAAGTGCAGTGAAAAGAACAATCAAGGGTACACACCACTGGTTGTTACTCACAATTTTGACTTCACTTTTAGTTT
10680
10690
10700
10710
10720
10730
10740
10750
10760
10770
10780
Wild ORF1ab TGATGTTGTTAGACAATGCTCAGGTGTTACTTTCCAAAGTGCAGTGAAAAGAACAATCAAGGGTACACACCACTGGTTGTTACTCACAATTTTGACTTCACTTTTAGTTT
Vac ORF1ab TGATGTTGTTAGACAATGCTCAGGTGTTACTTTCCAAAGTGCAGTGAAAAGAACAATCAAGGGTACACACCACTGGTTGTTACTCACAATTTTGACTTCACTTTTAGTTT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ACTCAGGGTTATTGGACATTCTATGCAAAATTGTGTACTTAAGCTTAAGGTTGATACAGCCAATCCTAAGACACCTAAGTATAAGTTTGTTCGCATTCAACCAGGACAGA
10020
10030
10040
10050
10060
10070
10080
10090
10100
10110
10120
Wild ORF1ab ACTCAGGGTTATTGGACATTCTATGCAAAATTGTGTACTTAAGCTTAAGGTTGATACAGCCAATCCTAAGACACCTAAGTATAAGTTTGTTCGCATTCAACCAGGACAGA
Vac ORF1ab ACTCAGGGTTATTGGACATTCTATGCAAAATTGTGTACTTAAGCTTAAGGTTGATACAGCCAATCCTAAGACACCTAAGTATAAGTTTGTTCGCATTCAACCAGGACAGA

CATAAGCATGCATTTCTCTGTTTGTTTTTGTTACCTTCTCTTGCCACTGTAGCTTATTTTAATATGGTCTATATGCCTGCTAGTTGGGTGATGCGTATTATGACATGGTT
10900
10910
10920
10930
10940
10950
10960
10970
10980
10990
11000
Wild ORF1ab CATAAGCATGCATTTCTCTGTTTGTTTTTGTTACCTTCTCTTGCCACTGTAGCTTATTTTAATATGGTCTATATGCCTGCTAGTTGGGTGATGCGTATTATGACATGGTT
Vac ORF1ab CATAAGCATGCATTTCTCTGTTTGTTTTTGTTACCTTCTCTTGCCACTGTAGCTTATTTTAATATGGTCTATATGCCTGCTAGTTGGGTGATGCGTATTATGACATGGTT

GGATATGGTAATCACTAGTTTGTCTGGTTTTAAGCTAAAAGACTGTGTTATGTATGCATCAGCTGTAGTGTTACTAATCCTTATGACAGCAAGAACTGTGTATGATGATG
11010
11020
11030
11040
11050
11060
11070
11080
11090
11100
11110
Wild ORF1ab GGATATGGTAATCACTAGTTTGTCTGGTTTTAAGCTAAAAGACTGTGTTATGTATGCATCAGCTGTAGTGTTACTAATCCTTATGACAGCAAGAACTGTGTATGATGATG
Vac ORF1ab GGATATGGTAATCACTAGTTTGTCTGGTTTTAAGCTAAAAGACTGTGTTATGTATGCATCAGCTGTAGTGTTACTAATCCTTATGACAGCAAGAACTGTGTATGATGATG

GTGCTAGGAGAGTGTGGACACTTATGAATGTCTTGACACTCGTTTATAAAGTTTATTATGGTAATGCTTTAGATCAAGCCATTTCCATGTGGGCTCTTATAATCTCTGTT
11120
11130
11140
11150
11160
11170
11180
11190
11200
11210
11220
Wild ORF1ab GTGCTAGGAGAGTGTGGACACTTATGAATGTCTTGACACTCGTTTATAAAGTTTATTATGGTAATGCTTTAGATCAAGCCATTTCCATGTGGGCTCTTATAATCTCTGTT
Vac ORF1ab GTGCTAGGAGAGTGTGGACACTTATGAATGTCTTGACACTCGTTTATAAAGTTTATTATGGTAATGCTTTAGATCAAGCCATTTCCATGTGGGCTCTTATAATCTCTGTT

ACTTCTAACTACTCAGGTGTAGTTACAACTGTCATGTTTTTGGCCAGAGGTATTGTTTTTATGTGTGTTGAGTATTGCCCTATTTTCTTCATAACTGGTAATACACTTCA
11230
11240
11250
11260
11270
11280
11290
11300
11310
11320
11330
Wild ORF1ab ACTTCTAACTACTCAGGTGTAGTTACAACTGTCATGTTTTTGGCCAGAGGTATTGTTTTTATGTGTGTTGAGTATTGCCCTATTTTCTTCATAACTGGTAATACACTTCA
Vac ORF1ab ACTTCTAACTACTCAGGTGTAGTTACAACTGTCATGTTTTTGGCCAGAGGTATTGTTTTTATGTGTGTTGAGTATTGCCCTATTTTCTTCATAACTGGTAATACACTTCA

GTGTATAATGCTAGTTTATTGTTTCTTAGGCTATTTTTGTACTTGTTACTTTGGCCTCTTTTGTTTACTCAACCGCTACTTTAGACTGACTCTTGGTGTTTATGATTACT
11340
11350
11360
11370
11380
11390
11400
11410
11420
11430
11440
Wild ORF1ab GTGTATAATGCTAGTTTATTGTTTCTTAGGCTATTTTTGTACTTGTTACTTTGGCCTCTTTTGTTTACTCAACCGCTACTTTAGACTGACTCTTGGTGTTTATGATTACT
Vac ORF1ab GTGTATAATGCTAGTTTATTGTTTCTTAGGCTATTTTTGTACTTGTTACTTTGGCCTCTTTTGTTTACTCAACCGCTACTTTAGACTGACTCTTGGTGTTTATGATTACT

TAGTTTCTACACAGGAGTTTAGATATATGAATTCACAGGGACTACTCCCACCCAAGAATAGCATAGATGCCTTCAAACTCAACATTAAATTGTTGGGTGTTGGTGGCAAA
11450
11460
11470
11480
11490
11500
11510
11520
11530
11540
11550
Wild ORF1ab TAGTTTCTACACAGGAGTTTAGATATATGAATTCACAGGGACTACTCCCACCCAAGAATAGCATAGATGCCTTCAAACTCAACATTAAATTGTTGGGTGTTGGTGGCAAA
Vac ORF1ab TAGTTTCTACACAGGAGTTTAGATATATGAATTCACAGGGACTACTCCCACCCAAGAATAGCATAGATGCCTTCAAACTCAACATTAAATTGTTGGGTGTTGGTGGCAAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TAGTCCAGAGTACTCAATGGTCTTTGTTCTTTTTTTTTTATGAAAATGCCTTTTTACCTTTTGCTATGGGTATTATTGCTATGTCTGCTTTTGCAATGATGTTTGTCAAA
10790
10800
10810
10820
10830
10840
10850
10860
10870
10880
10890
Wild ORF1ab TAGTCCAGAGTACTCAATGGTCTTTGTTCTTTTTTTTTTATGAAAATGCCTTTTTACCTTTTGCTATGGGTATTATTGCTATGTCTGCTTTTGCAATGATGTTTGTCAAA
Vac ORF1ab TAGTCCAGAGTACTCAATGGTCTTTGTTCTTTTTTTTGTATGAAAAAGCCTTTTTACCTTTTGCTATGGGGATTATTGCTATGTCTGCTTTTGCAATGATGTTTGTCAAA

GTGGGCTCAATGTGTCCAGTTACACAATGACATTCTCTTAGCTAAAGATACTACTGAAGCCTTTGAAAAAATGGTTTCACTACTTTCTGTTTTGCTTTCCATGCAGGGTG
11670
11680
11690
11700
11710
11720
11730
11740
11750
11760
11770
Wild ORF1ab GTGGGCTCAATGTGTCCAGTTACACAATGACATTCTCTTAGCTAAAGATACTACTGAAGCCTTTGAAAAAATGGTTTCACTACTTTCTGTTTTGCTTTCCATGCAGGGTG
Vac ORF1ab GTGGGCTCAATGTGTCCAGTTACACAATGACATTCTCTTAGCTAAAGATACTACTGAAGCCTTTGAAAAAATGGTTTCACTACTTTCTGTTTTGCTTTCCATGCAGGGTG

CTGTAGCCATAAACAAGCTTTGTGAAGAAATGCTGGACAACAGGGCAACCTTACAAGCTATAGCCTCAGAGTTTAGTTCCCTTCCATCATATGCAGCTTTTGCTACTGCT
11780
11790
11800
11810
11820
11830
11840
11850
11860
11870
11880
Wild ORF1ab CTGTAGACATAAACAAGCTTTGTGAAGAAATGCTGGACAACAGGGCAACCTTACAAGCTATAGCCTCAGAGTTTAGTTCCCTTCCATCATATGCAGCTTTTGCTACTGCT
Vac ORF1ab CTGTAGCCATAAACAAGCTTTGTGAAGAAATGCTGGACAACAGGGCAACCTTACAAGCTATAGCCTCAGAGTTTAGTTCCCTTCCATCATATGCAGCTTTTGCTACTGCT

CAAGAAGCTTATGAGCAGGCTGTTGCTAATGGTGATTCTGAAGTTGTTCTTAAAAAGTTGAAGAAGTCTTTGAATGTGGCTAAATCTGAATTTGACCGTGATGCAGCCAT
11890
11900
11910
11920
11930
11940
11950
11960
11970
11980
11990
Wild ORF1ab CAAGAAGCTTATGAGCAGGCTGTTGCTAATGGTGATTCTGAAGTTGTTCTTAAAAAGTTGAAGAAGTCTTTGAATGTGGCTAAATCTGAATTTGACCGTGATGCAGCCAT
Vac ORF1ab CAAGAAGCTTATGAGCAGGCTGTTGCTAATGGTGATTCTGAAGTTGTTCTTAAAAAGTTGAAGAAGTCTTTGAATGTGGCTAAATCTGAATTTGACCGTGATGCAGCCAT

GCAACGTAAGTTGGAAAAGATGGCTGATCAAGCTATGACCCAAATGTATAAACAGGCTAGATCTGAGGACAAGAGGGCAAAAGTTACTAGTGCTATGCAGACAATGCTTT
12000
12010
12020
12030
12040
12050
12060
12070
12080
12090
12100
Wild ORF1ab GCAACGTAAGTTGGAAAAGATGGCTGATCAAGCTATGACCCAAATGTATAAACAGGCTAGATCTGAGGACAAGAGGGCAAAAGTTACTAGTGCTATGCAGACAATGCTTT
Vac ORF1ab GCAACGTAAGTTGGAAAAGATGGCTGATCAAGCTATGACCCAAATGTATAAACAGGCTAGATCTGAGGACAAGAGGGCAAAAGTTACTAGTGCTATGCAGACAATGCTTT

TCACTATGCTTAGAAAGTTGGATAATGATGCACTCAACAACATTATCAACAATGCAAGAGATGGTTGTGTTCCCTTGAACATAATACCTCTTACAACAGCAGCCAAACTA
12110
12120
12130
12140
12150
12160
12170
12180
12190
12200
12210
Wild ORF1ab TCACTATGCTTAGAAAGTTGGATAATGATGCACTCAACAACATTATCAACAATGCAAGAGATGGTTGTGTTCCCTTGAACATAATACCTCTTACAACAGCAGCCAAACTA
Vac ORF1ab TCACTATGCTTAGAAAGTTGGATAATGATGCACTCAACAACATTATCAACAATGCAAGAGATGGTTGTGTTCCCTTGAACATAATACCTCTTACAACAGCAGCCAAACTA

ATGGTTGTCATACCAGACTATAACACATATAAAAATACGTGTGATGGTACAACATTTACTTATGCATCAGCATTGTGGGAAATCCAACAGGTTGTAGATGCAGATAGTAA
12220
12230
12240
12250
12260
12270
12280
12290
12300
12310
12320
Wild ORF1ab ATGGTTGTCATACCAGACTATAACACATATAAAAATACGTGTGATGGTACAACATTTACTTATGCATCAGCATTGTGGGAAATCCAACAGGTTGTAGATGCAGATAGTAA
Vac ORF1ab ATGGTTGTCATACCAGACTATAACACATATAAAAATACGTGTGATGGTACAACATTTACTTATGCATCAGCATTGTGGGAAATCCAACAGGTTGTAGATGCAGATAGTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

CCTTGTATCAAAGTAGCCACTGTACAGTCTAAAATGTCAGATGTAAAGTGCACATCAGTAGTCTTACTCTCAGTTTTGCAACAACTCAGAGTAGAATCATCATCTAAATT
11560
11570
11580
11590
11600
11610
11620
11630
11640
11650
11660
Wild ORF1ab CCTTGTATCAAAGTAGCCACTGTACAGTCTAAAATGTCAGATGTAAAGTGCACATCAGTAGTCTTACTCTCAGTTTTGCAACAACTCAGAGTAGAATCATCATCTAAATT
Vac ORF1ab CCTTGTATCAAAGTAGCCACTGTACAGTCTAAAATGTCAGATGTAAAGTGCACATCAGTAGTCTTACTCTCAGTTTTGCAACAACTCAGAGTAGAATCATCATCTAAATT

TTAGTCCTGTTGCACTACGACAGATGTCTTGTGCTGCCGGTACTACACAAACTGCTTGCACTGATGACAATGCGTTAGCTTACTACAACACAACAAAGGGAGGTAGGTTT
12440
12450
12460
12470
12480
12490
12500
12510
12520
12530
12540
Wild ORF1ab TTAGTCCTGTTGCACTACGACAGATGTCTTGTGCTGCCGGTACTACACAAACTGCTTGCACTGATGACAATGCGTTAGCTTACTACAACACAACAAAGGGAGGTAGGTTT
Vac ORF1ab TTAGTCCTGTTGCACTACGACAGATGTCTTGTGCTGCCGGTACTACACAAACTGCTTGCACTGATGACAATGCGTTAGCTTACTACAACACAACAAAGGGAGGTAGGTTT

GTACTTGCACTGTTATCCGATTTACAGGATTTGAAATGGGCTAGATTCCCTAAGAGTGATGGAACTGGTACTATCTATACAGAACTGGAACCACCTTGTAGGTTTGTTAC
12550
12560
12570
12580
12590
12600
12610
12620
12630
12640
12650
Wild ORF1ab GTACTTGCACTGTTATCCGATTTACAGGATTTGAAATGGGCTAGATTCCCTAAGAGTGATGGAACTGGTACTATCTATACAGAACTGGAACCACCTTGTAGGTTTGTTAC
Vac ORF1ab GTACTTGCACTGTTATCCGATTTACAGGATTTGAAATGGGCTAGATTCCCTAAGAGTGATGGAACTGGTACTATCTATACAGAACTGGAACCACCTTGTAGGTTTGTTAC

AGACACACCTAAAGGTCCTAAAGTGAAGTATTTATACTTTATTAAAGGATTAAACAACCTAAATAGAGGTATGGTACTTGGTAGTTTAGCTGCCACAGTACGTCTACAAG
12660
12670
12680
12690
12700
12710
12720
12730
12740
12750
12760
Wild ORF1ab AGACACACCTAAAGGTCCTAAAGTGAAGTATTTATACTTTATTAAAGGATTAAACAACCTAAATAGAGGTATGGTACTTGGTAGTTTAGCTGCCACAGTACGTCTACAAG
Vac ORF1ab AGACACACCTAAAGGTCCTAAAGTGAAGTATTTATACTTTATTAAAGGATTAAACAACCTAAATAGAGGTATGGTACTTGGTAGTTTAGCTGCCACAGTACGTCTACAAG

CTGGTAATGCAACAGAAGTGCCTGCCAATTCAACTGTATTATCTTTCTGTGCTTTTGCTGTAGATGCTGCTAAAGCTTACAAAGATTATCTAGCTAGTGGGGGACAACCA
12770
12780
12790
12800
12810
12820
12830
12840
12850
12860
12870
Wild ORF1ab CTGGTAATGCAACAGAAGTGCCTGCCAATTCAACTGTATTATCTTTCTGTGCTTTTGCTGTAGATGCTGCTAAAGCTTACAAAGATTATCTAGCTAGTGGGGGACAACCA
Vac ORF1ab CTGGTAATGCAACAGAAGTGCCTGCCAATTCAACTGTATTATCTTTCTGTGCTTTTGCTGTAGATGCTGCTAAAGCTTACAAAGATTATCTAGCTAGTGGGGGACAACCA

ATCACTAATTGTGTTAAGATGTTGTGTACACACACTGGTACTGGTCAGGCAATAACAGTTACACCGGAAGCCAATATGGATCAAGAATCCTTTGGTGGTGCATCGTGTTG
12880
12890
12900
12910
12920
12930
12940
12950
12960
12970
12980
Wild ORF1ab ATCACTAATTGCGTTAAGATGTTGTGTACACACACTGGTACTGGTCAGGCAATAACAGTTACACCGGAAGCCAATATGGATCAAGAATCCTTTGGTGGTGCATCGTGTTG
Vac ORF1ab ATCACTAATTGTGTTAAGATGTTGTGTACACACACTGGTACTGGTCAGGCAATAACAGTTACACCGGAAGCCAATATGGATCAAGAATCCTTTGGTGGTGCATCGTGTTG

TCTGTACTGCCGTTGCCACATAGATCATCCAAATCCTAAAGGATTTTGTGACTTAAAAGGTAAGTATGTGCAAATACCTACAACTTGTGCTAATGACCCTGTGGGTTTTA
12990
13000
13010
13020
13030
13040
13050
13060
13070
13080
13090
Wild ORF1ab TCTGTACTGCCGTTGCCACATAGATCATCCAAATCCTAAAGGATTTTGTGACTTAAAAGGTAAGTATGTGCAAATACCTACAACTTGTGCTAATGACCCTGTGGGTTTTA
Vac ORF1ab TCTGTACTGCCGTTGCCACATAGATCATCCAAATCCTAAAGGATTTTGTGACTTAAAAGGTAAGTATGTACAAATACCTACAACTTGTGCTAATGACCCTGTGGGTTTTA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

AATTGTTCAACTTAGTGAAATTAGTATGGACAATTCACCTAATTTAGCATGGCCTCTTATTGTAACAGCTTTAAGGGCCAATTCTGCTGTCAAATTACAGAATAATGAGC
12330
12340
12350
12360
12370
12380
12390
12400
12410
12420
12430
Wild ORF1ab AATTGTTCAACTTAGTGAAATTAGTATGGACAATTCACCTAATTTAGCATGGCCTCTTATTGTAACAGCTTTAAGGGCCAATTCTGCTGTCAAATTACAGAATAATGAGC
Vac ORF1ab AATTGTTCAACTTAGTGAAATTAGTATGGACAATTCACCTAATTTAGCATGGCCTCTTATTGTAACAGCTTTAAGGGCCAATTCTGCTGTCAAATTACAGAATAATGAGC

AACCGGGTTTGCGGTGTAAGTGCAGCCCGTCTTACACCGTGCGGCACAGGCACTAGTACTGATGTCGTATACAGGGCTTTTGACATCTACAATGATAAAGTAGCTGGTTT
13210
13220
13230
13240
13250
13260
13270
13280
13290
13300
13310
Wild ORF1ab AACCGGGTTTGCGGTGTAAGTGCAGCCCGTCTTACACCGTGCGGCACAGGCACTAGTACTGATGTCGTATACAGGGCTTTTGACATCTACAATGATAAAGTAGCTGGTTT
Vac ORF1ab AACCGGGTTTGCGGTGTAAGTGCAGCCCGTCTTACACCGTGCGGCACAGGCACTAGTACTGATGTCGTATACAGGGCTTTTGACATCTACAATGATAAAGTAGCTGGTTT

TGCTAAATTCCTAAAAACTAATTGTTGTCGCTTCCAAGAAAAGGACGAAGATGACAATTTAATTGATTCTTACTTTGTAGTTAAGAGACACACTTTCTCTAACTACCAAC
13320
13330
13340
13350
13360
13370
13380
13390
13400
13410
13420
Wild ORF1ab TGCTAAATTCCTAAAAACTAATTGTTGTCGCTTCCAAGAAAAGGACGAAGATGACAATTTAATTGATTCTTACTTTGTAGTTAAGAGACACACTTTCTCTAACTACCAAC
Vac ORF1ab TGCTAAATTCCTAAAAACTAATTGTTGTCGCTTCCAAGAAAAGGACGAAGATGACAATTTAATTGATTCTTACTTTGTAGTTAAGAGACACACTTTCTCTAACTACCAAC

ATGAAGAAACAATTTATAATTTACTTAAGGATTGTCCAGCTGTTGCTAAACATGACTTCTTTAAGTTTAGAATAGACGGTGACATGGTACCACATATATCACGTCAACGT
13430
13440
13450
13460
13470
13480
13490
13500
13510
13520
13530
Wild ORF1ab ATGAAGAAACAATTTATAATTTACTTAAGGATTGTCCAGCTGTTGCTAAACATGACTTCTTTAAGTTTAGAATAGACGGTGACATGGTACCACATATATCACGTCAACGT
Vac ORF1ab ATGAAGAAACAATTTATAATTTACTTAAGGATTGTCCAGCTGTTGCTAAACATGACTTCTTTAAGTTTAGAATAGACGGTGACATGGTACCACATATATCACGTCAACGT

CTTACTAAATACACAATGGCAGACCTCGTCTATGCTTTAAGGCATTTTGATGAAGGTAATTGTGACACATTAAAAGAAATACTTGTCACATACAATTGTTGTGATGATGA
13540
13550
13560
13570
13580
13590
13600
13610
13620
13630
13640
Wild ORF1ab CTTACTAAATACACAATGGCAGACCTCGTCTATGCTTTAAGGCATTTTGATGAAGGTAATTGTGACACATTAAAAGAAATACTTGTCACATACAATTGTTGTGATGATGA
Vac ORF1ab CTTACTAAATACACAATGGCAGACCTCGTCTATGCTTTAAGGCATTTTGATGAAGGTAATTGTGACACATTAAAAGAAATACTTGTCACATACAATTGTTGTGATGATGA

TTATTTCAATAAAAAGGACTGGTATGATTTTGTAGAAAACCCAGATATATTACGCGTATACGCCAACTTAGGTGAACGTGTACGCCAAGCTTTGTTAAAAACAGTACAAT
13650
13660
13670
13680
13690
13700
13710
13720
13730
13740
13750
Wild ORF1ab TTATTTCAATAAAAAGGACTGGTATGATTTTGTAGAAAACCCAGATATATTACGCGTATACGCCAACTTAGGTGAACGTGTACGCCAAGCTTTGTTAAAAACAGTACAAT
Vac ORF1ab TTATTTCAATAAAAAGGACTGGTATGATTTTGTAGAAAACCCAGATATATTACGCGTATACGCCAACTTAGGTGAACGTGTACGCCAAGCTTTGTTAAAAACAGTACAAT

TCTGTGATGCCATGCGAAATGCTGGTATTGTTGGTGTACTGACATTAGATAATCAAGATCTCAATGGTAACTGGTATGATTTCGGTGATTTCATACAAACCACGCCAGGT
13760
13770
13780
13790
13800
13810
13820
13830
13840
13850
13860
Wild ORF1ab TCTGTGATGCCATGCGAAATGCTGGTATTGTTGGTGTACTGACATTAGATAATCAAGATCTCAATGGTAACCGGTATGATTTCGGTGATTTCATACAAACCACGCCAGGT
Vac ORF1ab TCTGTGATGCCATGCGAAATGCTGGTATTGTTGGTGTACTGACATTAGATAATCAAGATCTCAATGGTAACTGGTATGATTTCGGTGATTTCATACAAACCACGCCAGGT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

CACTTAAAAACACAGTCTGTACCGTCTGCGGTATGTGGAAAGGTTATGGCTGTAGTTGTGATCAACTCCGCGAACCCATGCTTCAGTCAGCTGATGCACAATCGTTTTTA
13100
13110
13120
13130
13140
13150
13160
13170
13180
13190
13200
Wild ORF1ab CACTTAAAAACACAGTCTGTACCGTCTGCGGTATGTGGAAAGGTTATGGCTGTAGTTGTGATCAACTCCGCGAACCCATGCTTCAGTCAGCTGATGCACAATCGTTTTTA
Vac ORF1ab CACTTAAAAACACAGTCTGTACCGTCTGCGGTATGTGGAAAGGTTATGGCTGTAGTTGTGATCAACTCCGCGAACCCATGCTTCAGTCAGCTGATGCACAATCGTTTTTA

CATTAAGTGGGATTTGTTAAAATATGACTTCACGGAAGAGAGGTTAAAACTCTTTGACCGTTATTTTAAATATTGGGATCAGACATACCACCCAAATTGTGTTAACTGTT
13980
13990
14000
14010
14020
14030
14040
14050
14060
14070
14080
Wild ORF1ab CATTAAGTGGGATTTGTTAAAATATGACTTCACGGAAGAGAGGTTAAAACTCTTTGACCGTTATTTTAAATATTGGGATCAGACATACCACCCAAATTGTGTTAACTGTT
Vac ORF1ab CATTAAGTGGGATTTGTTAAAATATGACTTCACGGAAGAGAGGTTAAAACTCTTTGACCGTTATTTTAAATATTGGGATCAGACATACCACCCAAATTGTGTTAACTGTT

TGGATGACAGATGCATTCTGCATTGTGCAAACTTTAATGTTTTATTCTCTACAGTGTTCCCACCTACAAGTTTTGGACCACTAGTGAGAAAAATATTTGTTGATGGTGTT
14090
14100
14110
14120
14130
14140
14150
14160
14170
14180
14190
Wild ORF1ab TGGATGACAGATGCATTCTGCATTGTGCAAACTTTAATGTTTTATTCTCTACAGTGTTCCCACCTACAAGTTTTGGACCACTAGTGAGAAAAATATTTGTTGATGGTGTT
Vac ORF1ab TGGATGACAGATGCATTCTGCATTGTGCAAACTTTAATGTTTTATTCTCTACAGTGTTCCCACCTACAAGTTTTGGACCACTAGTGAGAAAAATATTTGTTGATGGTGTT

CCATTTGTAGTTTCAACTGGATACCACTTCAGAGAGCTAGGTGTTGTACATAATCAGGATGTAAACTTACATAGCTCTAGACTTAGTTTTAAGGAATTACTTGTGTATGC
14200
14210
14220
14230
14240
14250
14260
14270
14280
14290
14300
Wild ORF1ab CCATTTGTAGTTTCAACTGGATACCACTTCAGAGAGCTAGGTGTTGTACATAATCAGGATGTAAACTTACATAGCTCTAGACTTAGTTTTAAGGAATTACTTGTGTATGC
Vac ORF1ab CCATTTGTAGTTTCAACTGGATACCACTTCAGAGAGCTAGGTGTTGTACATAATCAGGATGTAAACTTACATAGCTCTAGACTTAGTTTTAAGGAATTACTTGTGTATGC

TGCTGACCCTGCTATGCACGCTGCTTCTGGTAATCTATTACTAGATAAACGCACTACGTGCTTTTCAGTAGCTGCACTTACTAACAATGTTGCTTTTCAAACTGTCAAAC
14310
14320
14330
14340
14350
14360
14370
14380
14390
14400
14410
Wild ORF1ab TGCTGACCCTGCTATGCACGCTGCTTCTGGTAATCTATTACTAGATAAACGCACTACGTGCTTTTCAGTAGCTGCACTTACTAACAATGTTGCTTTTCAAACTGTCAAAC
Vac ORF1ab TGCTGACCCTGCTATGCACGCTGCTTCTGGTAATCTATTACTAGATAAACGCACTACGTGCTTTTCAGTAGCTGCACTTACTAACAATGTTGCTTTTCAAACTGTCAAAC

CCGGTAGTTTTAACAAAGACTTCTATGACTTTGCTGTGTCTAAGGGTTTCTTTAAGGAAGGAAGTTCTGTTGAATTAAAACACTTCTTCTTTGCTCAGGATGGTAATGCT
14420
14430
14440
14450
14460
14470
14480
14490
14500
14510
14520
Wild ORF1ab CCGGTAGTTTTAACAAAGACTTCTATGACTTTGCTGTGTCTAAGGGTTTCTTTAAGGAAGGAAGTTCTGTTGAATTAAAACACTTCTTCTTTGCTCAGGATGGTAATGCT
Vac ORF1ab CCGGTAATTTTAACAAAGACTTCTATGACTTTGCTGTGTCTAAGGGTTTCTTTAAGGAAGGAAGTTCTGTTGAATTAAAACACTTCTTCTTTGCTCAGGATGGTAATGCT

GCTATCAGCGATTATGACTACTATCGTTATAATCTACCAACAATGTGTGATATCAGACAACTACTATTTGTAGTTGAAGTTGTTGATAAGTACTTTGATTGTTACGATGG
14530
14540
14550
14560
14570
14580
14590
14600
14610
14620
14630
Wild ORF1ab GCTATCAGCGATTATGACTACTATCGTTATAATCTACCAACAATGTGTGATATCAGACAACTACTATTTGTAGTTGAAGTTGTTGATAAGTACTTTGATTGTTACGATGG
Vac ORF1ab GCTATCAGCGATTATGACTACTATCGTTATAATCTACCAACAATGTGTGATATCAGACAACTACTATTTGTAGTTGAAGTTGTTGATAAGTACTTTGATTGTTACGATGG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

AGTGGAGTTCCTGTTGTAGATTCTTATTATTCATTGTTAATGCCTATATTAACCTTGACCAGGGCTTTAACTGCAGAGTCACATGTTGACACTGACTTAACAAAGCCTTA
13870
13880
13890
13900
13910
13920
13930
13940
13950
13960
13970
Wild ORF1ab AGTGGAGTTCCTGTTGTAGATTCTTATTATTCATTGTTAATGCCTATATTAACCTTGACCAGGGCTTTAACTGCAGAGTCACATGTTGACACTGACTTAACAAAGCCTTA
Vac ORF1ab AGTGGAGTTCCTGTTGTAGATTCTTATTATTCATTGTTAATGCCTATATTAACCTTGACCAGGGCTTTAACTGCAGAGTCACATGTTGACACTGACTTAACAAAGCCTTA

AGGATCAAGATGCACTTTTCGCATATACAAAACGTAATGTCATCCCTACTATAACTCAAATGAATCTTAAGTATGCCATTAGTGCAAAGAATAGAGCTCGCACCGTAGCT
14750
14760
14770
14780
14790
14800
14810
14820
14830
14840
14850
Wild ORF1ab AGGATCAAGATGCACTTTTCGCATATACAAAACGTAATGTCATCCCTACTATAACTCAAATGAATCTTAAGTATGCCATTAGTGCAAAGAATAGAGCTCGCACCGTAGCT
Vac ORF1ab AGGATCAAGATGCACTTTTCGCATATACAAAACGTAATGTCATCCCTACTATAACTCAAATGAATCTTAAGTATGCCATTAGTGCAAAGAATAGAGCTCGCACCGTAGCT

GGTGTCTCTATCTGTAGTACTATGACCAATAGACAGTTTCATCAAAAATTATTGAAATCAATAGCCGCCACTAGAGGAGCTACTGTAGTAATTGGAACAAGCAAATTCTA
14860
14870
14880
14890
14900
14910
14920
14930
14940
14950
14960
Wild ORF1ab GGTGTCTCTATCTGTAGTACTATGACCAATAGACAGTTTCATCAAAAATTATTGAAATCAATAGCCGCCACTAGAGGAGCTACTGTAGTAATTGGAACAAGCAAATTCTA
Vac ORF1ab GGTGTCTCTATCTGTAGTACTATGACCAATAGACAGTTTCATCAAAAATTATTGAAATCAATAGCCGCCACTAGAGGAGCTACTGTAGTAATTGGAACAAGCAAATTCTA

TGGTGGTTGGCACAACATGTTAAAAACTGTTTATAGTGATGTAGAAAACCCTCACCTTATGGGTTGGGATTATCCTAAATGTGATAGAGCCATGCCTAACATGCTTAGAA
14970
14980
14990
15000
15010
15020
15030
15040
15050
15060
15070
Wild ORF1ab TGGTGGTTGGCACAACATGTTAAAAACTGTTTATAGTGATGTAGAAAACCCTCACCTTATGGGTTGGGATTATCCTAAATGTGATAGAGCCATGCCTAACATGCTTAGAA
Vac ORF1ab TGGTGGTTGGCACAACATGTTAAAAACTGTTTATAGTGATGTAGAAAACCCTCACCTTATGGGTTGGGATTATCCTAAATGTGATAGAGCCATGCCTAACATGCTTAGAA

TTATGGCCTCACTTGTTCTTGCTCGCAAACATACAACGTGTTGTAGCTTGTCACACCGTTTCTATAGATTAGCTAATGAGTGTGCTCAAGTATTGAGTGAAATGGTCATG
15080
15090
15100
15110
15120
15130
15140
15150
15160
15170
15180
Wild ORF1ab TTATGGCCTCACTTGTTCTTGCTCGCAAACATACAACGTGTTGTAGCTTGTCACACCGTTTCTATAGATTAGCTAATGAGTGTGCTCAAGTATTGAGTGAAATGGTCATG
Vac ORF1ab TTATGGCCTCACTTGTTCTTGCTCGCAAACATACAACGTGTTGTAGCTTGTCACACCGTTTCTATAGATTAGCTAATGAGTGTGCTCAAGTATTGAGTGAAATGGTCATG

TGTGGCGGTTCACTATATGTTAAACCAGGTGGAACCTCATCAGGAGATGCCACAACTGCTTATGCTAATAGTGTTTTTAACATTTGTCAAGCTGTCACGGCCAATGTTAA
15190
15200
15210
15220
15230
15240
15250
15260
15270
15280
15290
Wild ORF1ab TGTGGCGGTTCACTATATGTTAAACCAGGTGGAACCTCATCAGGAGATGCCACAACTGCTTATGCTAATAGTGTTTTTAACATTTGTCAAGCTGTCACGGCCAATGTTAA
Vac ORF1ab TGTGGCGGTTCACTATATGTTAAACCAGGTGGAACCTCATCAGGAGATGCCACAACTGCTTATGCTAATAGTGTTTTTAACATTTGTCAAGCTGTCACGGCCAATGTTAA

TGCACTTTTATCTACTGATGGTAACAAAATTGCCGATAAGTATGTCCGCAATTTACAACACAGACTTTATGAGTGTCTCTATAGAAATAGAGATGTTGACACAGACTTTG
15300
15310
15320
15330
15340
15350
15360
15370
15380
15390
15400
Wild ORF1ab TGCACTTTTATCTACTGATGGTAACAAAATTGCCGATAAGTATGTCCGCAATTTACAACACAGACTTTATGAGTGTCTCTATAGAAATAGAGATGTTGACACAGACTTTG
Vac ORF1ab TGCACTTTTATCTACTGATGGTAACAAAATTGCCGATAAGTATGTCCGCAATTTACAACACAGACTTTATGAGTGTCTCTATAGAAATAGAGATGTTGACACAGACTTTG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TGGCTGTATTAATGCTAACCAAGTCATCGTCAACAACCTAGACAAATCAGCTGGTTTTCCATTTAATAAATGGGGTAAGGCTAGACTTTATTATGATTCAATGAGTTATG
14640
14650
14660
14670
14680
14690
14700
14710
14720
14730
14740
Wild ORF1ab TGGCTGTATTAATGCTAACCAAGTCATCGTCAACAACCTAGACAAATCAGCTGGTTTTCCATTTAATAAATGGGGTAAGGCTAGACTTTATTATGATTCAATGAGTTATG
Vac ORF1ab TGGCTGTATTAATGCTAACCAAGTCATCGTCAACAACCTAGACAAATCAGCTGGTTTTCCATTTAATAAATGGGGTAAGGCTAGACTTTATTATGATTCAATGAGTTATG

ATAAAGAACTTTAAGTCAGTTCTTTATTATCAAAACAATGTTTTTATGTCTGAAGCAAAATGTTGGACTGAGACTGACCTTACTAAAGGACCTCATGAATTTTGCTCTCA
15520
15530
15540
15550
15560
15570
15580
15590
15600
15610
15620
Wild ORF1ab ATAAAGAACTTTAAGTCAGTTCTTTATTATCAAAACAATGTTTTTATGTCTGAAGCAAAATGTTGGACTGAGACTGACCTTACTAAAGGACCTCATGAATTTTGCTCTCA
Vac ORF1ab ATAAAGAACTTTAAGTCAGTTCTTTATTATCAAAACAATGTTTTTATGTCTGAAGCAAAATGTTGGACTGAGACTGACCTTACTAAAGGACCTCATGAATTTTGCTCTCA

ACATACAATGCTAGTTAAACAGGGTGATGATTATGTGTACCTTCCTTACCCAGATCCATCAAGAATCCTAGGGGCCGGCTGTTTTGTAGATGATATCGTAAAAACAGATG
15630
15640
15650
15660
15670
15680
15690
15700
15710
15720
15730
Wild ORF1ab ACATACAATGCTAGTTAAACAGGGTGATGATTATGTGTACCTTCCTTACCCAGATCCATCAAGAATCCTAGGGGCCGGCTGTTTTGTAGATGATATCGTAAAAACAGATG
Vac ORF1ab ACATACAATGCTAGTTAAACAGGGTGATGATTATGTGTACCTTCCTTACCCAGATCCATCAAGAATCCTAGGGGCCGGCTGTTTTGTAGATGATATCGTAAAAACAGATG

GTACACTTATGATTGAACGGTTCGTGTCTTTAGCTATAGATGCTTACCCACTTACTAAACATCCTAATCAGGAGTATGCTGATGTCTTTCATTTGTACTTACAATACATA
15740
15750
15760
15770
15780
15790
15800
15810
15820
15830
15840
Wild ORF1ab GTACACTTATGATTGAACGGTTCGTGTCTTTAGCTATAGATGCTTACCCACTTACTAAACATCCTAATCAGGAGTATGCTGATGTCTTTCATTTGTACTTACAATACATA
Vac ORF1ab GTACACTTATGATTGAACGGTTCGTGTCTTTAGCTATAGATGCTTACCCACTTACTAAACATCCTAATCAGGAGTATGCTGATGTCTTTCATTTGTACTTACAATACATA

AGAAAGCTACATGATGAGTTAACAGGACACATGTTAGACATGTATTCTGTTATGCTTACTAATGATAACACTTCAAGGTATTGGGAACCTGAGTTTTATGAGGCTATGTA
15850
15860
15870
15880
15890
15900
15910
15920
15930
15940
15950
Wild ORF1ab AGAAAGCTACATGATGAGTTAACAGGACACATGTTAGACATGTATTCTGTTATGCTTACTAATGATAACACTTCAAGGTATTGGGAACCTGAGTTTTATGAGGCTATGTA
Vac ORF1ab AGAAAGCTACATGATGAGTTAACAGGACACATGTTAGACATGTATTCTGTTATGCTTACTAATGATAACACTTCAAGGTATTGGGAACCTGAGTTTTATGAGGCTATGTA

CACACCGCATACAGTCTTACAGGCTGTTGGGGCTTGTGTTCTTTGCAATTCACAGACTTCATTAAGATGTGGTGCTTGCATACGTAGACCATTCTTATGTTGTAAATGCT
15960
15970
15980
15990
16000
16010
16020
16030
16040
16050
16060
Wild ORF1ab CACACCGCATACAGTCTTACAGGCTGTTGGGGCTTGTGTTCTTTGCAATTCACAGACTTCATTAAGATGTGGTGCTTGCATACGTAGACCATTCTTATGTTGTAAATGCT
Vac ORF1ab CACACCGCATACAGTCTTACAGGCTGTTGGGGCTTGTGTTCTTTGCAATTCACAGACTTCATTAAGATGTGGTGCTTGCATACGTAGACCATTCTTATGTTGTAAATGCT

GTTACGACCATGTCATATCAACATCACATAAATTAGTCTTGTCTGTTAATCCGTATGTTTGCAATGCTCCAGGTTGTGATGTCACAGATGTGACTCAACTTTACTTAGGA
16070
16080
16090
16100
16110
16120
16130
16140
16150
16160
16170
Wild ORF1ab GTTACGACCATGTCATATCAACATCACATAAATTAGTCTTGTCTGTTAATCCGTATGTTTGCAATGCTCCAGGTTGTGATGTCACAGATGTGACTCAACTTTACTTAGGA
Vac ORF1ab GTTACGACCATGTCATATCAACATCACATAAATTAGTCTTGTCTGTTAATCCGTATGTTTGCAATGCTCCAGGTTGTGATGTCACAGATGTGACTCAACTTTACTTAGGA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TGAATGAGTTTTACGCATATTTGCGTAAACATTTCTCAATGATGATACTCTCTGACGATGCTGTTGTGTGTTTCAATAGCACTTATGCATCTCAAGGTCTAGTGGCTAGC
15410
15420
15430
15440
15450
15460
15470
15480
15490
15500
15510
Wild ORF1ab TGAATGAGTTTTACGCATATTTGCGTAAACATTTCTCAATGATGATACTCTCTGACGATGCTGCTGTGTGTTTCAATAGCACTTATGCATCTCAAGGTCTAGTGGCTAGC
Vac ORF1ab TGAATGAGTTTTACGCATATTTGCGTAAACATTTCTCAATGATGATACTCTCTGACGATGCTGTTGTGTGTTTCAATAGCACTTATGCATCTCAAGGTCTAGTGGCTAGC

TACTGACTTTAATGCAATTGCAACATGTGACTGGACAAATGCTGGTGATTACATTTTAGCTAACACCTGTACTGAAAGACTCAAGCTTTTTGCAGCAGAAACGCTCAAAG
16290
16300
16310
16320
16330
16340
16350
16360
16370
16380
16390
Wild ORF1ab TACTGACTTTAATGCAATTGCAACATGTGACTGGACAAATGCTGGTGATTACATTTTAGCTAACACCTGTACTGAAAGACTCAAGCTTTTTGCAGCAGAAACGCTCAAAG
Vac ORF1ab TACTGACTTTAATGCAATTGCAACATGTGACTGGACAAATGCTGGTGATTACATTTTAGCTAACACCTGTACTGAAAGACTCAAGCTTTTTGCAGCAGAAACGCTCAAAG

CTACTGAGGAGACATTTAAACTGTCTTATGGTATTGCTACTGTACGTGAAGTGCTGTCTGACAGAGAATTACATCTTTCATGGGAAGTTGGTAAACCTAGACCACCACTT
16400
16410
16420
16430
16440
16450
16460
16470
16480
16490
16500
Wild ORF1ab CTACTGAGGAGACATTTAAACTGTCTTATGGTATTGCTACTGTACGTGAAGTGCTGTCTGACAGAGAATTACATCTTTCATGGGAAGTTGGTAAACCTAGACCACCACTT
Vac ORF1ab CTACTGAGGAGACATTTAAACTGTCTTATGGTATTGCTACTGTACGTGAAGTGCTGTCTGACAGAGAATTACATCTTTCATGGGAAGTTGGTAAACCTAGACCACCACTT

AACCGAAATTATGTCTTTACTGGTTATCGTGTAACTAAAAACAGTAAAGTACAAATAGGAGAGTACACCTTTGAAAAAGGTGACTATGGTGATGCTGTTGTTTACCGAGG
16510
16520
16530
16540
16550
16560
16570
16580
16590
16600
16610
Wild ORF1ab AACCGAAATTATGTCTTTACTGGTTATCGTGTAACTAAAAACAGTAAAGTACAAATAGGAGAGTACACCTTTGAAAAAGGTGACTATGGTGATGCTGTTGTTTACCGAGG
Vac ORF1ab AACCGAAATTATGTCTTTACTGGTTATCGTGTAACTAAAAACAGTAAAGTACAAATAGGAGAGTACACCTTTGAAAAAGGTGACTATGGTGATGCTGTTGTTTACCGAGG

TACAACAACTTACAAATTAAATGTTGGTGATTATTTTGTGCTGACATCACATACAGTAATGCCATTAAGTGCACCTACACTAGTGCCACAAGAGCACTATGTTAGAATTA
16620
16630
16640
16650
16660
16670
16680
16690
16700
16710
16720
Wild ORF1ab TACAACAACTTACAAATTAAATGTTGGTGATTATTTTGTGCTGACATCACATACAGTAATGCCATTAAGTGCACCTACACTAGTGCCACAAGAGCACTATGTTAGAATTA
Vac ORF1ab TACAACAACTTACAAATTAAATGTTGGTGATTATTTTGTGCTGACATCACATACAGTAATGCCATTAAGTGCACCTACACTAGTGCCACAAGAGCACTATGTTAGAATTA

CTGGCTTATACCCAACACTCAATATCTCAGATGAGTTTTCTAGCAATGTTGCAAATTATCAAAAGGTTGGTATGCAAAAGTATTCTACATTCCAGGGACCACCTGGTACT
16730
16740
16750
16760
16770
16780
16790
16800
16810
16820
16830
Wild ORF1ab CTGGCTTATACCCAACACTCAATATCTCAGATGAGTTTTCTAGCAATGTTGCAAATTATCAAAAGGTTGGTATGCAAAAGTATTCTACACTCCAGGGACCACCTGGTACT
Vac ORF1ab CTGGCTTATACCCAACACTCAATATCTCAGATGAGTTTTCTAGCAATGTTGCAAATTATCAAAAGGTTGGTATGCAAAAGTATTCTACATTCCAGGGACCACCTGGTACT

GGTAAGAGTCATTTTGCTATTGGCCTAGCTCTCTACTACCCTTCTGCTCGCATAGTGTATACAGCTTGCTCTCATGCCGCTGTTGATGCACTATGTGAGAAGGCATTAAA
16840
16850
16860
16870
16880
16890
16900
16910
16920
16930
16940
Wild ORF1ab GGTAAGAGTCATTTTGCTATTGGCCTAGCTCTCTACTACCCTTCTGCTCGCATAGTGTATACAGCTTGCTCTCATGCCGCTGTTGATGCACTATGTGAGAAGGCATTAAA
Vac ORF1ab GGTAAGAGTCATTTTGCTATTGGCCTAGCTCTCTACTACCCTTCTGCTCGCATAGTGTATACAGCTTGCTCTCATGCCGCTGTTGATGCACTATGTGAGAAGGCATTAAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

GGTATGAGCTATTATTGTAAATCACATAAACCACCCATTAGTTTTCCATTGTGTGCTAATGGACAAGTTTTTGGTTTATATAAAAATACATGTGTTGGTAGCGATAATGT
16180
16190
16200
16210
16220
16230
16240
16250
16260
16270
16280
Wild ORF1ab GGTATGAGCTATTATTGTAAATCACATAAACCACCCATTAGTTTTCCATTGTGTGCTAATGGACAAGTTTTTGGTTTATATAAAAATACATGTGTTGGTAGCGATAATGT
Vac ORF1ab GGTATGAGCTATTATTGTAAATCACATAAACCACCCATTAGTTTTCCATTGTGTGCTAATGGACAAGTTTTTGGTTTATATAAAAATACATGTGTTGGTAGCGATAATGT

TAAATGCATTGCCTGAGACGACAGCAGATATAGTTGTCTTTGATGAAATTTCAATGGCCACAAATTATGATTTGAGTGTTGTCAATGCCAGATTACGTGCTAAGCACTAT
17060
17070
17080
17090
17100
17110
17120
17130
17140
17150
17160
Wild ORF1ab TAAATGCATTGCCTGAGACGACAGCAGATATAGTTGTCTTTGATGAAATTTCAATGGCCACAAATTATGATTTGAGTGTTGTCAATGCCAGATTACGTGCTAAGCACTAT
Vac ORF1ab TAAATGCATTGCCTGAGACGACAGCAGATATAGTTGTCTTTGATGAAATTTCAATGGCCACAAATTATGATTTGAGTGTTGTCAATGCCAGATTACGTGCTAAGCACTAT

GTGTACATTGGCGACCCTGCTCAATTACCTGCACCACGCACATTGCTAACTAAGGGCACACTAGAACCAGAATATTTCAATTCAGTGTGTAGACTTATGAAAACTATAGG
17170
17180
17190
17200
17210
17220
17230
17240
17250
17260
17270
Wild ORF1ab GTGTACATTGGCGACCCTGCTCAATTACCTGCACCACGCACATTGCTAACTAAGGGCACACTAGAACCAGAATATTTCAATTCAGTGTGTAGACTTATGAAAACTATAGG
Vac ORF1ab GTGTACATTGGCGACCCTGCTCAATTACCTGCACCACGCACATTGCTAACTAAGGGCACACTAGAACCAGAATATTTCAATTCAGTGTGTAGACTTATGAAAACTATAGG

TCCAGACATGTTCCTCGGAACTTGTCGGCGTTGTCCTGCTGAAATTGTTGACACTGTGAGTGCTTTGGTTTATGATAATAAGCTTAAAGCACATAAAGACAAATCAGCTC
17280
17290
17300
17310
17320
17330
17340
17350
17360
17370
17380
Wild ORF1ab TCCAGACATGTTCCTCGGAACTTGTCGGCGTTGTCCTGCTGAAATTGTTGACACTGTGAGTGCTTTGGTTTATGATAATAAGCTTAAAGCACATAAAGACAAATCAGCTC
Vac ORF1ab TCCAGACATGTTCCTCGGAACTTGTCGGCGTTGTCCTGCTGAAATTGTTGACACTGTGAGTGCTTTGGTTTATGATAATAAGCTTAAAGCACATAAAGACAAATCAGCTC

AATGCTTTAAAATGTTTTATAAGGGTGTTATCACGCATGATGTTTCATCTGCAATTAACAGGCCACAAATAGGCGTGGTAAGAGAATTCCTTACACGTAACCCTGCTTGG
17390
17400
17410
17420
17430
17440
17450
17460
17470
17480
17490
Wild ORF1ab AATGCTTTAAAATGTTTTATAAGGGTGTTATCACGCATGATGTTTCATCTGCAATTAACAGGCCACAAATAGGCGTGGTAAGAGAATTCCTTACACGTAACCCTGCTTGG
Vac ORF1ab AATGCTTTAAAATGTTTTATAAGGGTGTTATCACGCATGATGTTTCATCTGCAATTAACAGGCCACAAATAGGCGTGGTAAGAGAATTCCTTACACGTAACCCTGCTTGG

AGAAAAGCTGTCTTTATTTCACCTTATAATTCACAGAATGCTGTAGCCTCAAAGGTTTTGGGACTACCAACTCAAACTGTTGATTCATCACAGGGCTCAGAATATGACTA
17500
17510
17520
17530
17540
17550
17560
17570
17580
17590
17600
Wild ORF1ab AGAAAAGCTGTCTTTATCTCACCTTATAATTCACAGAATGCTGTAGCCTCAAAGGTTTTGGGACTACCAACTCAAACTGTTGATTCATCACAGGGCTCAGAATATGACTA
Vac ORF1ab AGAAAAGCTGTCTTTATTTCACCTTATAATTCACAGAATGCTGTAGCCTCAAAGATTTTGGGACTACCAACTCAAACTGTTGATTCATCACAGGGCTCAGAATATGACTA

TGTCATATTCACTCAAACCACTGAAACAGCTCACTCTTGTAATGTAAACAGATTTAATGTTGCTATTACCAGAGCAAAAGTAGGCATACTTTGCATAATGTCTGATAGAG
17610
17620
17630
17640
17650
17660
17670
17680
17690
17700
17710
Wild ORF1ab TGTCATATTCACTCAAACCACTGAAACAGCTCACTCTTGTAATGTAAACAGATTTAATGTTGCTATTACCAGAGCAAAAGTAGGCATACTTTGCATAATGTCTGATAGAG
Vac ORF1ab TGTCATATTCACTCAAACCACTGAAACAGCTCACTCTTGTAATGTAAACAGATTTAATGTTGCTATTACCAGAGCAAAAGTAGGCATACTTTGCATAATGTCTGATAGAG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATATTTGCCTATAGATAAATGTAGTAGAATTATACCTGCACGTGCTCGTGTAGAGTGTTTTGATAAATTCAAAGTGAATTCAACATTAGAACAGTATGTCTTTTGTACTG
16950
16960
16970
16980
16990
17000
17010
17020
17030
17040
17050
Wild ORF1ab ATATTTGCCTATAGATAAATGTAGTAGAATTATACCTGCACGTGCTCGTGTAGAGTGTTTTGATAAATTCAAAGTGAATTCAACATTAGAACAGTATGTCTTTTGTACTG
Vac ORF1ab ATATTTGCCTATAGATAAATGTAGTAGAATTATACCTGCACGTGCTCGTGTAGAGTGTTTTGATAAATTCAAAGTGAATTCAACATTAGAACAGTATGTCTTTTGTACTG

ACTGGGTTACATCCTACACAGGCACCTACACACCTCAGTGTTGACACTAAATTCAAAACTGAAGGTTTATGTGTTGACATACCTGGCATACCTAAGGACATGACCTATAG
17830
17840
17850
17860
17870
17880
17890
17900
17910
17920
17930
Wild ORF1ab ACTGGGTTACATCCTACACAGGCACCTACACACCTCAGTGTTGACACTAAATTCAAAACTGAAGGTTTATGTGTTGACATACCTGGCATACCTAAGGACATGACCTATAG
Vac ORF1ab ACTGGGTTACATCCTACACAGGCACCTACACACCTCAGTGTTGACACTAAATTCAAAACTGAAGGTTTATGTGTTGACATACCTGGCATACCTAAGGACATGACCTATAG

AAGACTCATCTCTATGATGGGTTTTAAAATGAATTATCAAGTTAATGGTTACCCTAACATGTTTATCACCCGCGAAGAAGCTATAAGACATGTACGTGCATGGATTGGCT
17940
17950
17960
17970
17980
17990
18000
18010
18020
18030
18040
Wild ORF1ab AAGACTCATCTCTATGATGGGTTTTAAAATGAATTATCAAGTTAATGGTTACCCTAACATGTTTATCACCCGCGAAGAAGCTATAAGACATGTACGTGCATGGATTGGCT
Vac ORF1ab AAGACTCATCTCTATGATGGGTTTTAAAATGAATTATCAAGTTAATGGTTACCCTAACATGTTTATCACCCGCGAAGAAGCTATAAGACATGTACGTGCATGGATTGGCT

TCGATGTCGAGGGGTGTCATGCTACTAGAGAAGCTGTTGGTACCAATTTACCTTTACAGCTAGGTTTTTCTACAGGTGTTAACCTAGTTGCTGTACCTACAGGTTATGTT
18050
18060
18070
18080
18090
18100
18110
18120
18130
18140
18150
Wild ORF1ab TCGATGTCGAGGGGTGTCATGCTACTAGAGAAGCTGTTGGTACCAATTTACCTTTACAGCTAGGTTTTTCTACAGGTGTTAACCTAGTTGCTGTACCTACAGGTTATGTT
Vac ORF1ab TCGATGTCGAGGGGTGTCATGCTACTAGAGAAGCTGTTGGTACCAATTTACCTTTACAGCTAGGTTTTTCTACAGGTGTTAACCTAGTTGCTGTACCTACAGGTTATGTT

GATACACCTAATAATACAGATTTTTCCAGAGTTAGTGCTAAACCACCGCCTGGAGATCAATTTAAACACCTCATACCACTTATGTACAAAGGACTTCCTTGGAATGTAGT
18160
18170
18180
18190
18200
18210
18220
18230
18240
18250
18260
Wild ORF1ab GATACACCTAATAATACAGATTTTTCCAGAGTTAGTGCTAAACCACCGCCTGGAGATCAATTTAAACACCTCATACCACTTATGTACAAAGGACTTCCTTGGAATGTAGT
Vac ORF1ab GATACACCTAATAATACAGATTTTTCCAGAGTTAGTGCTAAACCACCGCCTGGAGATCAATTTAAACACCTCATACCACTTATGTACAAAGGACTTCCTTGGAATGTAGT

GCGTATAAAGATTGTACAAATGTTAAGTGACACACTTAAAAATCTCTCTGACAGAGTCGTATTTGTCTTATGGGCACATGGCTTTGAGTTGACATCTATGAAGTATTTTG
18270
18280
18290
18300
18310
18320
18330
18340
18350
18360
18370
Wild ORF1ab GCGTATAAAGATTGTACAAATGTTAAGTGACACACTTAAAAATCTCTCTGACAGAGTCGTATTTGTCTTATGGGCACATGGCTTTGAGCTGACATCTATGAAGTATTTTG
Vac ORF1ab GCGTATAAAGATTGTACAAATGTTAAGTGACACACTTAAAAATCTCTCTGACAGAGTCGTATTTGTCTTATGGGCACATGGCTTTGAGTTGACATCTATGAAGTATTTTG

TGAAAATAGGACCTGAGCGCACCTGTTGTCTATGTGATAGACGTGCCACATGCTTTTCCACTGCTTCAGACACTTATGCCTGTTGGCATCATTCTATTGGATTTGATTAC
18380
18390
18400
18410
18420
18430
18440
18450
18460
18470
18480
Wild ORF1ab TGAAAATAGGACCTGAGCGCACCTGTTGTCTATGTGATAGACGTGCCACATGCTTTTCCACTGCTTCAGACACTTATGCCTGTTGGCATCATTCTATTGGATTTGATTAC
Vac ORF1ab TGAAAATAGGACCTGAGCGCACCTGTTGTCTATGTGATAGACGTGCCACATGCTTTTCCACTGCTTCAGACACTTATGCCTGTTGGCATCATTCTATTGGATTTGATTAC

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ACCTTTATGACAAGTTGCAATTTACAAGTCTTGAAATTCCACGTAGGAATGTGGCAACTTTACAAGCTGAAAATGTAACAGGACTCTTTAAAGATTGTAGTAAGGTAATC
17720
17730
17740
17750
17760
17770
17780
17790
17800
17810
17820
Wild ORF1ab ACCTTTATGACAAGTTGCAATTTACAAGTCTTGAAATTCCACGTAGGAATGTGGCAACTTTACAAGCTGAAAATGTAACAGGACTCTTTAAAGATTGTAGTAAGGTAATC
Vac ORF1ab ACCTTTATGACAAGTTGCAATTTACAAGTCTTGAAATTCCACGTAGGAATGTGGCAACTTTACAAGCTGAAAATGTAACAGGACTCTTTAAAGATTGTAGTAAGGTAATC

TGATGCAATCATGACTAGGTGTCTAGCTGTCCACGAGTGCTTTGTTAAGCGTGTTGACTGGACTATTGAATATCCTATAATTGGTGATGAACTGAAGATTAATGCGGCTT
18600
18610
18620
18630
18640
18650
18660
18670
18680
18690
18700
Wild ORF1ab TGATGCAATCATGACTAGGTGTCTAGCTGTCCACGAGTGCTTTGTTAAGCGTGTTGACTGGACTATTGAATATCCTATAATTGGTGATGAACTGAAGATTAATGCGGCTT
Vac ORF1ab TGATGCAATCATGACTAGGTGTCTAGCTGTCCACGAGTGCTTTGTTAAGCGTGTTGACTGGACTATTGAATATCCTATAATTGGTGATGAACTGAAGATTAATGCGGCTT

GTAGAAAGGTTCAACACATGGTTGTTAAAGCTGCATTATTAGCAGACAAATTCCCAGTTCTTCACGACATTGGTAACCCTAAAGCTATTAAGTGTGTACCTCAAGCTGAT
18710
18720
18730
18740
18750
18760
18770
18780
18790
18800
18810
Wild ORF1ab GTAGAAAGGTTCAACACATGGTTGTTAAAGCTGCATTATTAGCAGACAAATTCCCAGTTCTTCACGACATTGGTAACCCTAAAGCTATTAAGTGTGTACCTCAAGCTGAT
Vac ORF1ab GTAGAAAGGTTCAACACATGGTTGTTAAAGCTGCATTATTAGCAGACAAATTCCCAGTTCTTCACGACATTGGTAACCCTAAAGCTATTAAGTGTGTACCTCAAGCTGAT

GTAGAATGGAAGTTCTATGATGCACAGCCTTGTAGTGACAAAGCTTATAAAATAGAAGAATTATTCTATTCTTATGCCACACATTCTGACAAATTCACAGATGGTGTATG
18820
18830
18840
18850
18860
18870
18880
18890
18900
18910
18920
Wild ORF1ab GTAGAATGGAAGTTCTATGATGCACAGCCTTGTAGTGACAAAGCTTATAAAATAGAAGAATTATTCTATTCTTATGCCACACATTCTGACAAATTCACAGATGGTGTATG
Vac ORF1ab GTAGAATGGAAGTTCTATGATGCACAGCCTTGTAGTGACAAAGCTTATAAAATAGAAGAATTATTCTATTCTTATGCCACACATTCTGACAAATTCACAGATGGTGTATG

CCTATTTTGGAATTGCAATGTCGATAGATATCCTGCTAATTCCATTGTTTGTAGATTTGACACTAGAGTGCTATCTAACCTTAACTTGCCTGGTTGTGATGGTGGCAGTT
18930
18940
18950
18960
18970
18980
18990
19000
19010
19020
19030
Wild ORF1ab CCTATTTTGGAATTGCAATGTCGATAGATATCCTGCTAATTCCATTGTTTGTAGATTTGACACTAGAGTGCTATCTAACCTTAACTTGCCTGGTTGTGATGGTGGCAGTT
Vac ORF1ab CCTATTTTGGAATTGCAATGTCGATAGATATCCTGCTAATTCCATTGTTTGTAGATTTGACACTAGAGTGCTATCTAACCTTAACTTGCCTGGTTGTGATGGTGGCAGTT

TGTATGTAAATAAACATGCATTCCACACACCAGCTTTTGATAAAAGTGCTTTTGTTAATTTAAAACAATTACCATTTTTCTATTACTCTGACAGTCCATGTGAGTCTCAT
19040
19050
19060
19070
19080
19090
19100
19110
19120
19130
19140
Wild ORF1ab TGTATGTAAATAAACATGCATTCCACACACCAGCTTTTGATAAAAGTGCTTTTGTTAATTTAAAACAATTACCATTTTTCTATTACTCTGACAGTCCATGTGAGTCTCAT
Vac ORF1ab TGTATGTAAATAAACATGCATTCCACACACCAGCTTTTGATAAAAGTGCTTTTGTTAATTTAAAACAATTACCATTTTTCTATTACTCTGACAGTCCATGTGAGTCTCAT

GGAAAACAAGTAGTGTCAGATATAGATTATGTACCACTAAAGTCTGCTACGTGTATAACACGTTGCAATTTAGGTGGTGCTGTCTGTAGACATCATGCTAATGAGTACAG
19150
19160
19170
19180
19190
19200
19210
19220
19230
19240
19250
Wild ORF1ab GGAAAACAAGTAGTGTCAGATATAGATTATGTACCACTAAAGTCTGCTACGTGTATAACACGTTGCAATTTAGGTGGTGCTGTCTGTAGACATCATGCTAATGAGTACAG
Vac ORF1ab GGAAAACAAGTAGTGTCAGATATAGATTATGTACCACTAAAGTCTGCTACGTGTATAACACGTTGCAATTTAGGTGGTGCTGTCTGTAGACATCATGCTAATGAGTACAG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

GTCTATAATCCGTTTATGATTGATGTTCAACAATGGGGTTTTACAGGTAACCTACAAAGCAACCATGATCTGTATTGTCAAGTCCATGGTAATGCACATGTAGCTAGTTG
18490
18500
18510
18520
18530
18540
18550
18560
18570
18580
18590
Wild ORF1ab GTCTATAATCCGTTTATGATTGATGTTCAACAATGGGGTTTTACAGGTAACCTACAAAGCAACCATGATCTGTATTGTCAAGTCCATGGTAATGCACATGTAGCTAGTTG
Vac ORF1ab GTCTATAATCCGTTTATGATTGATGTTCAACAATGGGGTTTTACAGGTAACCTACAAAGCAACCATGATCTGTATTGTCAAGTCCATGGTAATGCACATGTAGCTAGTTG

TAGAAAATGTGGCTTTTAATGTTGTAAATAAGGGACACTTTGATGGACAACAGGGTGAAGTACCAGTTTCTATCATTAATAACACTGTTTACACAAAAGTTGATGGTGTT
19370
19380
19390
19400
19410
19420
19430
19440
19450
19460
19470
Wild ORF1ab TAGAAAATGTGGCTTTTAATGTTGTAAATAAGGGACACTTTGATGGACAACAGGGTGAAGTACCAGTTTCTATCATTAATAACACTGTTTACACAAAAGTTGATGGTGTT
Vac ORF1ab TAGAAAATGTGGCTTTTAATGTTGTAAATAAGGGACACTTTGATGGACAACAGGGTGAAGTACCAGTTTCTATCATTAATAACACTGTTTACACAAAAGTTGATGGTGTT

GATGTAGAATTGTTTGAAAATAAAACAACATTACCTGTTAATGTAGCATTTGAGCTTTGGGCTAAGCGCAACATTAAACCAGTACCAGAGGTGAAAATACTCAATAATTT
19480
19490
19500
19510
19520
19530
19540
19550
19560
19570
19580
Wild ORF1ab GATGTAGAATTGTTTGAAAATAAAACAACATTACCTGTTAATGTAGCATTTGAGCTTTGGGCTAAGCGCAACATTAAACCAGTACCAGAGGTGAAAATACTCAATAATTT
Vac ORF1ab GATGTAGAATTGTTTGAAAATAAAACAACATTACCGGTTAATGTAGCATTTGAGCTTTGGGCTAAGCGCAACATTAAACCAGTACCAGAGGTGAAAATACTCAATAATTT

GGGTGTGGACATTGCTGCTAATACTGTGATCTGGGACTACAAAAGAGATGCTCCAGCACATATATCTACTATTGGTGTTTGTTCTATGACTGACATAGCCAAGAAACCAA
19590
19600
19610
19620
19630
19640
19650
19660
19670
19680
19690
Wild ORF1ab GGGTGTGGACATTGCTGCTAATACTGTGATCTGGGACTACAAAAGAGATGCTCCAGCACATATATCTACTATTGGTGTTTGTTCTATGACTGACATAGCCAAGAAACCAA
Vac ORF1ab GGGTGTGGACATTGCTGCTAATACTGTGATCTGGGACTACAAAAGAGATGCTCCAGCACATATATCTACTATTGGTGTTTGTTCTATGACTGACATAGCCAAGAAACCAA

CTGAAACGATTTGTGCACCACTCACTGTCTTTTTTGATGGTAGAGTTGATGGTCAAGTAGACTTATTTAGAAATGCCCGTAATGGTGTTCTTATTACAGAAGGTAGTGTT
19700
19710
19720
19730
19740
19750
19760
19770
19780
19790
19800
Wild ORF1ab CTGAAACGATTTGTGCACCACTCACTGTCTTTTTTGATGGTAGAGTTGATGGTCAAGTAGACTTATTTAGAAATGCCCGTAATGGTGTTCTTATTACAGAAGGTAGTGTT
Vac ORF1ab CTGAAACGATTTGTGCACCACTCACTGTCTTTTTTGATGGTAGAGTTGATGGTCAAGTAGACTTATTTAGAAATGCCCGTAATGGTGTTCTTATTACAGAAGGTAGTGTT

AAAGGTTTACAACCATCTGTAGGTCCCAAACAAGCTAGTCTTAATGGAGTCACATTAATTGGAGAAGCCGTAAAAACACAGTTCAATTATTATAAGAAAGTTGATGGTGT
19810
19820
19830
19840
19850
19860
19870
19880
19890
19900
19910
Wild ORF1ab AAAGGTTTACAACCATCTGTAGGTCCCAAACAAGCTAGTCTTAATGGAGTCACATTAATTGGAGAAGCCGTAAAAACACAGTTCAATTATTATAAGAAAGTTGATGGTGT
Vac ORF1ab AAAGGTTTACAACCATCTGTAGGTCCCAAACAAGCTAGTCTTAATGGAGTCACATTAATTGGAGAAGCCGTAAAAACACAGTTCAATTATTATAAGAAAGTTGATGGTGT

TGTCCAACAATTACCTGAAACTTACTTTACTCAGAGTAGAAATTTACAAGAATTTAAACCCAGGAGTCAAATGGAAATTGATTTCTTAGAATTAGCTATGGATGAATTCA
19920
19930
19940
19950
19960
19970
19980
19990
20000
20010
20020
Wild ORF1ab TGTCCAACAATTACCTGAAACTTACTTTACTCAGAGTAGAAATTTACAAGAATTTAAACCCAGGAGTCAAATGGAAATTGATTTCTTAGAATTAGCTATGGATGAATTCA
Vac ORF1ab TGTCCAACAATTACCTGAAACTTACTTTACTCAGAGTAGAAATTTACAAGAATTTAAACCCAGGAGTCAAATGGAAATTGATTTCTTAGAATTAGCTATGGATGAATTCA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATTGTATCTCGATGCTTATAACATGATGATCTCAGCTGGCTTTAGCTTGTGGGTTTACAAACAATTTGATACTTATAACCTCTGGAACACTTTTACAAGACTTCAGAGTT
19260
19270
19280
19290
19300
19310
19320
19330
19340
19350
19360
Wild ORF1ab ATTGTATCTCGATGCTTATAACATGATGATCTCAGCTGGCTTTAGCTTGTGGGTTTACAAACAATTTGATACTTATAACCTCTGGAACACTTTTACAAGACTTCAGAGTT
Vac ORF1ab ATTGTATCTCGATGCTTATAACATGATGATCTCAGCTGGCTTTAGCTTGTGGGTTTACAAACAATTTGATACTTATAACCTCTGGAACACTTTTACAAGACTTCAGAGTT

AAGGAATCACCTTTTGAATTAGAAGATTTTATTCCTATGGACAGTACAGTTAAAAACTATTTCATAACAGATGCGCAAACAGGTTCATCTAAGTGTGTGTGTTCTGTTAT
20140
20150
20160
20170
20180
20190
20200
20210
20220
20230
20240
Wild ORF1ab AAGGAATCACCTTTTGAATTAGAAGATTTTATTCCTATGGACAGTACAGTTAAAAACTATTTCATAACAGATGCGCAAACAGGTTCATCTAAGTGTGTGTGTTCTGTTAT
Vac ORF1ab AAGGAATCACCTTTTGAATTAGAAGATTTTATTCCTATGGACAGTACAGTTAAAAACTATTTCATAACAGATGCGCAAACAGGTTCATCTAAGTGTGTGTGTTCTGTTAT

TGATTTATTACTTGATGATTTTGTTGAAATAATAAAATCCCAAGATTTATCTGTAGTTTCTAAGGTTGTCAAAGTGACTATTGACTATACAGAAATTTCATTTATGCTTT
20250
20260
20270
20280
20290
20300
20310
20320
20330
20340
20350
Wild ORF1ab TGATTTATTACTTGATGATTTTGTTGAAATAATAAAATCCCAAGATTTATCTGTAGTTTCTAAGGTTGTCAAAGTGACTATTGACTATACAGAAATTTCATTTATGCTTT
Vac ORF1ab TGATTTATTACTTGATGATTTTGTTGAAATAATAAAATCCCAAGATTTATCTGTAGTTTCTAAGGTTGTCAAAGTGACTATTGACTATACAGAAATTTCATTTATGCTTT

GGTGTAAAGATGGCCATGTAGAAACATTTTACCCAAAATTACAATCTAGTCAAGCGTGGCAACCGGGTGTTGCTATGCCTAATCTTTACAAAATGCAAAGAATGCTATTA
20360
20370
20380
20390
20400
20410
20420
20430
20440
20450
20460
Wild ORF1ab GGTGTAAAGATGGCCATGTAGAAACATTTTACCCAAAATTACAATCTAGTCAAGCGTGGCAACCGGGTGTTGCTATGCCTAATCTTTACAAAATGCAAAGAATGCTATTA
Vac ORF1ab GGTGTAAAGATGGCCATGTAGAAACATTTTACCCAAAATTACAATCTAGTCAAGCGTGGCAACCGGGTGTTGCTATGCCTAATCTTTACAAAATGCAAAGAATGCTATTA

GAAAAGTGTGACCTTCAAAATTATGGTGATAGTGCAACATTACCTAAAGGCATAATGATGAATGTCGCAAAATATACTCAACTGTGTCAATATTTAAACACATTAACATT
20470
20480
20490
20500
20510
20520
20530
20540
20550
20560
20570
Wild ORF1ab GAAAAGTGTGACCTTCAAAATTATGGTGATAGTGCAACATTACCTAAAGGCATAATGATGAATGTCGCAAAATATACTCAACTGTGTCAATATTTAAACACATTAACATT
Vac ORF1ab GAAAAGTGTGACCTTCAAAATTATGGTGATAGTGCAACATTACCTAAAGGCATAATGATGAATGTCGCAAAATATACTCAACTGTGTCAATATTTAAACACATTAACATT

AGCTGTACCCTATAATATGAGAGTTATACATTTTGGTGCTGGTTCTGATAAAGGAGTTGCACCAGGTACAGCTGTTTTAAGACAGTGGTTGCCTACGGGTACGCTGCTTG
20580
20590
20600
20610
20620
20630
20640
20650
20660
20670
20680
Wild ORF1ab AGCTGTACCCTATAATATGAGAGTTATACATTTTGGTGCTGGTTCTGATAAAGGAGTTGCACCAGGTACAGCTGTTTTAAGACAGTGGTTGCCTACGGGTACGCTGCTTG
Vac ORF1ab AGCTGTACCCTATAATATGAGAGTTATACATTTTGGTGCTGGTTCTGATAAAGGAGTTGCACCAGGTACAGCTGTTTTAAGACAGTGGTTGCCTACGGGTACGCTGCTTG

TCGATTCAGATCTTAATGACTTTGTCTCTGATGCAGATTCAACTTTGATTGGTGATTGTGCAACTGTACATACAGCTAATAAATGGGATCTCATTATTAGTGATATGTAC
20690
20700
20710
20720
20730
20740
20750
20760
20770
20780
20790
Wild ORF1ab TCGATTCAGATCTTAATGACTTTGTCTCTGATGCAGATTCAACTTTGATTGGTGATTGTGCAACTGTACATACAGCTAATAAATGGGATCTCATTATTAGTGATATGTAC
Vac ORF1ab TCGATTCAGATCTTAATGACTTTGTCTCTGATGCAGATTCAACTTTGATTGGTGATTGTGCAACTGTACATACAGCTAATAAATGGGATCTCATTATTAGTGATATGTAC

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TTGAACGGTATAAATTAGAAGGCTATGCCTTCGAACATATCGTTTATGGAGATTTTAGTCATAGTCAGTTAGGTGGTTTACATCTACTGATTGGACTAGCTAAACGTTTT
20030
20040
20050
20060
20070
20080
20090
20100
20110
20120
20130
Wild ORF1ab TTGAACGGTATAAATTAGAAGGCTATGCCTTCGAACATATCGTTTATGGAGATTTTAGTCATAGTCAGTTAGGTGGTTTACATCTACTGATTGGACTAGCTAAACGTTTT
Vac ORF1ab TTGAACGGTATAAATTAGAAGGCTATGCCTTCGAACATATCGTTTATGGAGATTTTAGTCATAGTCAGTTAGGTGGTTTACATCTACTGATTGGACTAGCTAAACGTTTT

AAAGATAACAGAACATTCTTGGAATGCTGATCTTTATAAGCTCATGGGACACTTCGCATGGTGGACAGCCTTTGTTACTAATGTGAATGCGTCATCATCTGAAGCATTTT
20910
20920
20930
20940
20950
20960
20970
20980
20990
21000
21010
Wild ORF1ab AAAGATAACAGAACATTCTTGGAATGCTGATCTTTATAAGCTCATGGGACACTTCGCATGGTGGACAGCCTTTGTTACTAATGTGAATGCGTCATCATCTGAAGCATTTT
Vac ORF1ab AAAGATAACAGAACATTCTTGGAATGCTGATCTTTATAAGCTCATGGGACACTTCGCATGGTGGACAGCCTTTGTTACTAATGTGAATGCGTCATCATCTGAAGCATTTT

TAATTGGATGTAATTATCTTGGCAAACCACGCGAACAAATAGATGGTTATGTCATGCATGCAAATTACATATTTTGGAGGAATACAAATCCAATTCAGTTGTGTTCCTAT
21020
21030
21040
21050
21060
21070
21080
21090
21100
21110
21120
Wild ORF1ab TAATTGGATGTAATTATCTTGGCAAACCACGCGAACAAATAGATGGTTATGTCATGCATGCAAATTACATATTTTGGAGGAATACAAATCCAATTCAGTTGTGTTCCTAT
Vac ORF1ab TAATTGGATGTAATTATCTTGGCAAACCACGCGAACAAATAGATGGTTATGTCATGCATGCAAATTACATATTTTGGAGGAATACAAATCCAATTCAGTTGTCTTCCTAT

TCTTTATTTGACATGAGTAAATTTCCCCTTAAATTAAGGGGTACTGCTGTTATGTCTTTAAAAGAAGGTCAAATCAATGATATGATTTTATCTCTTCTTAGTAAAGGTAG
21130
21140
21150
21160
21170
21180
21190
21200
21210
21220
21230
Wild ORF1ab TCTTTATTTGACATGAGTAAATTTCCCCTTAAATTAAGGGGTACTGCCGTTATGCCTTTAAAAGAAGGTCAAATCAATGATATGATTTTATCTCTTCTTAGTAAAGGTAG
Vac ORF1ab TCTTTATTTGACATGAGTAAATTTCCCCTTAAATTAAGGGGTACTGCTGTTATGTCTTTAAAAGAAGGTCAAATCAATGATATGATTTTATCTCTTCTTAGTAAAGGTAG

ACTTATAATTAGAGAAAACAACAGAGTTGTTATTTCTAGTGATGTTCTTGTTAACAACTAA
21240
21250
21260
21270
21280
21290
Wild ORF1ab ACTTATAATTAGAGAAAACAACAGAGTTGTTATTTCTAGTGATGTTCTTGTTAACAACTAA
Vac ORF1ab ACTTATAATTAGAGAAAACAACAGAGTTGTTATTTCTAGTGATGTTCTTGTTAACAACTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

GACCCTAAGACTAAAAATGTTACAAAAGAAAATGACTCTAAAGAGGGTTTTTTCACTTACATTTGTGGGTTTATACAACAAAAGCTAGCTCTTGGAGGTTCCGTGGCTAT
20800
20810
20820
20830
20840
20850
20860
20870
20880
20890
20900
Wild ORF1ab GACCCTAAGACTAAAAATGTTACAAAAGAAAATGACTCTAAAGAGGGTTTTTTCACTTACATTTGTGGGTTTATACAACAAAAGCTAGCTCTTGGAGGTTCCGTGGCTAT
Vac ORF1ab GACCCTAAGACTAAAAATGTTACAAAAGAAAATGACTCTAAAGAGGGTTTTTTCACTTACATTTGTGGGTTTATACAACAAAAGCTAGCTCTTGGAGGTTCCGTGGCTAT

TTGCCCTGACAAAGTTTTCAGATCCTCAGTTTTACATTCAACTCAGGACTTGTTCTTACCTTTCTTTTCCAATGTTACTTGGTTCCATGCTATACATGTCTCTGGGACCA
120
130
140
150
160
170
180
190
200
210
220
Wild S TTGCCCTGACAAAGTTTTCAGATCCTCAGTTTTACATTCAACTCAGGACTTGTTCTTACCTTTCTTTTCCAATGTTACTTGGTTCCATGCTATACATGTCTCTGGGACCA
Vac S TTACCCTGACAAAGTTTTCAGATCCTCAGTTTTACATTCAACTCAGGACTTGTTCTTACCTTTCTTTTCCAATGTTACTTGGTTCCATGCTATACATGTCTCTGGGACCA

ATGGTACTAAGAGGTTTGATAACCCTGTCCTACCATTTAATGATGGTGTTTATTTTGCTTCCATTGGGAAGTCTAACATAATAAGAGGCTGGATTTTTGGTACTACTTTA
230
240
250
260
270
280
290
300
310
320
330
Wild S ATGGTACTAAGAGGTTTGATAACCCTGTCCTACCATCTAATGATGGTGTTTATTTTGCTTCCATTGGGAAGTCTAACATAATAAGAGGCTGGATTTTTGGTACTACTTTA
Vac S ATGGTACTAAGAGGTTTGATAACCCTGTCCTACCATTTAATGATGGTGTTTATTTTGCTTCCATTGAGAAGTCTAACATAATAAGAGGCTGGATTTTTGGTACTACTTTA

GATTCGAAGACCCAGTCCCTACTTATTGTTAATAACGCTACTAATGTTGTTATTAAAGTCTGTGAATTTCAATTTTGTAATGATCCATTTTTGGGTGTTTATTACCACAA
340
350
360
370
380
390
400
410
420
430
440
Wild S GATTCGAAGACCCAGTCCCTACTTATTGTTAATAACGCTACTAATGTTGTTATTAAAGTCTGTGAATTTCAATTTTGTAATGATCCATTTTTGGGTGTTTATTACCACAA
Vac S GATTCGAAGACCCAGTCCCTACTTATTGTTAATAACGCTACTAATGTTGTTATTAAAGTCTGTGAATTTCAATTTTGTAATGATCCATTTTTGGGTGTTTATTACCACAA

AAACAACAAAGGTTGGATGGAAAGTGAGTTCAGAGTTTATTCTAGTGCGAATAATTGCACTTTTGAATATGTCTCTCAGCCTTTTCTTATGGACCTTGAAGGAAAACAGG
450
460
470
480
490
500
510
520
530
540
550
Wild S AAACAACAAAGGTTGGATGGAAAGTGAGTTCAGAGTTTATTCTAGTGCGAATAATTGCACTTTTGAATATGTCTCTCAGCCTTTTCTTATGGACCTTGAAGGAAAACAGG
Vac S AAACAACAAAAGTTGGATGGAAAGTGAGTTCAGAGTTTATTCTAGTGCGAATAATTGCACTTTTGAATATGTCTCTCAGCCTTTTCTTATGGACCTTGAAGGAAAACAGG

GTAAGTTCAAAAATCTTAGGGAATTTGTGTTTAAGAATATTGATGGTTATTTTAAAATATATTCTAAGCACACGCCTATTAATTTAGTGCGTGATCTCCCTCAGGGTTTT
560
570
580
590
600
610
620
630
640
650
660
Wild S GTAAGTTCAAAAATCTTAGGGAATTTGTGTTTAAGAATATTGATGGTTATTTTAAAATATATTCTAAGCACACGCCTATTAATTTAGTGCGTGATCTCCCTCAGGGTTTT
Vac S GTAAGTTCAAAAATCTTAGGGAATTTGTGTTTAAGAATATTGATGGTTATTTTAAAATATATTCTAAGCACACGCCTATTAATTTAGTGCGTGATCTCCCTCAGGGTTTT

TCGGCTTTAGAACCATTGGTAGATTTGCCAATAGGTATTAACATCACTAGGTTTCAAACTTTACTTGCTTTACATAGAAGTTATTTGACTCCTGGTGATTCTTCTTCAGG
670
680
690
700
710
720
730
740
750
760
770
Wild S TCGGCTTTAGAACCATTGGTAGATTTGCCAATAGGTATTAACATCACTAGGTTTCAAACTTTACTTGCTTTACATAGAAGTTATTTGACTCCTGGTGATTCTTCTTCAGG
Vac S TCGGCTTTAGAACCATTGGTAGATTTGCCAATAGGTATTAACATCACTAGGTTTCAAACTTTACTTGCTTTACATAGAAGTTATTTGACTCCTGGTGATTCTTCTTCAGG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGTTTGTTTTTCTTGTTTTATTGCCACTAGTCTCTAGTCAGTGTGTTAATCTTACAACCAGAACTCAATTACCCCCTGCATACACTAATTCTTTCACACGTGGTGTTTA
10
20
30
40
50
60
70
80
90
100
110
Wild S ATGTTTGTTTTTCTTGTTTTATTGCCACTAGTCTCTAGTCAGTGTGTTAATCTTACAACCAGAACTCAATTACCCCCTGCATACACTAATTCTTTCACACGTGGTGTTTA
Vac S ATGTTTGTTTTTCTTGTTTTATTGCCACTAGTCTCTAGTCAGTGTGTTAATCTTACAACCAGAACTCAATTACCCCCTGCATACACTAATTCTTTCACACGTGGTGTTTA

ACCCTCTCTCAGAAACAAAGTGTACGTTGAAATCCTTCACTGTAGAAAAAGGAATCTATCAAACTTCTAACTTTAGAGTCCAACCAACAGAATCTATTGTTAGATTTCCT
890
900
910
920
930
940
950
960
970
980
990
Wild S ACCCTCTCTCAGAAACAAAGTGTACGTTGAAATCCTTCACTGTAGAAAAAGGAATCTATCAAACTTCTAACTTTAGAGTCCAACCAACAGAATCTATTGTTAGATTTCCT
Vac S ACCCTCTCTCAGAAACAAAGTGTACGTTGAAATCCTTCACTGTAGAAAAAGGAATCTATCAAACTTCTAACTTTAGAGTCCAACCAACAGAATCTATTGTTAGATTTCCT

AATATTACAAACTTGTGCCCTTTTGGTGAAGTTTTTAACGCCACCAGATTTGCATCTGTTTATGCTTGGAACAGGAAGAGAATCAGCAACTGTGTTGCTGATTATTCTGT
1000
1010
1020
1030
1040
1050
1060
1070
1080
1090
1100
Wild S AATATTACAAACTTGTGCCCTTTTGGTGAAGTTTTTAACGCCACCAGATTTGCATCTGTTTATGCTTGGAACAGGAAGAGAATCAGCAACTGTGTTGCTGATTATTCTGT
Vac S AATATTACAAACTTGTGCCCTTTTGGTGAAGTTTTTAACGCCACCAGATTTGCATCTGTTTATGCTTGGAACAGGAAGAGAATCAGCAACTGTGTTGCTGATTATTCTGT

CCTATATAATTCCGCATCATTTTCCACTTTTAAGTGTTATGGAGTGTCTCCTACTAAATTAAATGATCTCTGCTTTACTAATGTCTATGCAGATTCATTTGTAATTAGAG
1110
1120
1130
1140
1150
1160
1170
1180
1190
1200
1210
Wild S CCTATATAATTCCGCATCATTTTCCACTTTTAAGTGTTATGGAGTGTCTCCTACTAAATTAAATGATCTCTGCTTTACTAATGTCTATGCAGATTCATTTGTAATTAGAG
Vac S CCTATATAATTCCGCATCATTTTCCACTTTTAAGTGTTATGGAGTGTCTCCTACTAAATTAAATGATCTCTGCTTTACTAATGTCTATGCAGATTCATTTGTAATTAGAG

GTGATGAAGTCAGACAAATCGCTCCAGGGCAAACTGGAAAGATTGCTGATTATAATTATAAATTACCAGATGATTTTACAGGCTGCGTTATAGCTTGGAATTCTAACAAT
1220
1230
1240
1250
1260
1270
1280
1290
1300
1310
1320
Wild S GTGATGAAGTCAGACAAATCGCTCCAGGGCAAACTGGAAAGATTGCTGATTATAATTATAAATTACCAGATGATTTTACAGGCTGCGTTATAGCTTGGAATTCTAACAAT
Vac S GTGATGAAGTCAGACAAATCGCTCCAGGGCAAACTGGAAAGATTGCTGATTATAATTATAAATTACCAGATGATTTTACAGGCTGCGTTATAGCTTGGAATTCTAACAAT

CTTGATTCTAAGGTTGGTGGTAATTATAATTACCTGTATAGATTGTTTAGGAAGTCTAATCTCAAACCTTTTGAGAGAGATATTTCAACTGAAATCTATCAGGCCGGTAG
1330
1340
1350
1360
1370
1380
1390
1400
1410
1420
1430
Wild S CTTGATTCTAAGGTTGGTGGTAATTATAATTACCTGTATAGATTGTTTAGGAAGTCTAATCTCAAACCTTTTGAGAGAGATATTTCAACTGAAATCTATCAGGCCGGTAG
Vac S CTTGATTCTAAGGTTGGTGGTAATTATAATTACCTGTATAGATTGTTTAGGAAGTCTAATCTCAAACCTTTTGAGAGAGATATTTCAACTGAAATCTATCAGGCCGGTAG

CACACCTTGTAATGGTGTTGAAGGTTTTAATTGTTACTTTCCTTTACAATCATATGGTTTCCAACCCACTAATGGTGTTGGTTACCAACCATACAGAGTAGTAGTACTTT
1440
1450
1460
1470
1480
1490
1500
1510
1520
1530
1540
Wild S CACACCTTGTAATGGTGTTGAAGGTTTTAATTGTTACTTTCCTTTACAATCATATGGTTTCCAACCCACTAATGGTGTTGGTTACCAACCATACAGAGTAGTAGTACTTT
Vac S CACACCTTGTAATGGTGTTGAAGGTTTTAATTGTTACTTTCCTTTACAATCATATGGTTTCCAACCCACTAATGGTGTTGGTTACCAACCATACAGAGTAGTAGTACTTT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TTGGACAGCTGGTGCTGCAGCTTATTATGTGGGTTATCTTCAACCTAGGACTTTTCTATTAAAATATAATGAAAATGGAACCATTACAGATGCTGTAGACTGTGCACTTG
780
790
800
810
820
830
840
850
860
870
880
Wild S TTGGACAGCTGGTGCTGCAGCTTATTATGTGGGTTATCTTCAACCTAGGACTTTTCTATTAAAATATAATGAAAATGGAACCATTACAGATGCTGTAGACTGTGCACTTG
Vac S TTGGACAGCTGGTGCTGCAGCTTATTATGTGGGTTATCTTCAACCTAGGACTTTTCTATTAAAATATAATGAAAATGGAACCATTACAGATGCTGTAGACTGTGCACTTG

GTTCTTACTGAGTCTAACAAAAAGTTTCTGCCTTTCCAACAATTTGGCAGAGACATTGCTGACACTACTGATGCTGTCCGTGATCCACAGACACTTGAGATTCTTGACAT
1660
1670
1680
1690
1700
1710
1720
1730
1740
1750
1760
Wild S GTTCTTACTGAGTCTAACAAAAAGTTTCTGCCTTTCCAACAATTTGGCAGAGACATTGCTGACACTACTGATGCTGTCCGTGATCCACAGACACTTGAGATTCTTGACAT
Vac S GTTCTTACTGAGTCTAACAAAAAGTTTCTGCCTTTCCAACAATTTGGCAGAGACATTGCTGACACTACTGATGCTGTCCGTGATCCACAGACACTTGAGATTCTTGACAT

TACACCATGTTCTTTTGGTGGTGTCAGTGTTATAACACCAGGAACAAATACTTCTAACCAGGTTGCTGTTCTTTATCAGGATGTTAACTGCACAGAAGTCCCTGTTGCTA
1770
1780
1790
1800
1810
1820
1830
1840
1850
1860
1870
Wild S TACACCATGTTCTTTTGGTGGTGTCAGTGTTATAACACCAGGAACAAATACTTCTAACCAGGTTGCTGTTCTTTATCAGGATGTTAACTGCACAGAAGTCCCTGTTGCTA
Vac S TACACCATGTTCTTTTGGTGGTGTCAGTGTTATAACACCAGGAACAAATACTTCTAACCAGGTTGCTGTTCTTTATCAGGATGTTAACTGCACAGAAGTCCCTGTTGCTA

TTCATGCAGATCAACTTACTCCTACTTGGCGTGTTTATTCTACAGGTTCTAATGTTTTTCAAACACGTGCAGGCTGTTTAATAGGGGCTGAACATGTCAACAACTCATAT
1880
1890
1900
1910
1920
1930
1940
1950
1960
1970
1980
Wild S TTCATGCAGATCAACTTACTCCTACTTGGCGTGTTTATTCTACAGGTTCTAATGTTTTTCAAACACGTGCAGGCTGTTTAATAGGGGCTGAACATGTCAACAACTCATAT
Vac S TTCATGCAGATCAACTTACTCCTACTTGGCGTGTTTATTCTACAGGTTCTAATGTTTTTCAAACACGTGCAGGCTGTTTAATAGGGGCTGAACATGTCAACAACTCATAT

GAGTGTGACATACCCATTGGTGCAGGTATATGCGCTAGTTATCAGACTCAGACTAATTCTCCTCGGCGGGCACGTAGTGTAGCTAGTCAATCCATCATTGCCTACACTAT
1990
2000
2010
2020
2030
2040
2050
2060
2070
2080
2090
Wild S GAGTGTGACATACCCATTGGTGCAGGTATATGCGCTAGTTATCAGACTCAGACTAATTCTCCTCGGCGGGCACGTAGTGTAGCTAGTCAATCCATCATTGCCTACACTAT
Vac S GAGTGTGACATACCCATTGGTGCAGGTATATGCGCTAGTTATCAGACTCAGACTAATTCTCCTCGGCGGGCACGTAGTGTAGCTAGTCAATCCATCATTGCCTACACTAT

GTCACTTGGTGCAGAAAATTCAGTTGCTTACTCTAATAACTCTATTGCCATACCCACAAATTTTACTATTAGTGTTACCACAGAAATTCTACCAGTGTCTATGACCAAGA
2100
2110
2120
2130
2140
2150
2160
2170
2180
2190
2200
Wild S GTCACTTGGTGCAGAAAATTCAGTTGCTTACTCTAATAACTCTATTGCCATACCCACAAATTTTACTATTAGTGTTACCACAGAAATTCTACCAGTGTCTATGACCAAGA
Vac S GTCACTTGGTGCAGAAAATTCAGTTGCTTACTCTAATAACTCTATTGCCATACCCACAAATTTTACTATTAGTGTTACCACAGAAATTCTACCAGTGTCTATGACCAAGA

CATCAGTAGATTGTACAATGTACATTTGTGGTGATTCAACTGAATGCAGCAATCTTTTGTTGCAATATGGCAGTTTTTGTACACAATTAAACCGTGCTTTAACTGGAATA
2210
2220
2230
2240
2250
2260
2270
2280
2290
2300
2310
Wild S CATCAGTAGATTGTACAATGTACATTTGTGGTGATTCAACTGAATGCAGCAATCTTTTGTTGCAATATGGCAGTTTTTGTACACAATTAAACCGTGCTTTAACTGGAATA
Vac S CATCAGTAGATTGTACAATGTACATTTGTGGTGATTCAACTGAATGCAGCAATCTTTTGTTGCAATATGGCAGTTTTTGTACACAATTAAACCGTGCTTTAACTGGAATA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

CTTTTGAACTTCTACATGCACCAGCAACTGTTTGTGGACCTAAAAAGTCTACTAATTTGGTTAAAAACAAATGTGTCAATTTCAACTTCAATGGTTTAACAGGCACAGGT
1550
1560
1570
1580
1590
1600
1610
1620
1630
1640
1650
Wild S CTTTTGAACTTCTACATGCACCAGCAACTGTTTGTGGACCTAAAAAGTCTACTAATTTGGTTAAAAACAAATGTGTCAATTTCAACTTCAATGGTTTAACAGGCACAGGT
Vac S CTTTTGAACTTCTACATGCACCAGCAACTGTTTGTGGACCTAAAAAGTCTACTAATTTGGTTAAAAACAAATGTGTCAATTTCAACTTCAATGGTTTAACAGGCACAGGT

AGATCCATCAAAACCAAGCAAGAGGTCATTTATTGAAGATCTACTTTTCAACAAAGTGACACTTGCAGATGCTGGCTTCATCAAACAATATGGTGATTGCCTTGGTGATA
2430
2440
2450
2460
2470
2480
2490
2500
2510
2520
2530
Wild S AGATCCATCAAAACCAAGCAAGAGGTCATTTATTGAAGATCTACTTTTCAACAAAGTGACACTTGCAGATGCTGGCTTCATCAAACAATACGGTGATTGCCTTGGTGATA
Vac S AGATCCATCAAAACCAAGCAAGAGGTCATTTATTGAAGATCTACTTTTCAACAAAGTGACACTTGCAGATGCTGGCTTCATCAAACAATATGGTGATTGCCTTGGTGATA

TTGCTGCTAGAGACCTCATTTGTGCACAAAAGTTTAACGGCCTTACTGTTTTGCCACCTTTGCTCACAGATGAAATGATTGCTCAATACACTTCTGCACTGTTAGCGGGT
2540
2550
2560
2570
2580
2590
2600
2610
2620
2630
2640
Wild S TTGCTGCTAGAGACCTCATTTGTGCACAAAAGTTTAACGGCCTTACTGTTTTGCCACCTTTGCTCACAGATGAAATGATTGCTCAATACACTTCTGCACTGTTAGCGGGT
Vac S TTGCTGCTAGAGACCTCATTTGTGCACAAAAGTTTAACGGCCTTACTGTTTTGCCACCTTTGCTCACAGATGAAATGATTGCTCAATACACTTCTGCACTGTTAGCGGGT

ACAATCACTTCTGGTTGGACCTTTGGTGCAGGTGCTGCATTACAAATACCATTTGCTATGCAAATGGCTTATAGGTTTAATGGTATTGGAGTTACACAGAATGTTCTCTA
2650
2660
2670
2680
2690
2700
2710
2720
2730
2740
2750
Wild S ACAATCACTTCTGGTTGGACCTTTGGTGCAGGTGCTGCATTACAAATACCATTTGCTATGCAAATGGCTTATAGGTTTAATGGTATTGGAGTTACACAGAATGTTCTCTA
Vac S ACAATCACTTCTGGTTGGACCTTTGGTGCAGGTGCTGCATTACAAATACCATTTGCTATGCAAATGGCTTATAGGTTTAATGGTATTGGAGTTACACAGAATGTTCTCTA

TGAGAACCAAAAATTGATTGCCAACCAATTTAATAGTGCTATTGGCAAAATTCAAGACTCACTTTCTTCCACAGCAAGTGCACTTGGAAAACTTCAAGATGTGGTCAACC
2760
2770
2780
2790
2800
2810
2820
2830
2840
2850
2860
Wild S TGAGAACCAAAAATTGATTGCCAACCAATTTAATAGTGCTATTGGCAAAATTCAAGACTCACTTTCTTCCACAGCAAGTGCACTTGGAAAACTTCAAGATGTGGTCAACC
Vac S TGAGAACCAAAAATTGATTGCCAACCAATTTAATAGTGCTATTGGCAAAATTCAAGACTCACTTTCTTCCACAGCAAGTGCACTTGGAAAACTTCAAGATGTGGTCAACC

AAAATGCACAAGCTTTAAACACGCTTGTTAAACAACTTAGCTCCAATTTTGGTGCAATTTCAAGTGTTTTAAATGATATCCTTTCACGTCTTGACAAAGTTGAGGCTGAA
2870
2880
2890
2900
2910
2920
2930
2940
2950
2960
2970
Wild S AAAATGCACAAGCTTTAAACACGCTTGTTAAACAACTTAGCTCCAATTTTGGTGCAATTTCAAGTGTTTTAAATGATATCCTTTCACGTCTTGACAAAGTTGAGGCTGAA
Vac S AAAATGCACAAGCTTTAAACACGCTTGTTAAACAACTTAGCGCCAATTTTGGTGCAATTTCAAGTGTTTTAAATGATATCCTTTCACGTCTTGACAAAGTTGAGGCTGAA

GTGCAAATTGATAGGTTGATCACAGGCAGACTTCAAAGTTTGCAGACATATGTGACTCAACAATTAATTAGAGCTGCAGAAATCAGAGCTTCTGCTAATCTTGCTGCTAC
2980
2990
3000
3010
3020
3030
3040
3050
3060
3070
3080
Wild S GTGCAAATTGATAGGTTGATCACAGGCAGACTCCAAAGTTTGCAGACATATGTGACTCAACAATTAATTAGAGCTGCAGAAATCAGAGCTTCTGCTAATCTTGCTGCTAC
Vac S GTGCAAATTGATAGGTTGATCACAGGCAGACTTCAAAGTTTGCAGACATATGTGACTCAACAATTAATTAGAGCTGCAGAAATCAGAGCTTCTGCTAATCTTGCTGCTAC

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

GCTGTTGAACAAGACAAAAACACCCAAGAAGTTTTTGCACAAGTCAAACAAATTTACAAAACACCACCAATTAAAGATTTTGGTGGTTTTAATTTTTCACAAATATTACC
2320
2330
2340
2350
2360
2370
2380
2390
2400
2410
2420
Wild S GCTGTTGAACAAGACAAAAACACCCAAGAAGTTTTTGCACAAGTCAAACAAATTTACAAAACACCACCAATTAAAGATTTTGGTGGTTTTAATTTTTCACAAATATTACC
Vac S GCTGTTGAACAAGACAAAAACACCCAAGAAGTTTTTGCACAAGTCAAACAAATTTACAAAACACCACCAATTAAAGATTTTGGTGGTTTTAATTTTTCACAAATATTACC

ATGTGACTTATGTCCCTGCACAAGAAAAGAACTTCACAACTGCTCCTGCCATTTGTCATGATGGAAAAGCACACTTTCCTCGTGAAGGTGTCTTTGTTTCAAATGGCACA
3200
3210
3220
3230
3240
3250
3260
3270
3280
3290
3300
Wild S ATGTGACTTATGTCCCTGCACAAGAAAAGAACTTCACAACTGCTCCTGCCATTTGTCATGATGGAAAAGCACACTTTCCTCGTGAAGGTGTCTTTGTTTCAAATGGCACA
Vac S ATGTGACTTATGTCCCTGCACAAGAAAAGAACTTCACAACTGCTCCTGCCATTTGTCATGATGGAAAAGCACACTTTCCTCGTGAAGGTGTCTTTGTTTCAAATGGCACA

CACTGGTTTGTAACACAAAGGAATTTTTATGAACCACAAATCATTACTACAGACAACACATTTGTGTCTGGTAACTGTGATGTTGTAATAGGAATTGTCAACAACACAGT
3310
3320
3330
3340
3350
3360
3370
3380
3390
3400
3410
Wild S CACTGGTTTGTAACACAAAGGAATTTTTATGAACCACAAATCATTACTACAGACAACACATTTGTGTCTGGTAACTGTGATGTTGTAATAGGAATTGTCAACAACACAGT
Vac S CACTGGTTTGTAACACAAAGGAATTTTTATGAACCACAAATCATTACTACAGACAACACATTTGTGTCTGGTAACTGTGATGTTGTAATAGGAATTGTCAACAACACAGT

TTATGATCCTTTGCAACCTGAATTAGACTCATTCAAGGAGGAGTTAGATAAATATTTTAAGAATCATACATCACCAGATGTTGATTTAGGTGACATCTCTGGCATTAATG
3420
3430
3440
3450
3460
3470
3480
3490
3500
3510
3520
Wild S TTATGATCCTTTGCAACCTGAATTAGACTCATTCAAGGAGGAGTTAGATAAATATTTTAAGAATCATACATCACCAGATGTTGATTTAGGTGACATCTCTGGCATTAATG
Vac S TTATGATCCTTTGCAACCTGAATTAGACTCATTCAAGGAGGAGTTAGATAAATATTTTAAGAATCATACATCACCAGATGTTGATTTAGGTGACATCTCTGGCATTAATG

CTTCAGTTGTAAACATTCAAAAAGAAATTGACCGCCTCAATGAGGTTGCCAAGAATTTAAATGAATCTCTCATCGATCTCCAAGAACTTGGAAAGTATGAGCAGTATATA
3530
3540
3550
3560
3570
3580
3590
3600
3610
3620
3630
Wild S CTTCAGTTGTAAACATTCAAAAAGAAATTGACCGCCTCAATGAGGTTGCCAAGAATTTAAATGAATCTCTCATCGATCTCCAAGAACTTGGAAAGTATGAGCAGTATATA
Vac S CTTCAGTTGTAAACATTCAAAAAGAAATTGACCGCCTCAATGAGGTTGCCAAGAATTTAAATGAATCTCTCATCGATCTCCAAGAACTTGGAAAGTATGAGCAGTATATA

AAATGGCCATGGTACATTTGGCTAGGTTTTATAGCTGGCTTGATTGCCATAGTAATGGTGACAATTATGCTTTGCTGTATGACCAGTTGCTGTAGTTGTCTCAAGGGCTG
3640
3650
3660
3670
3680
3690
3700
3710
3720
3730
3740
Wild S AAATGGCCATGGTACATTTGGCTAGGTTTTATAGCTGGCTTGATTGCCATAGTAATGGTGACAATTATGCTTTGCTGTATGACCAGTTGCTGTAGTTGTCTCAAGGGCTG
Vac S AAATGGCCATGGTACATTTGGCTAGGTTTTATAGCTGGCTTGATTGCCATAGTAATGGTGACAATTATGCTTTGCTGTATGACCAGTTGCTGTAGTTGTCTCAAGGGCTG

TTGTTCTTGTGGATCCTGCTGCAAATTTGATGAAGACGACTCTGAGCCAGTGCTCAAAGGAGTCAAATTACATTACACATAA
3750
3760
3770
3780
3790
3800
3810
3820
Wild S TTGTTCTTGTGGATCCTGCTGCAAATTTGATGAAGACGACTCTGAGCCAGTGCTCAAAGGAGTCAAATTACATTACACATAA
Vac S TTGTTCTTGTGGATCCTGCTGCAAATTTGATGAAGACGACTCTGAGCCAGTGCTCAAAGGAGTCAAATTACATTACACATAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TAAAATGTCAGAGTGTGTACTTGGACAATCAAAAAGAGTTGATTTTTGTGGAAAGGGCTATCATCTTATGTCCTTCCCTCAGTCAGCACCTCATGGTGTAGTCTTCTTGC
3090
3100
3110
3120
3130
3140
3150
3160
3170
3180
3190
Wild S TAAAATGTCAGAGTGTGTACTTGGACAATCAAAAAGAGTTGATTTTTGTGGAAAGGGCTATCATCTTATGTCCTTCCCTCAGTCAGCACCTCATGGTGTAGTCTTCTTGC
Vac S TAAAATGTCAGAGTGTGTACTTGGACAATCAAAAAGAGTTGATTTTTGTGGAAAGGGCTATCATCTTATGTCCTTCCCTCAGTCAGCACCTCATGGTGTAGTCTTCTTGC

ACAAGCCTCACTCCCTTTCGGATGGCTTATTGTTGGCGTTGCACTTCTTGCTGTTTTTCAGAGCGCTTCCAAAATCATAACCCTCAAAAAGAGATGGCAACTAGCACTCT
120
130
140
150
160
170
180
190
200
210
220
Wild ORF3a ACAAGCCTCACTCCCTTTCGGATGGCTTATTGTTGGCGTTGCACTTCTTGCTGTTTTTCAGAGCGCTTCCAAAATCATAACCCTCAAAAAGAGATGGCAACTAGCACTCT
Vac ORF3a ACAAGCCTCACTCCCTTTCGGATGGCTTATTGTTGGCGTTGCACTTCTTGCTGTTTTTCAGAGCGCTTCCAAAATCATAACCCTCAAAAAGAGATGGCAACTAGCACTCT

CCAAGGGTGTTCACTTTGTTTGCAACTTGCTGTTGTTGTTTGTAACAGTTTACTCACACCTTTTGCTCGTTGCTGCTGGCCTTGAAGCCCCTTTTCTCTATCTTTATGCT
230
240
250
260
270
280
290
300
310
320
330
Wild ORF3a CCAAGGGTGTTCACTTTGTTTGCAACTTGCTGTTGTTGTTTGTAACAGTTTACTCACACCTTTTGCTCGTTGCTGCTGGCCTTGAAGCCCCTTTTCTCTATCTTTATGCT
Vac ORF3a CCAAGGGTGTTCACTTTGTTTGCAACTTGCTGTTGTTGTTTGTAACAGTTTACTCACACCTTTTGCTCGTTGCTGCTGGCCTTGAAGCCCCTTTTCTCTATCTTTATGCT

TTAGTCTACTTCTTGCAGAGTATAAACTTTGTAAGAATAATAATGAGGCTTTGGCTTTGCTGGAAATGCCGTTCCAAAAACCCATTACTTTATGATGCCAACTATTTTCT
340
350
360
370
380
390
400
410
420
430
440
Wild ORF3a TTAGTCTACTTCTTGCAGAGTATAAACTTTGTAAGAATAATAATGAGGCTTTGGCTTTGCTGGAAATGCCGTTCCAAAAACCCATTACTTTATGATGCCAACTATTTTCT
Vac ORF3a TTAGTCTACTTCTTGCAGAGTATAAACTTTGTAAGAATAATAATGAGGCTTTGGCTTTGCTGGAAATGCCGTTCCAAAAACCCATTACTTTATGATGCCAACTATTTTCT

TTGCTGGCATACTAATTGTTACGACTATTGTATACCTTACAATAGTGTAACTTCTTCAATTGTCATTACTTCAGGTGATGGCACAACAAGTCCTATTTCTGAACATGACT
450
460
470
480
490
500
510
520
530
540
550
Wild ORF3a TTGCTGGCATACTAATTGTTACGACTATTGTATACCTTACAATAGTGTAACTTCTTCAATTGTCATTACTTCAGGTGATGGCACAACAAGTCCTATTTCTGAACATGACT
Vac ORF3a TTGCTGGCATACTAATTGTTACGACTATTGTATACCTTACAATAGTGTAACTTCTTCAATTGTCATTACTTCAGGTGATGGCACAACAAGTCCTATTTCTGAACATGACT

ACCAGATTGGTGGTTATACTGAAAAATGGGAATCTGGAGTAAAAGACTGTGTTGTATTACACAGTTACTTCACTTCAGACTATTACCAGCTGTACTCAACTCAATTGAGT
560
570
580
590
600
610
620
630
640
650
660
Wild ORF3a ACCAGATTGGTGGTTATACTGAAAAATGGGAATCTGGAGTAAAAGACTGTGTTGTATTACACAGTTACTTCACTTCAGACTATTACCAGCTGTACTCAACTCAATTGAGT
Vac ORF3a ACCAGATTGGTGGTTATACTGAAAAATGGGAATCTGGAGTAAAAGACTGTGTTGTATTACACAGTTACTTCACTTCAGACTATTACCAGCTGTACTCAACTCAATTGAGT

ACAGACACTGGTGTTGAACATGTTACCTTCTTCATCTACAATAAAATTGTTGATGAGCCTGAAGAACATGTCCAAATTCACACAATCGACGGTTCATCCGGAGTTGTTAA
670
680
690
700
710
720
730
740
750
760
770
Wild ORF3a ACAGACACTGGTGTTGAACATGTTACCTTCTTCATCTACAATAAAATTGTTGATGAGCCTGAAGAACATGTCCAAATTCACACAATCGACGGTTCATCCGGAGTTGTTAA
Vac ORF3a ACAGACACTGGTGTTGAACATGTTACCTTCTTCATCTACAATAAAATTGTTGATGAGCCTGAAGAACATGTCCAAATTCACACAATCGACGGTTCATCCGGAGTTGTTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGGATTTGTTTATGAGAATCTTCACAATTGGAACTGTAACTTTGAAGCAAGGTGAAATCAAGGATGCTACTCCTTCAGATTTTGTTCGCGCTACTGCAACGATACCGAT
10
20
30
40
50
60
70
80
90
100
110
Wild ORF3a ATGGATTTGTTTATGAGAATCTTCACAATTGGAACTGTAACTTTGAAGCAAGGTGAAATCAAGGATGCTACTCCTTCAGATTTTGTTCGCGCTACTGCAACGATACCGAT
Vac ORF3a ATGGATTTGTTTATGAGAATCTTCACAATTGGAACTGTAACTTTGAAGCAAGGTGAAATCAAGGATGCTACTCCTTCAGATTTTGTTCGCGCTACTGCAACGATACCGAT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

TCCAGTAATGGAACCAATTTATGATGAACCGACGACGACTACTAGCGTGCCTTTGTAA
780
790
800
810
820
Wild ORF3a TCCAGTAATGGAACCAATTTATGATGAACCGACGACGACTACTAGCGTGCCTTTGTAA
Vac ORF3a TCCAGTAATGGAACCAATTTATGATGAACCGACGACGACTACTAGCGTGCCTTTGTAA

TCGATTGTGTGCGTACTGCTGCAATATTGTTAACGTGAGTCTTGTAAAACCTTCTTTTTACGTTTACTCTCGTGTTAAAAATCTGAATTCTTCTAGAGTTCCTGATCTTC
120
130
140
150
160
170
180
190
200
210
220
Wild E TCGATTGTGTGCGTACTGCTGCAATATTGTTAACGTGAGTCTTGTAAAACCTTCTTTTTACGTTTACTCTCGTGTTAAAAATCTGAATTCTTCTAGAGTTCCTGATCTTC
Vac E TCGATTGTGTGCGTACTGCTGCAATATTGTTAACGTGAGTCTTGTAAAACCTTCTTTTTACGTTTACTCTCGTGTTAAAAATCTGAATTCTTCTAGAGTTCCTGATCTTC

TGGTCTAA
Wild E TGGTCTAA
Vac E TGGTCTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGTACTCATTCGTTTCGGAAGAGACAGGTACGTTAATAGTTAATAGCGTACTTCTTTTTCTTGCTTTCGTGGTATTCTTGCTAGTTACACTAGCCATCCTTACTGCGCT
10
20
30
40
50
60
70
80
90
100
110
Wild E ATGTACTCATTCGTTTCGGAAGAGACAGGTACGTTAATAGTTAATAGCGTACTTCTTTTTCTTGCTTTCGTGGTATTCTTGCTAGTTACACTAGCCATCCTTACTGCGCT
Vac E ATGTACTCATTCGTTTCGGAAGAGACAGGTACGTTAATAGTTAATAGCGTACTTCTTTTTCTTGCTTTCGTGGTATTCTTGCTAGTTACACTAGCCATCCTTACTGCGCT

TGCCTATGCCAACAGGAATAGGTTTTTGTATATAATTAAGTTAATTTTCCTCTGGCTGTTATGGCCAGTAACTTTAGCTTGTTTTGTGCTTGCTGCTGTTTACAGAATAA
120
130
140
150
160
170
180
190
200
210
220
Wild M TGCCTATGCCAACAGGAATAGGTTTTTGTATATAATTAAGTTAATTTTCCTCTGGCTGTTATGGCCAGTAACTTTAGCTTGTTTTGTGCTTGCTGCTGTTTACAGAATAA
Vac M TGCCTATGCCAACAGGAATAGGTTTTTGTATATAATTAAGTTAATTTTCCTCTGGCTGTTATGGCCAGTAACTTTAGCTTGTTTTGTGCTTGCTGCTGTTTACAGAATAA

ATTGGATCACCGGTGGAATTGCTATCGCAATGGCTTGTCTTGTAGGCTTGATGTGGCTCAGCTACTTCATTGCTTCTTTCAGACTGTTTGCGCGTACGCGTTCCATGTGG
230
240
250
260
270
280
290
300
310
320
330
Wild M ATTGGATCACCGGTGGAATTGCTATCGCAATGGCTTGTCTTGTAGGCTTGATGTGGCTCAGCTACTTCATTGCTTCTTTCAGACTGTTTGCGCGTACGCGTTCCATGTGG
Vac M ATTGGATCACCGGTGGAATTGCTATCGCAATGGCTTGTCTTGTAGGCTTGATGTGGCTCAGCTACTTCATTGCTTCTTTCAGACTGTTTGCGCGTACGCGTTCCATGTGG

TCATTCAATCCAGAAACTAACATTCTTCTCAACGTGCCACTCCATGGCACTATTCTGACCAGACCGCTTCTAGAAAGTGAACTCGTAATCGGAGCTGTGATCCTTCGTGG
340
350
360
370
380
390
400
410
420
430
440
Wild M TCATTCAATCCAGAAACTAACATTCTTCTCAACGTGCCACTCCATGGCACTATTCTGACCAGACCGCTTCTAGAAAGTGAACTCGTAATCGGAGCTGTGATCCTTCGTGG
Vac M TCATTCAATCCAGAAACTAACATTCTTCTCAACGTGCCACTCCATGGCACTATTCTGACCAGACCGCTTCTAGAAAGTGAACTCGTAATCGGAGCTGTGATCCTTCGTGG

ACATCTTCGTATTGCTGGACACCATCTAGGACGCTGTGACATCAAGGACCTGCCTAAAGAAATCACTGTTGCTACATCACGAACGCTTTCTTATTATAAATTGGGAGCTT
450
460
470
480
490
500
510
520
530
540
550
Wild M ACATCTTCGTATTGCTGGACACCATCTAGGACGCTGTGACATCAAGGACCTGCCTAAAGAAATCACTGTTGCTACATCACGAACGCTTTCTTATTACAAATTGGGAGCTT
Vac M ACATCTTCGTATTGCTGGACACCATCTAGGACGCTGTGACATCAAGGACCTGCCTAAAGAAATCACTGTTGCTACATCACGAACGCTTTCTTATTATAAATTGGGAGCTT

CGCAGCGTGTAGCAGGTGACTCAGGTTTTGCTGCATACAGTCGCTACAGGATTGGCAACTATAAATTAAACACAGACCATTCCAGTAGCAGTGACAATATTGCTTTGCTT
560
570
580
590
600
610
620
630
640
650
660
Wild M CGCAGCGTGTAGCAGGTGACTCAGGTTTTGCTGCATACAGTCGCTACAGGATTGGCAACTATAAATTAAACACAGACCATTCCAGTAGCAGTGACAATATTGCTTTGCTT
Vac M CGCAGCGTGTAGCAGGTGACTCAGGTTTTGCTGCATACAGTCGCTACAGGATTGGCAACTATAAATTAAACACAGACCATTCCAGTAGCAGTGACAATATTGCTTTGCTT

GTACAGTAA
Wild M GTACAGTAA
Vac M GTACAGTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGGCAGATTCCAACGGTACTATTACCGTTGAAGAGCTTAAAAAGCTCCTTGAACAATGGAACCTAGTAATAGGTTTCCTATTCCTTACATGGATTTGTCTTCTACAATT
10
20
30
40
50
60
70
80
90
100
110
Wild M ATGGCAGATTCCAACGGTACTATTACCGTTGAAGAGCTTAAAAAGCTCCTTGAACAATGGAACCTAGTAATAGGTTTCCTATTCCTTACATGGATTTGTCTTCTACAATT
Vac M ATGGCAGATTCCAACGGTACTATTACCGTTGAAGAGCTTAAAAAGCTCCTTGAACAATGGAACCTAGTAATAGGTTTCCTATTCCTTACATGGATTTGTCTTCTACAATT

TAAAAATTTATCTAAGTCACTAACTGAGAATAAATATTCTCAATTAGATGAAGAGCAACCAATGGAGATTGATTAA
120
130
140
150
160
170
180
Wild ORF6 TAAAAATTTATCTAAGTCACTAACTGAGAATAAATATTCTCAATTAGATGAAGAGCAACCAATGGAGATTGATTAA
Vac ORF6 TAAAAATTTATCTAAGTCACTAACTGAGAATAAATATTCTCAATTAGATGAAGAGCAACCAATGGAGATTGATTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGTTTCATCTCGTTGACTTTCAGGTTACTATAGCAGAGATATTACTAATTATTATGAGGACTTTTAAAGTTTCCATTTGGAATCTTGATTACATCATAAACCTCATAAT
10
20
30
40
50
60
70
80
90
100
110
Wild ORF6 ATGTTTCATCTCGTTGACTTTCAGGTTACTATAGCAGAGATATTACTAATTATTATGAGGACTTTTAAAGTTTCCATTTGGAATCTTGATTACATCATAAACCTCATAAT
Vac ORF6 ATGTTTCATCTCGTTGACTTTCAGGTTACTATAGCAGAGATATTACTAATTATTATGAGGACTTTTAAAGTTTCCATTTGGAATCTTGATTACATCATAAACCTCATAAT

TGGAACATACGAGGGCAATTCACCATTTCATCCTCTAGCTGATAACAAATTTGCACTGACTTGCTTTAGCACTCAATTTGCTTTTGCTTGTCCTGACGGCGTAAAACACG
120
130
140
150
160
170
180
190
200
210
220
Wild ORF7a TGGAACATACGAGGGCAATTCACCATTTCACCCTCTAGCTGATAACAAATTTGCACTGACTTGCTTTAGCACTCAATTTGCTTTTGCTTATCCTGACGGCGTAAAACACG
Vac ORF7a TGGAACATACGAGGGCAATTCACCATTTCATCCTCTAGCTGATAACAAATTTGCACTGACTTGCTTTAGCACTCAATTTGCTTTTGCTTGTCCTGACGGCGTAAAACACG

TCTATCAGTTACGTGCCAGATCAGTTTCACCTAAACTGTTCATCAGACAAGAGGAAGTTCAAGAACTTTACTCTCCAATTTTTCTTATTGTTGCGGCAATAGTGTTTATA
230
240
250
260
270
280
290
300
310
320
330
Wild ORF7a TCTATCAGTTACGTGCCAGATCAGTTTCACCTAAACTGTTCATCAGACAAGAGGAAGTTCAAGAACTTTACTCTCCAATTTTTCTTATTGTTGCGGCAATAGTGTTTATA
Vac ORF7a TCTATCAGTTACGTGCCAGATCAGTTTCACCTAAACTGTTCATCAGACAAGAGGAAGTTCAAGAACTTTACTCTCCAATTTTTCTTATTGTTGCGGCAATAGTGTTTATA

ACACTTTGCTTCACACTCAAAAGAAAGACAGAATGA
340
350
360
Wild ORF7a ACACTTTGCTTCACACTCAAAAGAAAGACAGAATGA
Vac ORF7a ACACTTTGCTTCACACTCAAAAGAAAGACAGAATGA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGAAAATTATTCTTTTCTTGGCACTGATAACACTCGCTACTTGTGAGCTTTATCACTACCAAGAGTGTGTTAGAGGTACAACAGTACTTTTAAAAGAACCTTGCTCTTC
10
20
30
40
50
60
70
80
90
100
110
Wild ORF7a ATGAAAATTATTCTTTTCTTGGCACTGATAACACTCGCTACTTGTGAGCTTTATCACTACCAAGAGTGTGTTAGAGGTACAACAGTACTTTTAAAAGAACCTTGCTCTTC
Vac ORF7a ATGAAAATTATTCTTTTCTTGGCACTGATAACACTCGCTACTTGTGAGCTTTATCACTACCAAGAGTGTGTTAGAGGTACAACAGTACTTTTAAAAGAACCTTGCTCTTC

TAATGAAACTTGTCACGCCTAA
120
130
Wild ORF7b TAATGAAACTTGTCACGCCTAA
Vac ORF7b TAATGAAACTTGTCACGCCTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGATTGAACTTTCATTAATTGACTTCTATTTGTGCTTTTTAGCCTTTCTGCTATTCCTTGTTTTAATTATGCTTATTATCTTTTGGTTCTCACTTGAACTGCAAGATCA
10
20
30
40
50
60
70
80
90
100
110
Wild ORF7b ATGATTGAACTTTCATTAATTGACTTCTATTTGTGCTTTTTAGCCTTTCTGCTATTCCTTGTTTTAATTATGCTTATTATCTTTTGGTTCTCACTTGAACTGCAAGATCA
Vac ORF7b ATGATTGAACTTTCATTAATTGACTTCTATTTGTGCTTTTTAGCCTTTCTGCTATTCCTTGTTTTAATTATGCTTATTATCTTTTGGTTCTCACTTGAACTGCAAGATCA

TCCTATTCACTTCTATTCTAAATGGTATATTAGAGTAGGAGCTAGAAAATCAGCACCTTTAATTGAATTGTGCGTGGATGAGGCTGGTTCTAAATCACCCATTCAGTACA
120
130
140
150
160
170
180
190
200
210
220
wild ORF8 TCCTATTCACTTCTATTCTAAATGGTATATTAGAGTAGGAGCTAGAAAATCAGCACCTTTAATTGAATTGTGCGTGGATGAGGCTGGTTCTAAATCACCCATTCAGTACA
Vac ORF8 TCCTATTCACTTCTATTCTAAATGGTATATTAGAGTAGGAGCTAGAAAATCAGCACCTTTAATTGAATTGTGCGTGGATGAGGCTGGTTCTAAATCACCCATTCAGTACA

TCGATATCGGTAATTATACAGTTTCCTGTTCACCTTTTACAATTAATTGCCAGGAACCTAAATTGGGTAGTCTTGTAGTGCGTTGTTCGTTCTATGAAGACTTTTTAGAG
230
240
250
260
270
280
290
300
310
320
330
wild ORF8 TCGATATCGGTAATTATACAGTTTCCTGTTCACCTTTTACAATTAATTGCCAGGAACCTAAATTGGGTAGTCTTGTAGTGCGTTGTTCGTTCTATGAAGACTTTTTAGAG
Vac ORF8 TCGATATCGGTAATTATACAGTTTCCTGTTCACCTTTTACAATTAATTGCCAGGAACCTAAATTGGGTAGTCTTGTAGTGCGTTGTTCGTTCTATGAAGACTTTTTAGAG

TATCATGACGTTCGTGTTGTTTTAGATTTCATCTAA
340
350
360
wild ORF8 TATCATGACGTTCGTGTTGTTTTAGATTTCATCTAA
Vac ORF8 TATCATGACGTTCGTGTTGTTTTAGATTTCATCTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGAAATTTCTTGTTTTCTTAGGAATCATCACAACTGTAGCTGCATTTCACCAAGAATGTAGTTTACAGTCATGTACTCAACATCAACCATATGTAGTTGATGACCCGTG
10
20
30
40
50
60
70
80
90
100
110
wild ORF8 ATGAAATTTCTTGTTTTCTTAGGAATCATCACAACTGTAGCTGCATTTCACCAAGAATGTAGCTTACAGTCATGTACTCAACATCAACCATATGTAGTTGATGACCCGTG
Vac ORF8 ATGAAATTTCTTGTTTTCTTAGGAATCATCACAACTGTAGCTGCATTTCACCAAGAATGTAGTTTACAGTCATGTACTCAACATCAACCATATGTAGTTGATGACCCGTG

AAAACAACGTCGGCCCCAAGGTTTACCCAATAATACTGCGTCTTGGTTCACCGCTCTCACTCAACATGGCAAGGAAGACCTTAAATTCCCTCGAGGACAAGGCGTTCCAA
120
130
140
150
160
170
180
190
200
210
220
Wild N AAAACAACGTCGGCCCCAAGGTTTACCCAATAATACTGCGTCTTGGTTCACCGCTCTCACTCAACATGGCAAGGAAGACCTTAAATTCCCTCGAGGACAAGGCGTTCCAA
Vac N AAAACAACGTCGGCCCCAAGGTTTACCCAATAATACTGCGTCTTGGTTCACCGCTCTCACTCAACATGGCAAGGAAGACCTTAAATTCCCTCGAGGACAAGGCGTTCCAA

TTAACACCAATAGCAGTCCAGATGACCAAATTGGCTACTACCGAAGAGCTACCAGACGAATTCGTGGTGGTGACGGTAAAATGAAAGATCTCAGTCCAAGATGGTATTTC
230
240
250
260
270
280
290
300
310
320
330
Wild N TTAACACCAATAGCAGTCCAGACGACCAAATTGGCTACTACCGAAGAGCTACCAGACGAATTCGTGGTGGTGACGGTAAAATGAAAGATCTCAGTCCAAGATGGTATTTC
Vac N TTAACACCAATAGCAGTCCAGATGACCAAATTGGCTACTACCGAAGAGCTACCAGACGAATTCGTGGTGGTGACGGTAAAATGAAAGATCTCAGTCCAAGATGGTATTTC

TACTACCTAGGAACTGGGCCAGAAGCTGGACTTCCCTATGGTGCTAACAAAGACGGCATCATATGGGTTGCAACTGAGGGAGCCTTGAATACACCAAAAGATCACATTGG
340
350
360
370
380
390
400
410
420
430
440
Wild N TACTACCTAGGAACTGGGCCAGAAGCTGGACTTCCCTATGGTGCTAACAAAGACGGCATCATATGGGTTGCAACTGAGGGAGCCTTGAATACACCAAAAGATCACATTGG
Vac N TACTACCTAGGAACTGGGCCAGAAGCTGGACTTCCCTATGGTGCTAACAAAGACGGCATCATATGGGTTGCAACTGAGGGAGCCTTGAATACACCAAAAGATCACATTGG

CACCCGCAATCCTGCTAACAATGCTGCAATCGTGCTACAACTTCCTCAAGGAACAACATTGCCAAAAGGCTTCTACGCAGAAGGGAGCAGAGGCGGCAGTCAAGCCTCTT
450
460
470
480
490
500
510
520
530
540
550
Wild N CACCCGCAATCCTGCTAACAATGCTGCAATCGTGCTACAACTTCCTCAAGGAACAACATTGCCAAAAGGCTTCTACGCAGAAGGGAGCAGAGGCGGCAGTCAAGCCTCTT
Vac N CACCCGCAATCCTGCTAACAATGCTGCAATCGTGCTACAACTTCCTCAAGGAACAACATTGCCAAAAGGCTTCTACGCAGAAGGGAGCAGAGGCGGCAGTCAAGCCTCTT

CTCGTTCCTCATCACGTAGTCGCAACAGTTCAAGAAATTCAACTCCAGGCAGCAGTAGGGGAACTTCTCCTGCTAGAATGGCTGGCAATGGCGGTGATGCTGCTCTTGCT
560
570
580
590
600
610
620
630
640
650
660
Wild N CTCGTTCCTCATCACGTAGTCGCAACAGTTCAAGAAATTCAACTCCAGGCAGCAGTAGGGGAACTTCTCCTGCTAGAATGGCTGGCAATGGCGGTGATGCTGCTCTTGCT
Vac N CTCGTTCCTCATCACGTAGTCGCAACAGTTCAAGAAATTCAACTCCAGGCAGCAGTAGGGGAACTTCTCCTGCTAGAATGGCTGGCAATGGCGGTGATGCTGCTCTTGCT

TTGCTGCTGCTTGACAGATTGAACCAGCTTGAGAGCAAAATGTCTGGTAAAGGCCAACAACAACAAGGCCAAACTGTCACTAAGAAATCTGCTGCTGAGGCTTCTAAGAA
670
680
690
700
710
720
730
740
750
760
770
Wild N TTGCTGCTGCTTGACAGATTGAACCAGCTTGAGAGCAAAATGTCTGGTAAAGGCCAACAACAACAAGGCCAAACTGTCACTAAGAAATCTGCTGCTGAGGCTTCTAAGAA
Vac N TTGCTGCTGCTTGACAGATTGAACCAGCTTGAGAGCAAAATGTCTGGTAAAGGCCAACAACAACAAGGCCAAACTGTCACTAAGAAATCTGCTGCTGAGGCTTCTAAGAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGTCTGATAATGGACCCCAAAATCAGCGAAATGCACCCCGCATTACGTTTGGTGGACCCTCAGATTCAACTGGCAGTAACCAGAATGGAGAACGCAGTGGGGCGCGATC
10
20
30
40
50
60
70
80
90
100
110
Wild N ATGTCTGATAATGGACCCCAAAATCAGCGAAATGCACCCCGCATTACGTTTGGTGGACCCTCAGATTCAACTGGCAGTAACCAGAATGGAGAACGCAGTGGGGCGCGATC
Vac N ATGTCTGATAATGGACCCCAAAATCAGCGAAATGCACCCCGCATTACGTTTGGTGGACCCTCAGATTCAACTGGCAGTAACCAGAATGGAGAACGCAGTGGGGCGCGATC

AAGGAACTGATTACAAACATTGGCCGCAAATTGCACAATTTGCCCCCAGCGCTTCAGCGTTCTTCGGAATGTCGCGCATTGGCATGGAAGTCACACCTTCGGGAACGTGG
890
900
910
920
930
940
950
960
970
980
990
Wild N AAGGAACTGATTACAAACATTGGCCGCAAATTGCACAATTTGCCCCCAGCGCTTCAGCGTTCTTCGGAATGTCGCGCATTGGCATGGAAGTCACACCTTCGGGAACGTGG
Vac N AAGGAACTGATTACAAACATTGGCCGCAAATTGCACAATTTGCCCCCAGCGCTTCAGCGTTCTTCGGAATGTCGCGCATTGGCATGGAAGTCACACCTTCGGGAACGTGG

TTGACCTACACAGGTGCCATCAAATTGGATGACAAAGATCCAAATTTCAAAGATCAAGTCATTTTGCTGAATAAGCATATTGACGCATACATAACATTCCCACCAACAGA
1000
1010
1020
1030
1040
1050
1060
1070
1080
1090
1100
Wild N TTGACCTACACAGGTGCCATCAAATTGGATGACAAAGATCCAAATTTCAAAGATCAAGTCATTTTGCTGAATAAGCATATTGACGCATACATAACATTCCCACCAACAGA
Vac N TTGACCTACACAGGTGCCATCAAATTGGATGACAAAGATCCAAATTTCAAAGATCAAGTCATTTTGCTGAATAAGCATATTGACGCATACAAAACATTCCCACCAACAGA

GCCTAAAAAGGACAAAAAGAAGAAGGCTGATGAAACTCAAGCCTTACCGCAGAGACAGAAGAAACAGCAAACTGTGACTCTTCTTCCTGCTGCAGATTTGGATGATTTCT
1110
1120
1130
1140
1150
1160
1170
1180
1190
1200
1210
Wild N GCCTAAAAAGGACAAAAAGAAGAAGGCTGATGAAACTCAAGCCTTACCGCAGAGACAGAAGAAACAGCAAACTGTGACTCTTCTTCCTGCTGCAGATTTGGATGATTTCT
Vac N GCCTAAAAAGGACAAAAAGAAGAAGGCTGATGAAACTCAAGCCTTACCGCAGAGACAGAAGAAACAGCAAACTGTGACTCTTCTTCCTGCTGCAGATTTGGATGATTTCT

CCAAACAATTGCAACAATCCATGAGCAGTGCTGACTCAACTCAGGCCTAA
1220
1230
1240
1250
1260
Wild N CCAAACAATTGCAACAATCCATGAGCAGTGCTGACTCAACTCAGGCCTAA
Vac N CCAAACAATTGCAACAATCCATGAGCAGTGCTGACTCAACTCAGGCCTAA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

GCCTCGGCAAAAACGTACTGCCACTAAAGCATACAATGTAACACAAGCTTTCGGCAGACGTGGTCCAGAACAAACCCAAGGAAATTTTGGGGACCAGGAACTAATCAGAC
780
790
800
810
820
830
840
850
860
870
880
Wild N GCCTCGGCAAAAACGTACTGCCACTAAAGCATACAATGTAACACAAGCTTTCGGCAGACGTGGTCCAGAACAAACCCAAGGAAATTTTGGGGACCAGGAACTAATCAGAC
Vac N GCCTCGGCAAAAACGTACTGCCACTAAAGCATACAATGTAACACAAGCTTTCGGCAGACGTGGTCCAGAACAAACCCAAGGAAATTTTGGGGACCAGGAACTAATCAGAC

CACATAG
Wild ORF10 CACATAG
Vac ORF10 CACATAG

Fig. S9. Nucleotide alignment of cold-adapted live attenuated SARS-CoV-2 vaccine strain. Full nucleotide sequences of coldadapted live attenuated SARS-CoV-2 vaccine strain (CoV-2-CNUHV 03-CA22℃) were aligned with that of wild-type SARS- CoV-2
(CoV-2-CNUHV03) using DNASTAR Lasergene.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ATGGGCTATATAAACGTTTTCGCTTTTCCGTTTACGATATATAGTCTACTCTTGTGCAGAATGAATTCTCGTAACTACATAGCACAAGTAGATGTAGTTAACTTTAATCT
10
20
30
40
50
60
70
80
90
100
110
Wild ORF10 ATGGGCTATATAAACGTTTTCGCTTTTCCGTTTACGATATATAGTCTACTCTTGTGCAGAATGAATTCTCGTAACTACATAGCACAAGTAGATGTAGTTAACTTTAATCT
Vac ORF10 ATGGGCTATATAAACGTTTTCGCTTTTCCGTTTACGATATATAGTCTACTCTTGTGCAGAATGAATTCTCGTAACTACATAGCACAAGTAGATGTAGTTAACTTTAATCT

VGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLD
120
130
140
150
160
170
180
190
200
210
220
Wild ORF1ab VGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLD
Vac ORF1ab VGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLD

FIDTKRGVYCCRGHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETS
230
240
250
260
270
280
290
300
310
320
330
Wild ORF1ab FIDTKRGVYCCRGHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETS
Vac ORF1ab FIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETS

WQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVG
340
350
360
370
380
390
400
410
420
430
440
Wild ORF1ab WQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVG
Vac ORF1ab WQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVG

EGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSR
450
460
470
480
490
500
510
520
530
540
550
Wild ORF1ab EGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSR
Vac ORF1ab EGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSR

TLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIV
560
570
580
590
600
610
620
630
640
650
660
Wild ORF1ab TLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIV
Vac ORF1ab TLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIV

GGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPT
670
680
690
700
710
720
730
740
750
760
770
Wild ORF1ab GGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPT
Vac ORF1ab GGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVVVELVAELEGIQYGRSGETLGVLVPH
10
20
30
40
50
60
70
80
90
100
110
Wild ORF1ab MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPH
Vac ORF1ab MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPH---VVELVAELEGIQYGRSGETLGVLVPH

KTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQ
890
900
910
920
930
940
950
960
970
980
990
Wild ORF1ab KTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQ
Vac ORF1ab KTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQ

QDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVG
1000
1010
1020
1030
1040
1050
1060
1070
1080
1090
1100
Wild ORF1ab QDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVG
Vac ORF1ab QDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVG

GSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEE
1110
1120
1130
1140
1150
1160
1170
1180
1190
1200
1210
Wild ORF1ab GSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYNKLVSSFLEMKSEKQVEQKIAEIPKEE
Vac ORF1ab GSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEE

VKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKV
1220
1230
1240
1250
1260
1270
1280
1290
1300
1310
1320
Wild ORF1ab VKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKV
Vac ORF1ab VKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKV

PTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTT
1330
1340
1350
1360
1370
1380
1390
1400
1410
1420
1430
Wild ORF1ab PTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTT
Vac ORF1ab PTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTT

VASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSN
1440
1450
1460
1470
1480
1490
1500
1510
1520
1530
1540
Wild ORF1ab VASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSN
Vac ORF1ab VASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSN

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

SEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVI
780
790
800
810
820
830
840
850
860
870
880
Wild ORF1ab SEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVI
Vac ORF1ab SEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVI

NHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQT
1660
1670
1680
1690
1700
1710
1720
1730
1740
1750
1760
Wild ORF1ab NHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQT
Vac ORF1ab NHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQT

TLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKE
1770
1780
1790
1800
1810
1820
1830
1840
1850
1860
1870
Wild ORF1ab TLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKE
Vac ORF1ab TLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKE

NSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPSASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFK
1880
1890
1900
1910
1920
1930
1940
1950
1960
1970
1980
Wild ORF1ab NSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPSASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFK
Vac ORF1ab NSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFK

KGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEV
1990
2000
2010
2020
2030
2040
2050
2060
2070
2080
2090
Wild ORF1ab KGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEV
Vac ORF1ab KGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEV

GHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAK
2100
2110
2120
2130
2140
2150
2160
2170
2180
2190
2200
Wild ORF1ab GHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAK
Vac ORF1ab GHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAK

NTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQIT
2210
2220
2230
2240
2250
2260
2270
2280
2290
2300
2310
Wild ORF1ab NTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQIT
Vac ORF1ab NTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQIT

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

PTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVGMSMTYGQQFGPTYFDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSAL
1550
1560
1570
1580
1590
1600
1610
1620
1630
1640
1650
Wild ORF1ab PTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVGMSMTYGQQFGPTYFDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSAL
Vac ORF1ab PTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYFDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSAL

VECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRAN
2430
2440
2450
2460
2470
2480
2490
2500
2510
2520
2530
Wild ORF1ab VECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRAN
Vac ORF1ab VECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRAN

NTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQG
2540
2550
2560
2570
2580
2590
2600
2610
2620
2630
2640
Wild ORF1ab NTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQG
Vac ORF1ab NTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQG

FVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQV
2650
2660
2670
2680
2690
2700
2710
2720
2730
2740
2750
Wild ORF1ab FVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQPRKQIRSAAKKNNLPFKLTCATTRQV
Vac ORF1ab FVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQV

VNAVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITR
2760
2770
2780
2790
2800
2810
2820
2830
2840
2850
2860
Wild ORF1ab VNAVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITR
Vac ORF1ab VNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITR

EVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLE
2870
2880
2890
2900
2910
2920
2930
2940
2950
2960
2970
Wild ORF1ab EVGFVVPGLPSTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLE
Vac ORF1ab EVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLE

GSVRVVTTFDSEYCGHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAF
2980
2990
3000
3010
3020
3030
3040
3050
3060
3070
3080
Wild ORF1ab GPVRVVTTFDSEYCGHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAF
Vac ORF1ab GSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAF

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

ISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLAQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATR
2320
2330
2340
2350
2360
2370
2380
2390
2400
2410
2420
Wild ORF1ab ISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLAQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATR
Vac ORF1ab ISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATR

LKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVY
3200
3210
3220
3230
3240
3250
3260
3270
3280
3290
3300
Wild ORF1ab LKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVY
Vac ORF1ab LKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVY

CPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGS
3310
3320
3330
3340
3350
3360
3370
3380
3390
3400
3410
Wild ORF1ab CPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGS
Vac ORF1ab CPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGS

VGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQT
3420
3430
3440
3450
3460
3470
3480
3490
3500
3510
3520
Wild ORF1ab VGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQT
Vac ORF1ab VGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQT

GIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVK
3530
3540
3550
3560
3570
3580
3590
3600
3610
3620
3630
Wild ORF1ab GIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVK
Vac ORF1ab GIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYEKAFLPFAMGIIAMSAFAMMFVK

HKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVITSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISV
3640
3650
3660
3670
3680
3690
3700
3710
3720
3730
3740
Wild ORF1ab HKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVITSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISV
Vac ORF1ab HKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVITSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISV

TSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGK
3750
3760
3770
3780
3790
3800
3810
3820
3830
3840
3850
Wild ORF1ab TSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGK
Vac ORF1ab TSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGK

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

NTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMY
3090
3100
3110
3120
3130
3140
3150
3160
3170
3180
3190
Wild ORF1ab NTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMY
Vac ORF1ab NTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMY

QEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKL
3970
3980
3990
4000
4010
4020
4030
4040
4050
4060
4070
Wild ORF1ab QEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKL
Vac ORF1ab QEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKL

MVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRF
4080
4090
4100
4110
4120
4130
4140
4150
4160
4170
4180
Wild ORF1ab MVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRF
Vac ORF1ab MVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRF

VLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQP
4190
4200
4210
4220
4230
4240
4250
4260
4270
4280
4290
Wild ORF1ab VLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQP
Vac ORF1ab VLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQP

ITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFL
4300
4310
4320
4330
4340
4350
4360
4370
4380
4390
4400
Wild ORF1ab ITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFL
Vac ORF1ab ITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFL

NRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQR
4410
4420
4430
4440
4450
4460
4470
4480
4490
4500
4510
Wild ORF1ab NRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQR
Vac ORF1ab NRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQR

LTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNRYDFGDFIQTTPG
4520
4530
4540
4550
4560
4570
4580
4590
4600
4610
4620
Wild ORF1ab LTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNRYDFGDFIQTTPG
Vac ORF1ab LTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

PCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVAINKLCEEMLDNRATLQAIASEFSSLPSYAAFATA
3860
3870
3880
3890
3900
3910
3920
3930
3940
3950
3960
Wild ORF1ab PCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATA
Vac ORF1ab PCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVAINKLCEEMLDNRATLQAIASEFSSLPSYAAFATA

PFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGSFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNA
4740
4750
4760
4770
4780
4790
4800
4810
4820
4830
4840
Wild ORF1ab PFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGSFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNA
Vac ORF1ab PFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNA

AISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVA
4850
4860
4870
4880
4890
4900
4910
4920
4930
4940
4950
Wild ORF1ab AISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVA
Vac ORF1ab AISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVA

GVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVM
4960
4970
4980
4990
5000
5010
5020
5030
5040
5050
5060
Wild ORF1ab GVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVM
Vac ORF1ab GVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVM

CGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAAVCFNSTYASQGLVAS
5070
5080
5090
5100
5110
5120
5130
5140
5150
5160
5170
Wild ORF1ab CGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAAVCFNSTYASQGLVAS
Vac ORF1ab CGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVAS

IKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYI
5180
5190
5200
5210
5220
5230
5240
5250
5260
5270
5280
Wild ORF1ab IKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYI
Vac ORF1ab IKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYI

RKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLG
5290
5300
5310
5320
5330
5340
5350
5360
5370
5380
5390
Wild ORF1ab RKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLG
Vac ORF1ab RKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLG

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

SGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGV
4630
4640
4650
4660
4670
4680
4690
4700
4710
4720
4730
Wild ORF1ab SGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGV
Vac ORF1ab SGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGV

NRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGT
5510
5520
5530
5540
5550
5560
5570
5580
5590
5600
5610
Wild ORF1ab NRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGT
Vac ORF1ab NRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTFQGPPGT

GKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHY
5620
5630
5640
5650
5660
5670
5680
5690
5700
5710
5720
Wild ORF1ab GKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHY
Vac ORF1ab GKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHY

VYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAW
5730
5740
5750
5760
5770
5780
5790
5800
5810
5820
5830
Wild ORF1ab VYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAW
Vac ORF1ab VYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAW

RKAVFISPYNSQNAVASKVLGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVI
5840
5850
5860
5870
5880
5890
5900
5910
5920
5930
5940
Wild ORF1ab RKAVFISPYNSQNAVASKVLGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVI
Vac ORF1ab RKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVI

TGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYV
5950
5960
5970
5980
5990
6000
6010
6020
6030
6040
6050
Wild ORF1ab TGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYV
Vac ORF1ab TGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYV

DTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDY
6060
6070
6080
6090
6100
6110
6120
6130
6140
6150
6160
Wild ORF1ab DTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDY
Vac ORF1ab DTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDY

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

GMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPL
5400
5410
5420
5430
5440
5450
5460
5470
5480
5490
5500
Wild ORF1ab GMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPL
Vac ORF1ab GMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPL

VEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESH
6280
6290
6300
6310
6320
6330
6340
6350
6360
6370
6380
Wild ORF1ab VEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESH
Vac ORF1ab VEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESH

GKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGV
6390
6400
6410
6420
6430
6440
6450
6460
6470
6480
6490
Wild ORF1ab GKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGV
Vac ORF1ab GKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGV

DVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSV
6500
6510
6520
6530
6540
6550
6560
6570
6580
6590
6600
Wild ORF1ab DVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSV
Vac ORF1ab DVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSV

KGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRF
6610
6620
6630
6640
6650
6660
6670
6680
6690
6700
6710
Wild ORF1ab KGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRF
Vac ORF1ab KGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRF

KESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLL
6720
6730
6740
6750
6760
6770
6780
6790
6800
6810
6820
Wild ORF1ab KESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLL
Vac ORF1ab KESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLL

EKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMY
6830
6840
6850
6860
6870
6880
6890
6900
6910
6920
6930
Wild ORF1ab EKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMY
Vac ORF1ab EKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMY

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

VYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQAD
6170
6180
6190
6200
6210
6220
6230
6240
6250
6260
6270
Wild ORF1ab VYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQAD
Vac ORF1ab VYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQAD

SLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN7050
7060
7070
7080
7090
Wild ORF1ab SLFDMSKFPLKLRGTAVMPLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN.
Vac ORF1ab SLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

DPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSY
6940
6950
6960
6970
6980
6990
7000
7010
7020
7030
7040
Wild ORF1ab DPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLCSY
Vac ORF1ab DPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSY

DSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKGWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGKFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGF
120
130
140
150
160
170
180
190
200
210
220
Wild S DSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKGWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGKFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGF
Vac S DSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGKFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGF

SALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFP
230
240
250
260
270
280
290
300
310
320
330
Wild S SALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFP
Vac S SALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFP

NITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNN
340
350
360
370
380
390
400
410
420
430
440
Wild S NITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNN
Vac S NITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNN

LDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTG
450
460
470
480
490
500
510
520
530
540
550
Wild S LDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTG
Vac S LDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTG

VLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
560
570
580
590
600
610
620
630
640
650
660
Wild S VLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
Vac S VLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY

ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGI
670
680
690
700
710
720
730
740
750
760
770
Wild S ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGI
Vac S ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGI

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPSNDGVYFASIGKSNIIRGWIFGTTL
10
20
30
40
50
60
70
80
90
100
110
Wild S MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYCPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPSNDGVYFASIGKSNIIRGWIFGTTL
Vac S MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTL

TITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSANFGAISSVLNDILSRLDKVEAE
890
900
910
920
930
940
950
960
970
980
990
Wild S TITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAE
Vac S TITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSANFGAISSVLNDILSRLDKVEAE

VQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGT
1000
1010
1020
1030
1040
1050
1060
1070
1080
1090
1100
Wild S VQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGT
Vac S VQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGT

HWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI
1110
1120
1130
1140
1150
1160
1170
1180
1190
1200
1210
Wild S HWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI
Vac S HWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI

KWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT1220
1230
1240
1250
1260
1270
Wild S KWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT.
Vac S KWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

AVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAG
780
790
800
810
820
830
840
850
860
870
880
Wild S AVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAG
Vac S AVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAG

LVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNCYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLS
120
130
140
150
160
170
180
190
200
210
220
Wild ORF3a LVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNCYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLS
Vac ORF3a LVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNCYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLS

TDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL230
240
250
260
270
Wild ORF3a TDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL.
Vac ORF3a TDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYA
10
20
30
40
50
60
70
80
90
100
110
Wild ORF3a MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYA
Vac ORF3a MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYA

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNIVNVSLVKPSFYVYSRVKNLNSSRVPDLLV10
20
30
40
50
60
70
Wild E MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNIVNVSLVKPSFYVYSRVKNLNSSRVPDLLV.
Vac E MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNIVNVSLVKPSFYVYSRVKNLNSSRVPDLLV.

SFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALL
120
130
140
150
160
170
180
190
200
210
220
Wild M SFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALL
Vac M SFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALL

VQWild M VQ.
Vac M VQ.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNRFLYIIKLIFLWLLWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMW
10
20
30
40
50
60
70
80
90
100
110
Wild M MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNRFLYIIKLIFLWLLWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMW
Vac M MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNRFLYIIKLIFLWLLWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMW

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MFHLVDFQVTIAEILLIIMRTFKVSIWNLDYIINLIIKNLSKSLTENKYSQLDEEQPMEID10
20
30
40
50
60
Wild ORF6 MFHLVDFQVTIAEILLIIMRTFKVSIWNLDYIINLIIKNLSKSLTENKYSQLDEEQPMEID.
Vac ORF6 MFHLVDFQVTIAEILLIIMRTFKVSIWNLDYIINLIIKNLSKSLTENKYSQLDEEQPMEID.

TLCFTLKRKTE120
Wild ORF7a TLCFTLKRKTE.
Vac ORF7a TLCFTLKRKTE.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSSGTYEGNSPFHPLADNKFALTCFSTQFAFAYPDGVKHVYQLRARSVSPKLFIRQEEVQELYSPIFLIVAAIVFI
10
20
30
40
50
60
70
80
90
100
110
Wild ORF7a MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSSGTYEGNSPFHPLADNKFALTCFSTQFAFAYPDGVKHVYQLRARSVSPKLFIRQEEVQELYSPIFLIVAAIVFI
Vac ORF7a MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSSGTYEGNSPFHPLADNKFALTCFSTQFAFACPDGVKHVYQLRARSVSPKLFIRQEEVQELYSPIFLIVAAIVFI

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MIELSLIDFYLCFLAFLLFLVLIMLIIFWFSLELQDHNETCHA10
20
30
40
Wild ORF7b MIELSLIDFYLCFLAFLLFLVLIMLIIFWFSLELQDHNETCHA.
Vac ORF7b MIELSLIDFYLCFLAFLLFLVLIMLIIFWFSLELQDHNETCHA.

YHDVRVVLDFI120
wild ORF8 YHDVRVVLDFI.
Vac ORF8 YHDVRVVLDFI.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MKFLVFLGIITTVAAFHQECSLQSCTQHQPYVVDDPCPIHFYSKWYIRVGARKSAPLIELCVDEAGSKSPIQYIDIGNYTVSCSPFTINCQEPKLGSLVVRCSFYEDFLE
10
20
30
40
50
60
70
80
90
100
110
wild ORF8 MKFLVFLGIITTVAAFHQECSLQSCTQHQPYVVDDPCPIHFYSKWYIRVGARKSAPLIELCVDEAGSKSPIQYIDIGNYTVSCSPFTINCQEPKLGSLVVRCSFYEDFLE
Vac ORF8 MKFLVFLGIITTVAAFHQECSLQSCTQHQPYVVDDPCPIHFYSKWYIRVGARKSAPLIELCVDEAGSKSPIQYIDIGNYTVSCSPFTINCQEPKLGSLVVRCSFYEDFLE

YYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALA
120
130
140
150
160
170
180
190
200
210
220
Wild N YYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALA
Vac N YYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALA

LLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTW
230
240
250
260
270
280
290
300
310
320
330
Wild N LLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTW
Vac N LLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTW

LTYTGAIKLDDKDPNFKDQVILLNKHIDAYITFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA340
350
360
370
380
390
400
410
420
Wild N LTYTGAIKLDDKDPNFKDQVILLNKHIDAYITFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA.
Vac N LTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYF
10
20
30
40
50
60
70
80
90
100
110
Wild N MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYF
Vac N MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYF

Fig. S10. Amino acid alignment of cold-adapted live attenuated SARS-CoV-2 vaccine strain. Full amino acidsequences of cold
-adapted live attenuated SARS-CoV-2 vaccine strain (CoV-2-CNUHV03-CA22℃) were aligned with that of wild-type SARS-CoV
-2 (CoV-2-CNUHV03) using DNASTAR Lasergene.

bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235689; this version posted August 4, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

MGYINVFAFPFTIYSLLLCRMNSRNYIAQVDVVNFNLT10
20
30
Wild ORF10 MGYINVFAFPFTIYSLLLCRMNSRNYIAQVDVVNFNLT.
Vac ORF10 MGYINVFAFPFTIYSLLLCRMNSRNYIAQVDVVNFNLT.

